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Abstract 
This thesis presents a dual pronged approach to understanding malaria through the use 
of mathematical models. We present models both of infection within the host and of the 
immune response in the vector. 
The within host malaria model explores effects of the parasite's preference for young 
cells and the replacement rate of red blood cells (RBCs). We quantify the preference of 
the P. berghei parasite for young RBCs at 150 fold over older cells and deduce that the 
production of new cells is not suppressed during this rodent malaria infection. By 
altering the model slightly we apply it to a human malaria infection, and predict an 
optimal rate of RBC replacement during a malaria infection. This optimal rate is 
dependent on the preference of the parasite for younger cells and is generally far lower 
than the "healthy" replacement rate. This observation can explain experimental findings 
that iron deficient and anaemic children are less susceptible to malaria whilst iron 
supplemented children are more susceptible. 
The work pertaining to the vector response involves a model of cooperative gene 
regulation by two transcription factors. This is of particular relevance to studying the 
mosquito's immune response to the malaria parasite, as the immune genes are believed 
to be regulated by two transcription factors, REL1 and REL2. Using data from wild-
type and knockdown cells we extract the activity profiles of the two transcription 
factors, and predict the sensitivity of target genes to each of the factors. This model 
should aid in understanding the mosquito immune response. 
Overall the thesis presents attempts at modelling the effects of malaria in mice, men and 
mosquitoes. The conclusions we are able to draw from our models provide insight into 
the factors affecting the dynamics of infection and form as a basis on which further 
studies can be built. 
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Chapter 1 
Introduction 
This work is an attempt to gain further insight into the dynamics of a malaria infection 
using mathematical modelling techniques. We present a dual pronged approach towards 
understanding infection and tackle the problem by first modelling the infection within 
the human / animal host, and then modelling the mosquito immune response. This dual 
pronged approach is similar to that which is being taken more globally in the fight 
against malaria. General approaches towards malaria control and eradication include 
methods designed to protect the host, as well as those to prevent the mosquito vector 
from transmitting the disease. Host protective approaches consist of ongoing research 
into malaria drugs and vaccines, while vector eradication approaches include research 
into genetically modified mosquitoes that do not transmit the disease. Insecticide treated 
nets are an example of an approach which both protects the host and helps to eliminate 
the vector. Within this thesis we aim to highlight the importance of such a dual pronged 
approach in combating malaria and so present models both of the host and vector 
response to malaria. 
1.1 Modelling the effects of malaria on the human / animal host 
Infection with malaria is commonly associated with severe malarial anaemia (SMA). It 
is currently not known whether this malaria related anaemia stems from a decreased 
production of red blood cells (RBCs), an increased destruction of RBCs or a 
combination of these factors. By creating a mathematical model of red blood cell 
production, infection and destruction during malaria we can consider the ramifications 
of different levels of red blood cell production and their effect on parasite growth. An 
important factor in this consideration is the preference of the parasite for younger cells. 
We include this preference in our model and analyse its effect. 
We first use our model to determine whether we can find evidence for erythropoietic 
suppression (lowered red cell production) during murine infection with P. berghei (a 
strain of mouse malaria) and quantify the preference of the P. berghei parasite for 
reticulocytes (young RBCs). We subsequently extend the model to consider more 
generally the effects both of different compensatory responses to anaemia and of the 
preference of malaria parasite for younger cells on the dynamics of a malaria infection. 
-19- 
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For this we construct a structured integro-differential equation model which allows us to 
capture the discrete processes of reticulocyte maturation and parasite rupture, as well as 
the more continuous processes of parasite growth and red cell decay. We later show that 
a continuous differential equation model provides similar (but less exact) solutions to 
the structured model. 
The work relating to this theme is divided into three sections. The first section is 
contained in Chapter 3, and is a body of work which was published in the International 
Journal for Parasitology in July 2006 (Cromer et al., 2006). We apply our model for red 
blood cell production, destruction and parasitisation to data obtained from mice infected 
with the P. berghei strain of rodent malaria (Evans et al., 2006). We use the model to 
quantify the preference of the P. berghei parasite for invading reticulocytes (young red 
blood cells) at around 150 fold over invading erythrocytes (older red blood cells). 
Although it was previously known that P. berghei preferentially invades reticulocytes, 
to the best of our knowledge the extent of this preference had not been quantified. 
Having quantified the preference of the parasite for reticulocytes, we are also able to use 
our model to consider red blood cell replacement during a P. berghei infection. 
Previously it has been reported that the level of erythropoiesis during a rodent malaria 
infection may not be appropriate for the degree of anaemia (Maggio-Price et al., 1985, 
Chang et al., 2004a). We use our model to compare reticulocyte counts during a 
P. berghei infection with those obtained during Phenylhydrazine (PHZ) induced 
anaemia (a chemically induced anaemia caused by oxidation of the erythrocyte 
membrane). Once the strong preference of P. berghei for reticulocytes is taken into 
account, we are able to show that the erythropoietic response during the latter stage of 
P. berghei infection is in fact similar to that induced after treatment with PHZ and so is 
appropriate for the degree of anaemia. 
The second section (contained in Chapter 4) encompasses work which has been 
submitted for publication. We extend the model from Chapter 3 so that it is self 
contained. We are then able to use the model to analyse the effects that parameter 
variations have on clinical disease. We consider four markers of disease severity: Acute 
and long term levels of anaemia; and maximum and equilibrium parasite levels. By 
varying what we term the "reticulocyte replacement rate" (RRR) and parasite preference 
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for reticulocytes during an infection we are able to show that associated with each 
preference level is a threshold RRR. Increasing the RRR above this threshold level 
(which is usually below the "normal" RRR) confers no benefit to the patient (in terms of 
the four disease severity makers listed above). This work shows that the lower than 
normal RRR seen in some patients during a malaria infection (Abdalla et al., 1980) 
could in fact be a host protective effect. 
A third section in Chapter 5 analyses the behaviour of an ordinary differential equation 
(ODE) model based on the more complex integro-differential equation model presented 
in Chapter 4. Although the ODE model does not achieve the same accuracy as the 
earlier model we show that qualitatively similar behaviour is obtained. We find 
equilibrium solutions to the ODE model and show that the long term effects of altering 
the red blood cell replacement rate and preference of the parasite for reticulocytes are 
not consequences of the model complexity, but are behaviours which are evident even 
in a simplified ODE model. We also integrate the differential equation model 
numerically and show that it displays a similar threshold RRR (which minimises 
anaemia during acute infection) to the earlier, more complex model. 
1.2 Modelling the immune response of the mosquito to a malaria 
infection 
In response to an infected blood meal, parasite forms develop in the mosquito and enter 
the mosquito midgut. This initiates an innate immune response in the mosquito which 
attempts to eliminate the parasite. The immune response is partially successful and 
removes 90-99% of the early parasite forms (Christophides et al., 2004); however the 
few remaining parasites that develop and migrate to the salivary glands of the mosquito 
are sufficient to infect a host during the mosquito's next feed. 
It is postulated that two transcription factors, REL1 and REL2 (the mosquito homologs 
of members of the NF-x13 family), are involved in regulating genes that are responsible 
for the mosquito immune response against the parasite. It is unclear however, which (if 
any) genes are exclusively downstream of each of these transcription factors, and how 
the transcription factors might cooperate to regulate gene transcription. We develop and 
apply a mathematical model involving cooperative transcription factors to elicit 
information about the temporal profiles of REL1 and REL2 following infection, and to 
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determine genes that are sensitive to each of the transcription factors. This knowledge 
should aid in understanding the mosquito immune system, and thus in the fight to 
control the parasite within the mosquito vector. 
The work on this theme is divided into two sections. The first section (presented in 
Chapter 6) provides a general model with which we can analyse cooperative gene 
transcription. This model can be applied to any system in which there are two 
transcription factors involved in regulating the same genes. The second section, in 
chapter 7, applies the model both to published and to specifically generated gene 
expression data from mosquitoes in response to challenge. By applying the model to 
experimental data we are able to elicit information on the activity profiles of REL1 and 
REL2. 
The model presented in chapter 6 is a significant extension to the model for gene 
transcription proposed by Barenco et. al. (Barenco et al., 2006). Their model succeeds 
in eliciting the temporal profile and targets of one transcription factor, p53. We extend 
their work to model the profiles and targets of two transcription factors that may 
cooperatively regulate the same gene(s). Our enhanced model requires data from both 
wild-type cells and cells that have been knocked down for one or more of the 
transcription factors of interest. 
We first apply our model to simulated data with a reasonable amount of added 
measurement error. In so doing we show that the model is capable of extracting good 
estimates for the activity profiles of both transcription factors. We also extract estimates 
for the efficacy of each knock-down of the active transcription factors, something that 
cannot be done using conventional measurement techniques. Finally we are able to 
determine genes that are more sensitive to one or the other of the transcription factors 
and pick out genes that are cooperatively regulated by the two transcription factors. 
In chapter 7 we apply the general model developed in chapter 6 to two different sets of 
experimental data from mosquitoes. The first set considers the response of whole 
mosquitoes to Plasmodium challenge while the second considers the response of 
mosquito cell lines to challenge with peptidoglycan. Both sets contain data from wild-
type mosquitoes / cells as well as ones knocked down for REL1, REL2 and both of 
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REL1 and REL2. We estimate the efficacy of the knock-downs for each experimental 
dataset and show that REL2 is more effectively knocked down than REL1. We also 
hypothesise, based on our modelling, that active levels of REL2 may oscillate, while 
REL1 may display a more stable profile. Further experimental work is necessary to 
confirm these results. 
Chapter 2 
Biological and Modelling Background 
2.1 Burden of Disease 
Malaria is one of the World Health Organisation's (WHO) "Big 3" diseases (HIV and 
Tuberculosis are the other two) that are responsible for the greatest number of deaths 
worldwide (from a specific disease). In the 1997 WHO report malaria still eclipsed HIV 
in the number of deaths per year (WHO, 1997) and it was not until the 1998 WHO 
report that HIV deaths overtook malaria deaths (WHO, 1998). Current estimates for the 
global malaria burden rely on data from 2002 and estimate that nearly 1.3 million 
people die from malaria each year, with over 1.1 million of these deaths occurring in 
Africa (WHO, 2004). The majority of deaths are in children under the age of 5. An 
estimated 3.2 billion people are exposed to malaria (WHO, 2005) with between 300 and 
660 million clinical episodes occurring annually (WHO, 2005, Snow et al., 2005). The 
majority of these episodes occur in Africa, with significant numbers also occurring in 
South America and Asia (Snow et al., 2005). Recently efforts have been under way to 
better map global malaria risk and spatial limits as it is believed that the reporting of the 
malaria burden from many countries is an underestimate (Hay and Snow, 2006, Hay et 
al., 2004, Snow et al., 2005). 
2.1.1 Genetic selection of the parasite 
Malaria has exerted significant evolutionary pressure on the human genome. It's 
selective pressure was recognised by Haldane as early as 1948, in what is now known as 
the malaria hypothesis (Haldane, 1948), which predicts that a+ thalassemia is prevalent 
in the African population due to its protective effects against malaria. The best known 
example of malarial genetic selection is the prevalence of the gene for sickle cell 
anaemia (HbS) in the African population (Allison, 1954). Homozygotes of HbS suffer 
from sickle cell anaemia and increased risk of morbidity and mortality however 
heterozygotes are afforded a 10 fold reduction in risk of severe malarial disease 
(Ackerman et al., 2005). 
There are many other genetic disorders which have been selected for in malaria endemic 
regions that have been found to be protective against malaria. Examples of these are 
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G6PD deficiency (Ganczakowski et al., 1995, Kaneko et al., 1998) and a+-thalassemia 
(Flint et al., 1986, Haldane, 1948). In what is possibly a similar selection process most 
of the African population are Duffy blood group negative (Hamblin and Di Rienzo, 
2000). Since P. vivax can only invade Duffy antigen positive red blood cells (Miller et 
al., 1976) they are not susceptible to this strain and as a result there are very few areas 
of Africa where P. vivax is prevalent. 
2.2 The Malaria Life Cycle 
The complete malaria life cycle takes place in both the human (or animal) host and the 
mosquito vector (Figure 2.1). The development of malaria is similar in all vertebrate 
species and so the description given in this section applies to all host species. The aim 
of this review is to understand human malaria infections, and thus we will refer to the 
host as a human host, and use parameters of infection applicable to humans. 
Interaction between humans and mosquitoes is required for malaria transmission. The 
sexual stage of the malaria parasite's reproduction occurs inside the mosquito and only 
asexual replication of the parasite occurs within the host. These stages are depicted in 
Figure 2.1 and described in sections 2.2.2 and 2.2.3. It is interesting to note that 
although the mosquito is generally considered to be the vector of the disease and the 
human considered to be the host, this is perhaps a misrepresentation considering that 
sexual reproduction occurs inside the mosquito. 
2.2.1 Species of malaria 
Malaria results from protozoan (unicellular, eukaryote) parasites of the genus 
Plasmodium. There are four main species of malaria which infect humans. These are 
Plasmodium fakiparum, Plasmodium vivax, Plasmodium ovale and Plasmodium 
malariae. In addition, it has been reported that Plasmodium knowlesi (a monkey 
malaria) is now capable of infecting humans (Cox-Singh et al., 2008). In general the 
first word Plasmodium is shortened to P. and so, for example, Plasmodium falciparum 
is expressed as P. falciparum. 
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Figure 2.1 Lifecycle of malaria in the human host and mosquito vector 
(Image courtesy of the CDC website for laboratory identification of parasites and 
accessed via: http://www.uni-tuebingen.de/modeling/Mod Malaria Cycle en. html on 
21st January, 2008.) 
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2.2.2 Malaria in the human host 
The bite 
Malaria is transmitted to humans through the bite of an infected female Anopheles 
mosquito. When taking a blood-meal the infected mosquito injects sporozoites from her 
salivary glands into the host, thereby initiating infection. These sporozoites migrate to 
the liver where they invade hepatocytes (liver cells). Sporozoites migrate through a 
number of hepatocytes before finally infecting one (Mota et al., 2001, Mota et al., 
2002). It is thought that the migration through a number of hepatocytes triggers the 
release of hepatocyte growth factor which renders the liver cells more susceptible to 
infection (Carrolo et al., 2003, Kappe et al., 2004). 
The liver (exo-erythrocytic) stage 
Inside an infected hepatocyte the parasite forms a schizont and replicates asexually, 
producing thousands of merozoites (the cells which parasitise red blood cells) 
(Prudencio et al., 2006). This is known as exo-erythrocytic schizogony. The schizonts 
rupture on average 6.5 days after infection, releasing 20,000-30,000 merozoites which 
make their way into the blood stream (Moorthy et al., 2004). This begins the 
erythrocytic stage of a malaria infection. 
During a P. vivax or P. ovale infection the development of the liver schizonts may be 
retarded and formation of a dormant form called a hypnozoite can result (Krotoski et al., 
1982). Presence of these hypnozoites for a period of years may result in malarial relapse 
well after the parasite has been cleared from the bloodstream (Lalloo et al., 2007). 
The blood (erythrocytic) stage 
Merozoites invade red blood cells during the erythrocytic stage and undergo asexual 
replication within them. Inside the red cell the parasite progresses through a number of 
stages. The first is known as the ring stage and is so called as when viewed under a 
microscope the parasite resembles a signet ring. After 12-24 hours pigment (haematin) 
begins to appear in the cytoplasm and the parasite expands to occupy a large part of the 
cell. The pigment is the residue of the cell's haemoglobin, which has been digested 
(Garnham, 1988). This enlarged but still single nucleus form of the parasite is known as 
the trophozoite stage. The nucleus then undergoes division to create the schizont which 
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contains 8-32 merozoites (Garnham, 1988). Often the only form of the parasite that is 
visible in peripheral blood is the ring stage, as later stages of the parasite can sequester 
in microvasculature and tissues and so be absent from peripheral blood (Berendt et al., 
1994). Sequestration is advantageous for the parasite as by sequestering it avoids 
passage through the liver and spleen, and so bypasses clearance mechanisms that have 
been activated (Andrews and Lanzer, 2002). 
The parasitised erythrocyte then ruptures releasing merozoites into the blood stream. In 
the case of P. falciparum this occurs two days (48 hours) after the entry of the original 
merozoite into the red blood cell. Merozoites have a very short lifetime outside of an 
erythrocyte (approximately 20 minutes) and either go on to infect new erythrocytes or 
are rapidly cleared. 
Sexual development 
In parallel with the cycle presented above, some ring stage erythrocytes develop to 
produce gametocytes — the sexual form of the parasite - rather than proceeding to form 
trophozoites. This process is known as gametocytogenesis. Both male and female 
gametocytes are taken up by a female mosquito during a blood meal and it is these that 
are responsible for infecting the mosquito. 
2.2.3 Malaria in the mosquito 
Malaria is transmitted by the female anopheles mosquito. The main vector of human 
malaria in Africa is Anopheles gambiae and it is on this vector that much of the research 
into malaria vectors has been carried out (Vlachou and Kafatos, 2005). 
Lifecycle in the mosquito 
The female mosquito ingests gametocytes during a blood meal from an infected 
individual. Sexual reproduction then occurs as the ingested gametocytes transform into 
male and female gametes within the midgut lumen and then combine to form a zygote 
(Vlachou and Kafatos, 2005). Approximately 5-18 hours after ingestion this zygote 
transforms into a single motile ookinete which invades the mosquito midgut by 
traversing through the midgut epithelial cells (Sinden, 2002). As the ookinete is 
traversing through the epithelium the invaded cells undergo apoptosis. 
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On the basal side of the midgut epithelium the ookinete develops into an oocyst. Losses 
in parasite numbers occur at all stages of parasite development within the mosquito 
however some of the most dramatic parasite losses occur during the ookinete's traversal 
of the midgut epithelium and oocyst transformation (Vlachou and Kafatos, 2005). In 
wild-type infection the number of surviving ookinetes may be under ten, however even 
such a small number is sufficient to allow disease transmission. The response of the 
mosquito that causes the parasite losses is discussed in more detail in the section on 
mosquito immunity (section 2.7). 
Over a period of 10-24 days the oocyst undergoes asexual replication, called sporogony, 
dividing approximately once each day (Sinden, 2002, Ghosh et al., 2000). This results 
in thousands of sporozoites being contained within the oocyst. At the end of this period 
the oocyst ruptures releasing sporozoites into the haemolymph of the mosquito. From 
there they migrate to the mosquito salivary gland (Beier and Vanderberg, 1998). The 
sporozoites then reside in the salivary gland until they are injected into a host during a 
blood meal. 
2.3 Combating Malaria 
Since the discovery of the malarial parasite in 1880 (Kitchen, 1949a) malaria has 
evaded attempts at eradication. It now appears that a multi-pronged attack is the best 
approach towards eradicating the disease. Current avenues under research are protection 
of the host, removal of the vector or both. Such a multi-pronged attack is the approach 
presented within this thesis, as we consider models of malaria infection in both the host 
and vector. 
2.3.1 Host Protection 
2.3.1.1 Anti-malarial drugs 
Anti-malarial drugs are fairly effective, and are able to cure all except a few drug 
resistant strains. The drugs act by destroying the parasite in the host and act in a curative 
rather than a prophylactic manner. Cloroquine, a derivative of quinine, was once the 
drug of choice to treat and prevent malaria, however resistance to it has developed 
almost everywhere (except limited areas in Central America, Central Asia and the 
Middle East). Resistance to other drugs, such as Sulfadoxine-Pyrimethamine and 
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Mefloquine (another quinine derivative) is also growing as the use of these drugs 
increases (Bloland, 2001). 
Introduction of combination therapy should increase the effective lifetime of many of 
the drugs and lower the rate of development of drug resistance. Artemisinin based 
combination therapy (ACT) combines anti-malarials with a long half life (such as those 
listed above) with Artemisinin (an extremely effective, fast acting anti-malarial with a 
very short half-life), and has now been introduced in a bid to halt the growing resistance 
to antimalarial drugs. Artemisinin reduces parasite levels by 10000 fold per cycle, 
compared with 100 fold for other antimalarials (White, 1997). Resistance to Artemisinin 
is unlikely to develop as the drug is not present at sub-treatment levels for any 
significant length of time. There are very few parasites not killed by the Artemisinin 
which are exposed to the longer acting drug alone (White et al., 1999) meaning that 
resistance to the longer acting drug is also far les likely to develop. ACT has thus far 
provided a very effective treatment against malaria and helped to stop the spread of 
drug resistance. 
2.3.1.2 Vaccines against malaria 
Despite the significant effort devoted to developing a vaccine against malaria, current 
vaccines are still able to provide only partial protection against the disease and are not 
in widespread use. During natural infection individuals do not acquire sterilizing 
immunity to malaria (Wykes and Good, 2007, Matuschewski and Mueller, 2007). It is 
thus difficult to develop a vaccine which provides complete protection against the 
disease as there is no full natural immunity on which to model it. 
Vaccines can be divided into three broad classes, corresponding to different stages of 
the malaria parasite lifecycle. Pre-erythrocytic vaccines target the liver stage of 
infection and present some of the most advanced vaccination strategies. Blood stage 
vaccines target the erythrocytic stage of infection, while transmission blocking vaccines 
target the sexual stage of the parasite and attempt to block transmission of gametocytes. 
Pre-erythrocytic vaccines 
Pre-erythrocytic vaccines which target the liver stage of infection present one of the 
most promising candidates for a malaria vaccine. This is due to the fact that there is a 
relatively large window of opportunity during which these vaccines can act, combined 
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with the fact that there are relatively few infected hepatocytes to be targeted. In 
addition, the liver stage of infection is not known to exhibit the antigenic variation that 
is seen during the blood stage of infection (Mikolajczak et al., 2007). One barrier to 
targeting the liver stage of infection is that a vaccine must be completely effective, as 
even one remaining infected hepatocyte can give rise to tens of thousands of infectious 
merozoites. 
The most advanced vaccine candidate to date (in terms of progression through clinical 
trials) is the RTS,S/ASO2D malaria vaccine. It is a pre-erythrocytic vaccine which 
combines the circumsporozoite protein (CSP) of P. falciparum with a surface antigen of 
hepatitis B to protect against infection. The CSP antigen protects against hepatocyte 
invasion by parasites while the hepatitis B surface antigen increases the immunogenicity 
of the vaccine. Recent trials of this vaccine have found it to be both safe and well 
tolerated (Aponte et al., 2007) as well as effective. The vaccine was found to reduce 
incidence of clinical malaria by 35% and incidence of severe malaria by 49%. Vaccine 
protection was shown to be sustainable for a period of up to 18 months (Alonso et al., 
2004, Alonso et al., 2005). 
Another vaccination strategy targeting the pre-erythrocytic stage of infection uses whole 
organism vaccines. These vaccines inject whole sporozoites that have been altered so 
that they cannot undergo development within the liver. This was first reported in 1967 
(Nussenzweig et al., 1967) by injecting x-irradiated P. berghei sporozoites into rodents 
with some success. More recently it has been shown that injection of irradiated 
sporozoites into humans can provide sterilizing immunity against P. falciparum 
(Hoffman et al., 2002) by inducing a partial liver stage of infection which does not 
progress to the blood stage. Concerns exist about using irradiated sporozoites to protect 
against infection, as over-irradiation of the sporozoites can prevent them from being 
protective from infection, while under-irradiation can mean that they remain infectious 
and can trigger a blood stage of infection (Mikolajczak et al., 2007). These safety 
concerns may be able to be alleviated through the use of genetically attenuated parasites 
(Mueller et al., 2005) which have been shown to provide complete protection against 
rodent P. berghei infection. 
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Blood Stage Vaccines 
Development is also underway for vaccines that target the blood stage of the parasite 
lifecycle. Support for such a vaccination approach stems from the fact that volunteers 
challenged with low doses of blood stage parasites developed immunity to re-challenge 
(Pombo et al., 2002, Genton and Reed, 2007). Blood stage vaccines target proteins on 
the surface of parasites and infected cells. Many of these vaccines target the merozoite 
surface proteins (MSP), however problems can arise as these proteins have different 
alleles, and a vaccine developed for protection from one allele may not protect against 
other alleles (Fluck et al., 2004). 
It is commonly believed that a single antigen will not be sufficient to provide protection 
against the blood stage of infection, and so vaccines are being developed which 
combine a number of different antigens (Genton and Reed, 2007). Currently the most 
advanced asexual blood stage vaccine is one known as Combination B. This vaccine 
targets MSP-1 and one allele of MSP-2 as well as Ring-infected Erythrocyte Surface 
Antigen (RESA). This vaccine has been shown to reduce parasite density in children 
who have not been pre-treated with sulfadoxine-pyrimethamine by 62% (Genton et al., 
2002). 
Transmission Blocking Vaccines 
Transmission blocking vaccines target the sexual stages of the parasite and prevent 
sexual replication of the parasite occurring in the mosquito. This achieved by the 
provision of antibodies to humans, which are taken up by a mosquito during an infected 
blood meal. These antibodies then halt the sexual stage of development inside the 
mosquito by reacting with parasite antigens (Tsuboi et al., 2003). Current transmission 
blocking vaccines use the P25 protein, occurring on the surface of zygotes and 
ookinetes. Antibodies to another related protein, P28 can also block transmission (Saul, 
2007). A Phase I trial has shown that Pvs25 (the P.vivax version of P25) is effective at 
generating transmission blocking immunity in humans (Malkin et al., 2005). Since the 
level of anti-P25 antibody will not be boosted through infection (as the proteins are not 
expressed in humans) a transmission blocking vaccine will have to provide sufficient 
antibody to provide a continued antibody response (Saul, 2007). 
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2.3.2 Targeting the vector 
Environmental management approaches which aim to eliminate the mosquito vector 
have been used in endemic areas for over 2,000 years (Konradsen et al., 2004) and still 
prove highly effective. They focus on creating unfavourable conditions for mosquito 
reproduction and survival. Examples of such techniques include the draining of swamps 
(Keiser et al., 2005) or introducing a species (such as larvivorous fish) which feed on 
mosquito larvae and so prevent the growth of adult mosquitoes (Ghosh et al., 2005, 
Ghosh and Dash, 2007). Introduction of the insecticide dicholorodiethyltrichloroethane 
(DDT) in 1955 significantly reduced the number of mosquitoes and was effective in 
removing malaria from Europe and North America as well as some parts of South 
America and Asia. Due to environmental campaigns DDT was removed from use in the 
1960's (Carson, 1962). It has recently been reintroduced into the fight against malaria in 
a more limited scope (Weissmann, 2006). 
A far more recent approach to eliminate the mosquito vector involves genetically 
modifying mosquitoes to render them sterile and so force them into extinction (Burt, 
2003). Although little more than a scientific hypothesis at this stage, it is an attractive 
option as removal of the mosquito vector would halt transmission of the disease. The 
potential environmental and ecological effects of mosquito removal in this manner have 
not been reported. 
Work is also underway to produce transgenic mosquitoes that are refractory (resistant) 
to malaria (Ito et al., 2002). Recently refractory mosquitoes have been produced that 
have increased fitness levels when fed on Plasmodium infected blood meals. This 
increased fitness would ensure their survival amongst a population of heavily infected 
hosts, however would not do so in an uninfected population (Marrelli et al., 2007). 
2.3.3 Combination approaches 
Insecticide treated bed nets (ITNs) present a combined approach that both protects the 
host and also targets the vector. These nets have been shown to have a protective effect 
both on individuals using them (Greenwood et al., 2005) and also on an entire 
community even when only a fraction of members use the nets (Hawley et al., 2003). 
The presence of ITNs reduces both the number of mosquitoes and the number of 
infected individuals, thereby lowering the reproductive ratio of the parasite. Recent 
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increase in the availability of ITNs through free distribution has meant that 
approximately two-thirds of children in rural Kenya now sleep under these nets (Noor et 
al., 2007). 
2.4 Pathogenesis of Malaria 
Although malaria is a life threatening illness, causing both morbidity and mortality, a 
large number of infections, are mild and self resolving and do not lead to severe disease. 
It has been estimated that under 0.5% of malaria cases lead to death and only 1-2% lead 
to severe disease (Greenwood et al., 1991). 
A large body of data on the natural course of a malaria infection is available from 
neurosyphilitic patients who were given treatment via malaria therapy. This form of 
treatment was first used by Wagner-Jauregg in 1917 to treat paresis (Wagner-Jauregg, 
1922) who was awarded the Nobel Prize for Medicine in 1927 as a result of his studies 
in the area of malaria therapy. This form of treatment was routinely used in the United 
States to treat neurosyphilis patients from 1931 through to 1963 (Collins and Jeffery, 
1999b, Collins and Jeffery, 1999a). Patients were infected either through inoculation of 
sporozoites or through injections of parasitized red blood cells. Patients were sometimes 
treated with non-curative doses of anti-malarial drugs as required to control the 
infection. Analyses of the course of malaria infections in these patients have provided 
much of the information on the natural course of a malaria infection in humans. 
2.4.1 Initial stage of the disease 
Initial symptoms of both P. falciparum and P. vivax malaria are similar to those of other 
acute infections, and consist of headache, general illness, aches and pains, gastro-
intestinal upsets and periodic low grade fever (Kitchen, 1949a, Kitchen, 1949c). These 
symptoms may be periodic, however that is not always the case (Kitchen, 1949b), and 
the fact that many early symptoms are similar to other infections can make diagnosis 
difficult, if parasites are not yet detectable in the blood. Two markers are used to define 
disease onset. One is the time until detection of parasites, and is called the pre-patent 
period. The second marker is the time until the onset of febrile illness and is called the 
intrinsic incubation period. 
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The average pre-patent period of 428 documented P. vivax cases of malaria during 
malaria therapy was 12.2 days and in 220 induced P. falciparum cases was 11 days. 
Both these periods were on average shorter than the intrinsic incubation period, which 
occurred after 13.4 days and 13.1 days for P. vivax and P. falciparum respectively 
(Kitchen, 1949b). This means that in general parasites were detectable at the time of 
onset of febrile illness. 
2.4.2 Acute stage of disease 
An attack with P. falciparum malaria is characterised by an initial period of clinical 
activity, which typically lasts approximately two weeks. During this period a peak in 
parasitaemia is observed and is accompanied by tertian fevers (Kitchen, 1949a). 
Gametocytes, the sexual stage of the parasite, are generally observed 9-10 days after the 
detection of parasites (Kitchen, 1949a). 
A single strain infection with P. vivax commonly gives rise to periodic fevers, and 
parasite density increases until a maximum density is reached, usually during the second 
week of infection (Kitchen, 1949c). A decrease in parasite density follows the peak as 
the infection is controlled by the host. Periodic fevers continue until the host overcomes 
the parasite (Kitchen, 1949c, Collins et al., 2003). A P. vivax infection may also be 
subject to recrudescences or relapses due to latent forms of the parasite (Kitchen, 
1949c). 
2.4.3 Parasitaemia of malaria 
The primary parasite peak during acute infection with P. falciparum is controlled by the 
host's immune response, and is followed by a series of parasite recrudescences. These 
recrudescences typically occur at 2-3 week intervals and are of decreasing magnitude 
(Collins and Jeffery, 1999b). It is likely that these recrudescences occur as a result of a 
process known as clonal antigenic variation (Gupta, 2005). This is a process whereby 
Plasmodium infected red cells express varying antigens on their surface (termed variant 
surface antigens, or VSAs). These VSAs consist of a family of membrane proteins 
termed Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) and are 
encoded by the var gene family (Newbold, 1999). Patients infected with malaria 
develop variant-specific antibodies directed against the surface antigens currently being 
expressed, along with a more limited antibody response against heterologous surface 
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antigens (Bull et al., 1998). It is likely that following clearance of the primary parasite 
peak, antigenic switching allows for the emergence of a new parasite population against 
which there is only limited non-specific immunity (Brown et al., 1968). Each 
subsequent parasite peak increases to a lower density than the previous parasite 
population due to some conserved immunity (Collins and Jeffery, 1999b). The parasite 
is finally cleared from the system after a number of months (Langhorne et al., 2008, 
Kitchen, 1949a). The process of antigenic variation has also been linked to the 
establishment of chronic infection in P. vivax malaria (del Portillo et al., 2001). 
Similar observations of parasite recrudescence have been made in nulligravid rhesus 
monkeys infected with P. coatneyi. Parasite recrudescence occurred approximately 
every 3.5 weeks, but included intervals as short as 2 weeks (Davison et al., 2005). 
Recrudescences have also been observed in rodent systems infected with P. chabaudi 
(Phillips et al., 1997) and P. berghei (Cox, 1959) as well as rhesus monkeys infected 
with P. knowlesi (Brown et al., 1968, Brown and Brown, 1965) and have all been linked 
with antigenic variation. 
2.4.4 Anaemia of malaria 
Malaria is a significant cause of childhood anaemia (Wickramasinghe and Abdalla, 
2000, Abdalla et al., 1980), and is also an important contributor to anaemia during 
pregnancy. Severe malarial anaemia (discussed below) is associated with P. falciparum 
infection and occurs in under 1% of cases, however mild to moderate anaemia can occur 
during cases of both P. vivax and P. falciparum malaria (Sina, 2002, Mendis et al., 
2001). In one study of approximately 4000 patients presenting with P. falciparum 
malaria, 18% were found to be anaemic (Price et al., 2001), while another study showed 
that 14/20 patients admitted to hospital with P. falciparum malaria were either mildly or 
severely anaemic, and experienced a rise in haemoglobin levels following anti-malarial 
treatment (Abdalla et al., 1980). In a study of 28 patients infected with by P. vivax 
malaria, all but one were found to be anaemic (Rodriguez-Morales et al., 2006). 
Malaria related anaemia is contributed to by the direct parasitisation and rupture of red 
blood cells (Phillips and Pasvol, 1992), but in both P. falciparum and P. vivax malaria 
may also derive from the destruction of uninfected RBCs and their sub-optimal 
replacement (Jakeman et al., 1999, Price et al., 2001, Collins et al., 2003). P. falciparum 
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malaria has been associated with decreases in RBC levels that are up to 90% greater 
than can be accounted for by the rupture of parasitised cells alone (Price et al., 2001, 
Jakeman et al., 1999) and has also been associated with insufficient red cell replacement 
(Abdalla, 1990, Srichaikul et al., 1967). Similarly, a retrospective examination of 
neurosyphilitic patients infected with P. vivax malaria showed a decrease in 
haemoglobin concentration following the first week of infection that was greater than 
could be accounted for due to parasitized cell rupture (Collins et al., 2003), suggesting 
the destruction of uninfected RBCs. Despite a decrease in parasite levels following the 
second week of infection, haemoglobin levels did not recover to pre-infection levels 
during the 11 weeks of parasitaemia that were monitored, suggesting sub-optimal red 
cell replacement.. 
It has been suggested that in fact all untreated cases of P. falciparum malaria show a 
sub-optimal reticulocyte response to anaemia (Wickramasinghe and Abdalla, 2000) and 
that during P. vivax malaria the reticulocyte count is not increased from baseline, 
regardless of the degree of anaemia (Srichaikul et al., 1967). This sub-optimal 
reticulocyte replacement could serve to prolong anaemia. During chronic malaria there 
is an increase in the total erythropoietic activity, however this is often ineffective 
(Wickramasinghe and Abdalla, 2000), although following treatment for P. falciparum 
reticulocyte levels generally increase (Abdalla et al., 1980), and so contribute to red cell 
replacement. 
2.4.5 Febrile Attacks 
All four human malaria strains give rise to recurring fevers. These febrile attacks occur 
as a result of the rupture of infected erythrocytes and the release of merozoites into the 
blood stream (Kitchen, 1949b). The febrile attacks may be irregular initially, before the 
parasitised erythrocytes synchronise their rupturing. Subsequently fevers occur at 
regular intervals as the erythrocytic cycle is synchronised within the host. Parasites in 
P. falciparum and P. ovale infections rupture (thereby inducing fevers) at two day 
intervals and are known as tertian malarias. P. vivax parasites also rupture after 48 
hours, but may exist in two cohorts within the host. Each cohort's developmental cycle 
is separated by 24 hours, and so parasites rupture daily, causing a quotidian fever. If 
only one cohort of parasites exists within the host, then P. vivax also exhibits tertian 
fevers (Kitchen, 1949c). P. malariae is a quartan malaria and has parasites rupturing 
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(and fever occurring) at three day intervals. Of the four strains of malaria, P. falciparum 
is by far the most clinically severe, and gives rise to the symptoms commonly 
associated with malaria, namely cerebral malaria and severe malarial anaemia. 
2.4.6 Severe Malaria 
Severe Malaria is most commonly associated with P. falciparum malaria and occurs in 
1-2% of malaria cases (Greenwood et al., 1991). It typically takes one of two forms —
Cerebral Malaria (CM) or Severe Malarial Anaemia (SMA) (discussed below). Severe 
malaria can also induce respiratory distress, hypoglycaemia, hyperlactataemia, 
metabolic acidosis, prostration, convulsions, jaundice, haemoglobinuria, bleeding 
circulatory collapse and hyperparasitaemia (WHO, 2000). The age profile of severe 
malaria is interesting with SMA commonly occurring in younger children (1-3 years of 
age) and CM occurring in older children (Snow et al., 1997). Also interesting is that the 
risk of severe disease is higher in areas of low transmission than in areas of high 
transmission (Snow et al., 1997). 
2.4.6.1 Cerebral Malaria 
Cerebral malaria (CM) is commonly associated with P. falciparum malaria and affects 
1.12 children out of every 1,000 in sub Saharan Africa (Snow et al., 2003). CM also 
occurs in adults in South East Asia (Hunt et al., 2006) although it is not known if the 
pathogenesis causing the disease in the two groups is the same. The mortality rate from 
CM in children is 18.6% (Newton and Krishna, 1998) and when untreated it leads to 
death 21-79 hours after the onset of coma (Phillips et al., 1986). While the majority of 
recovering CM patients experience no long term neurological damage, up to 11% of 
children who survive the disease experience neurological complications (Newton and 
Krishna, 1998). 
Patients present with a 1-4 day history of fever often combined with headache and 
drowsiness. They also commonly experience convulsions which lead to a coma 
(Newton et al., 2000). The WHO has developed a definition of CM which specifies that 
a patient "is unable to localise a painful stimulus; has peripheral asexual falciparum 
parasitaemia; has no other causes of an encephalopathy" (Newton and Krishna, 1998). 
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There are two main hypotheses as to the cause of CM, the sequestration hypothesis 
(Berendt et al., 1994) and the cytokine hypothesis (Clark and Rockett, 1994). The 
sequestration hypothesis focuses on the fact that during a malarial episode parasitised 
red blood cells sequester in the cerebral microvasculature (and other parts of the 
microvasculature) in order to avoid clearance by the spleen (Newton et al., 2000). This, 
as well as decreased deformability of parasitised red blood cells and the tendency for 
parasitised cells to form rosettes (where parasitised cell and unparasitised cells join 
together), can result in a lack of oxygen and blood flow to the brain (Idro et al., 2005). 
The cytokine theory suggests that the products of schizogony trigger the release of 
cytokines into the blood stream, and that these cytokines can trigger CM (Clark and 
Rockett, 1994), potentially through the generation of Nitric Oxide (NO) which can 
cause coma (Clark et al., 1992). Malaria does trigger the release of proinflammatory 
cytokines (such as TNFa and IL-6), however it has been shown that levels of these 
cytokines are actually lower in CM patients than in patients with other forms of malaria 
(Day et al., 1999). Thus it is unclear whether proinflammatory cytokines are in fact a 
cause of cerebral malaria (Newton et al., 2000). 
2.4.6.2 Severe Malarial Anaemia and Erythropoietic Suppression 
Anaemia is a major complication associated with malaria, and is observed in patients 
infected with both P. falciparum and P. vivax malaria (Wickramasinghe and Abdalla, 
2000). Severe malarial anaemia (SMA) is defined by the WHO as a haemoglobin (Hb) 
level of < 5g/dL in the presence of malaria parasites (WHO, 1990, Menendez et al., 
2000) (normal haemoglobin levels are 12-18g/dL). Mortality rates in children vary with 
geographical region and have been estimated as ranging between 8.1% (low 
transmission areas) and upwards of 13% (high transmission areas) (Murphy and 
Breman, 2001). SMA is also prevalent in pregnant women and has a large effect on 
their mortality rates (Granja et al., 1998, Shulman et al., 1996). 
Many questions remain unanswered about the pathophysiology of SMA (Menendez et 
al., 2000), in large part due to the fact that it can occur as a result of a number of factors 
associated with the disease. A major contributor is the destruction of red blood cells 
(RBCs) due to direct invasion by parasites and their subsequent rupture or clearance 
(Phillips and Pasvol, 1992). However SMA is often far more severe than can be 
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accounted for simply by clearance of infected cells, and it is almost certain that 
destruction of uninfected cells must also contribute to the anaemia. In addition it is 
possible that a reduced erythropoietic response is a cause of SMA. 
Both parasitised and unparasitised cells have been found in the spleens of infected 
patients (Abdalla, 1988), suggesting that clearance of uninfected cells occurs during a 
malaria attack and contributes to the anaemia. It has been estimated that clearance of 
unparasitised RBCs accounts for more than 90% of all cells destroyed (Price et al., 
2001). This has been supported by modelling, with one model suggesting that 
unparasitised RBCs must be cleared at a ratio of 8.5:1 when compared with parasitised 
cells in order to account for the resulting anaemia (Jakeman et al., 1999). 
Reduced RBC deformability during a malaria infection renders uninfected cells more 
likely to be cleared by the spleen (Dondorp et al., 1999). In addition, the 
reticuloendothelial system is upregulated during a malarial attack, increasing the 
numbers of macrophages present to phagocytose both parasitised and unparasitised cells 
(Menendez et al., 2000). Increased cytokine production can also contribute to RBC 
destruction (Ekvall, 2003). Both pro- and anti-inflammatory cytokines are produced 
during a malarial infection, and the balance of these can determine the degree of RBC 
clearance. A high ratio of IL-10 (an anti-inflammatory cytokine) to TNFa (a 
proinflammatory cytokine) has been recorded in cases of malarial anaemia (Othoro et 
al., 1999) and hypothesised to contribute to SMA. 
There has been some evidence of a suppression of the erythropoietic response which 
could contribute to prolonged bouts of anaemia. Evidence for erythropoietic suppression 
includes: (i) results of transcriptional profiling (Sexton et al., 2004), (ii) reduced 
numbers of circulating reticulocytes (young red blood cells) during a malaria infection, 
with a dramatic increase in reticulocytes post treatment (Abdalla et al., 1980) and 
(iii) reduced levels of erythropoietin (EPO), the hormone responsible for production of 
red blood cell precursors in the bone marrow, during a malaria infection (Burgmann et 
al., 1996, el Hassan et al., 1997). This last point has been the subject of debate, with 
some arguing that EPO production during a malaria infection is in fact normal 
(Kurtzhals et al., 1997, Burchard et al., 1995) but that the bone marrow response to EPO 
may be impaired (Kurtzhals et al., 1997). 
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2.5 	Comparison of P. falciparum and P. vivax malaria 
P. falciparum and P. vivax malaria are the two most common strains of malaria 
occurring in humans. P. falciparum is dominant in Africa, while P. vivax predominates 
in outside of Africa (in Asia, Central and South America and the Middle East) (Mendis 
et al., 2001). P. falciparum is by far the more lethal strain, and is the strain most 
commonly associated with both of the complications of severe malaria — Cerebral 
Malaria (CM) and Severe Malarial Anaemia (SMA). Although P. vivax is often 
considered to be the benign form of malaria, recent reports have suggested that its 
severity and impact may be underestimated (Genton et al., 2008, Tjitra et al., 2008, 
Price et al., 2007). 
P. vivax induces more pronounced paroxysms of shorter duration (4-8 hours) than 
uncomplicated P. falciparum (during which paroxysms may extend over 24 hours) 
(Karunaweera et al., 1992, Price et al., 2007, Mendis et al., 2001). It also has a lower 
pyrogenic threshold (Luxemburger et al., 1996) and induces a stronger inflammatory 
response at a lower level of parasitaemia than does P. falciparum (Hemmer et al., 
2006). 
Both P. falciparum and P. vivax show a preference for invading young red blood cells, 
however this preference is far stronger for P. vivax. P. falciparum is capable of invading 
cells of all ages, but has a preference for invading younger cells (Pasvol et al., 1980), 
while P. vivax almost exclusively invades reticulocytes (the youngest form of red blood 
cell) (Mons, 1990). In addition, P. vivax can only invade host cells expressing the Duffy 
antigen. This explains why P. vivax malaria is largely absent from Africa, where the 
majority of the population is Duffy blood group negative (and so do not express the 
Duffy antigen) (Miller et al., 1976). 
The latter stages of P. falciparum parasites sequester into deep tissues (Miller, 1969), 
however the same is not true of a P. vivax infection (Price et al., 2007). Therefore, only 
the early parasite stages are visible during an infection with P. falciparum, while all 
parasite stages are visible in the peripheral blood during a P. vivax infection. It is likely 
that this inability to sequester accounts for many of the differences between the 
pathogenesis of the two strains, and especially explains why P. vivax does not induce 
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cerebral malaria (which is thought to be induced by the sequestration of parasitised 
cells). 
As P. falciparum infected erythrocytes mature they increase in rigidity, which leads to 
increased clearance of these cells by the spleen. Infected erythrocytes therefore avoid 
splenic clearance by sequestration in deep tissues. It is likely that the deformability of 
uninfected RBCs is also reduced during P. falciparum infection, leading to their 
clearance by the spleen (Dondorp et al., 1999) and contributing to anaemia. In contrast, 
erythrocytes infected with P. vivax malaria become progressively more deformable as 
they mature, and so avoid avoiding splenic clearance without the need for sequestration 
(Suwanarusk et al., 2004). 
As discussed above, both P. falciparum and P. vivax strains of malaria can induce 
anaemia, however, the most severe form of anaemia, severe malarial anaemia, is 
classically and most commonly associated with P. falciparum (Newton et al., 1997). 
Recent reports have challenged this dogma, and have suggested that P. vivax may also 
associated with severe anaemia (Genton et al., 2008, Tjitra et al., 2008). 
2.6 Rodent Models of Malaria 
Rodent models have provided many insights into the pathogenesis and immune 
response of a malaria infection. There are four species of rodent malaria, P. berghei, P. 
chabaudi, P. yoelii and P. vinckei, and each of these is able to infect a number of 
different mice strains. Each Plasmodium I mouse strain combination results in slightly 
different disease characteristics and can be used to study various syndromes of human 
malarial disease. 
Some of the key features of the human response to malaria are the febrile response, 
cerebral malaria and severe malarial anaemia. There are no models of febrile response 
in mice (Lamb et al., 2006), however numerous models of the latter two malarial 
outcomes exist. Both P. berghei and P. yoelii can induce cerebral malaria in mice when 
paired with appropriate strains (de Souza and Riley, 2002), and have been instructive in 
the study of CM. P. berghei is the only strain which sequesters in the microvasculature, 
and so has formed the focus of many of the rodent studies of CM. Comparing the 
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Plasmodium / 
Mouse Strain 
Lethal? Cell 
Preference? 
Disease feature modelled 
P. chabaudi 
C57BL/6 No No Resolving anaemia (Chang et al., 2004b) 
ALT Yes No Severe anaemia (Chang et al., 2004b) 
CBA No No Sequestration of infected cells (Mota et al., 
2000) 
P. berghei 
BALB/c Yes Reticulocytes Anaemia with low parasite burden in semi-
immune mice (Evans et al., 2006) 
C57BL/6 and 
CBA 
Yes Reticulocytes Inadequate reticulocyte response (Maggio- 
Price et al., 1985) 
Cerebral Malaria (Amani et al., 1998) 
P. yoelii I7X 
BALB/c No Reticulocytes Removal of uninfected RBCs (Salmon et al., 
1997) 
P. yoelii 17X1, 
BALB/c, Swiss 
and C57BL/6 
Yes No Infected RBC sequestration and adherence 
(Kaul et al., 1998) 
Effects of the spleen on malaria (Weiss, 
1989, Weiss et al., 1989) 
Cerebral Malaria (Hague et al., 2001) 
P. vinckei 
BALB/c Yes Mature cells Inhibition of erythropoiesis (Miller et al., 
1989) 
Table 2.1 Strains of Rodent malaria and their characteristics 
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response of C57BL/6 mice, which are susceptible to CM and produce a strong pro-
inflammatory immune response to the response of BALB/C mice which are not 
susceptible, has allowed researchers to confirm the association between a strong pro-
inflammatory cytokine response and CM (de Kossodo and Grau, 1993). 
Anaemia occurs in all Plasmodium / mouse strain combinations, however severe 
anaemia is restricted to some specific combinations (Table 2.1). Various combinations 
have been used to study different aspects malarial anaemia such as: (i) the effects of 
reticulocytosis on the course of anaemia (Zuckerman, 1957); (ii) insufficient 
erythropoiesis (Maggio-Price et al., 1985, Chang and Stevenson, 2004); (ii) the effect of 
modification of the EPO response (Chang et al., 2004b) and (iv) removal of uninfected 
RBCs (Salmon et al., 1997). 
Some insights into malarial anaemia that have stemmed from mouse models are that 
increasing the reticulocyte response to anaemia can exacerbate anaemia and 
parasitaemia (Chang et al., 2004b, Zuckerman, 1957), while a suppression of the 
reticulocyte response can have protective effects (Ladda and Lalli, 1966, Singer, 1953). 
Mouse models have also contributed to the debate (see section 2.4.6.2 on SMA above) 
about whether the EPO response to anaemia during a malarial episode is sufficient, and 
have added support to human studies that suggest EPO production is normal, however 
the bone marrow response to EPO is suboptimal (Chang et al., 2004a). 
Table 2.1 gives a summary of the different Plasmodium / mouse strain combinations 
and the aspects of disease they have been used to consider. The data in Table 2.1 is 
adapted from Table 1 in (Lamikanra et al., 2007) and Table 1 of (Lamb et al., 2006). 
2.7 Immune Response of the Mosquito to the Parasite 
The passage of the parasite through the mosquito begins with the uptake of gametocytes 
from an infected individual. The sexual reproduction of these gametocytes inside the 
mosquito results in the development of a series of parasite forms. Far from being a 
benign process, these changes in the parasite elicit a response from the mosquito which 
aims to eliminate the growing foreign body (Vlachou and Kafatos, 2005). 
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As mosquitoes do not possess an adaptive immune system, the innate immune response 
is used to combat the parasite. An immune cascade is initiated by the recognition of 
pathogen signatures by pattern recognition receptors (PRRs). The end result of the 
cascade is the nuclear localisation of transcription factors which activate the 
transcription of a number of genes involved in host defence (Christophides et al., 2004). 
The transcription factors believed to be responsible for gene activation in response to 
parasite invasion are REL I and REL2 (Dimopoulos et al., 2001). Both RELI and REL2 
are mosquito homologs of mammalian Nuclear Factor kappa B (NF-KB), which is 
discussed in more detail in section 2.8. 
Certain genes have been shown to be strongly involved in parasite killing, most notably 
TEP I and LRIM1 which are responsible for killing up to 80% of ookinetes (Blandin et 
al., 2004, Osta et al., 2004). However many genes may be involved in the mosquito 
defence, with micro-array studies recently showing that up to 7% of the mosquito 
genome is differentially regulated during infection (Vlachou et al., 2005). Losses of the 
parasite occur during all critical development phases, however major losses are 
experienced during the ookinete to oocyst transition when 90-99% of ookinetes may be 
lost (Christophides et al., 2004). These losses occur during invasion of the mosquito 
midgut (Vlachou and Kafatos, 2005). 
2.8 NF-KB transcription factor family 
NF-KB is a transcription factor present in most cells types. It regulates the transcription 
of many genes involved in immune responses as well as genes involved in 
inflammatory, stress, growth and apoptosis responses (Hoffmann et al., 2002, Covert et 
al., 2005). Five proteins make up mammalian NF-KB, these are ReIA/p65,cRel, Re1B, 
p50 and p52. In Drosophila the NF-KB family of proteins is made up of Dorsal, Diff, 
and Relish while in mosquitoes it consists of REL1 and REL2. NF-KB is held inactive 
in the cytoplasm until a signalling cascade initiates its release from its inhibitor. This 
allows the NF-KB protein to become active and enter the nucleus where it initiates 
transcription. In mammalian cells the inhibitor is a protein called 'KB, in Drosophila it 
is called Cactus while in mosquitoes it is either a protein called CACT, or an ankyrin 
repeat domain on the REL2 protein which must be cleaved before the transcription 
factor REL2 can become active. 
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In mammals two pathways regulate NF-KB activation and are commonly referred to as 
the Toll-like receptor (TLR) pathway and the Tumor necrosis factor receptor (TNF-R) 
pathway. These correspond to two signalling pathways in the insect innate immune 
system, called the Toll and Immune deficiency (IMD) pathways respectively. The 
mammalian TLR pathway is activated when pathogens bind to a member of the Toll-
like receptor family and initiate a signalling cascade leading to the nuclear localisation 
of NF-KB. The Toll signalling pathway in Drosophila, which leads to the activation of 
Dorsal and Diff (Ezekowitz and Hoffmann, 2003, Khush et al., 2001), contains many 
homologs with the mammalian TLR pathway. Dorsal has a mosquito homolog in REL1, 
and the Toll pathway of mosquitoes is thought to be homologous to the TLR signalling 
pathway in mammals (Christophides et al., 2004, Christophides et al., 2002). Thus the 
pathway that activates REL1 in mosquitoes is similar to the mammalian TLR pathway. 
The mammalian TNF-R pathway is activated through the binding of Tumour necrosis 
factor alpha (TNFa) to the TNF receptor. Once again a signalling cascade is activated 
that leads to the nuclear localisation of NF-KB. This pathway is similar to the IMD 
pathway in Drosophila, which leads to the nuclear localisation of Relish (Ezekowitz and 
Hoffmann, 2003, Khush et al., 2001). Components of the Drosophila IMD pathway are 
conserved in mosquitoes, and REL2 is a mosquito homolog of Relish (Christophides et 
al., 2004, Christophides et al., 2002). Thus the pathway activating REL2 is similar to 
the mammalian TNF-R pathway. 
2.9 Epidemiological Modelling of Malaria 
Epidemiological modelling of malaria has a long history, beginning with Ronald Ross 
in the early part of the 20th Century. Following his confirmation of Manson's hypothesis 
that malaria is transmitted by the Anopheles mosquito (Manson, 1898) (for which he 
received the Nobel Prize in Physiology or Medicine in 1902), Ross went on to develop 
epidemiological models of malaria (Ross, 1911) which applied mathematical techniques 
to analyse malaria transmission dynamics. He deduced that a multi-pronged intervention 
strategy would have an increased chance of controlling malaria. He also observed that a 
reduction in the number of mosquitoes below a threshold level would be sufficient to 
combat malaria (Ross, 1911, Ross, 1928, McKenzie and Samba, 2004). 
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In the 1950's Macdonald expanded on Ross' models. By considering the effects of 
various intervention strategies on the basic reproductive rate, he suggested that 
increasing mortality of the mosquito would be an effective strategy to overcome malaria 
(Macdonald, 1956). This conclusion was especially pertinent at a time when the DDT 
malaria eradication campaign was underway. Later, in the 1970's and 1980's 
epidemiological models were expanded upon to include the effect of immunity on 
transmission (Dietz et al., 1974, Molineaux et al., 1978) and consider the effects of 
vaccination on both individuals (Struchiner et al., 1989) and on the population (Halloran 
et al., 1989). 
Epidemiological models are now widely used to model the spread of malaria, and assist 
in predicting the effects of a number of different factors influencing its transmission and 
persistence. Some examples of factors that have been included in models include 
vaccination (Maire et al., 2006c), antigenic diversity (Gupta et al., 1994), indoor 
residual spraying (Worrall et al., 2007), insecticide treated bed nets (Killeen et al., 
2006) and drug resistance (Hastings and Mackinnon, 1998). 
2.10 Within-host Models of Malaria 
Within-host modelling of disease dynamics is a continuously expanding area of 
research. Many deterministic within-host models monitor levels of infected and 
uninfected cell populations as well the levels of a pathogen of interest. Although the 
exact form of the model varies according to the particular pathogen and experimental 
condition, similar three equation models have been used to describe HIV (Herz et al., 
1996, Perelson et al., 1996), hepatitis B (Nowak et al., 1996), hepatitis C (Perelson, 
1999) and malaria (Anderson et al., 1989). This model is described for malaria in 
equations 2.1 - 2.3 below. 
Despite being relatively simple, when combined with appropriate experimental data this 
three equation model has the ability to provide deep insights into disease dynamics. In 
the case of HIV, by combining this model with experimental data the belief that HIV 
was a slow growing infection developing over a time scale of years was shown to be 
incorrect. Instead it was shown that virus is rapidly produced with a half life of only a 
couple of days (Wei et al., 1995, Ho et al., 1995). This realisation has altered treatment 
of the disease and dramatically extended life expectancy (Perelson and Nelson, 1999). 
Chapter 2: Biological and Modelling Background 	 - 48 - 
In this section we review the within-host models of a malaria infection, and discuss the 
disease dynamics which they have helped to uncover. 
2.10.1 The basic malaria model and its extensions 
The majority of the malaria models are based on the simple three population model first 
proposed by Anderson et. al. (Anderson et al., 1989) in 1989. The three populations it 
includes are uninfected red blood cells, parasitised red blood cells and merozoites. 
Subsequent models have added to the basic model in various ways in order to explore 
different aspects of an infection. 
The basic model is described by three coupled differential equations (one for each of the 
cell populations) and is given in equations 2.1 - 2.3. 
dx(t) = 
= 
A - /3x(t)m(t) - fa(t) 
/3x(t)m(t) - ay(t) 
ray(t) - /3x(t)m(t) - bin(t) 
(2.1) 
(2.2) 
(2.3) 
dt 
dy(t) 
dt 
dm(t) 
dt 
Uninfected cells, x, are created at a constant rate, A, and live for an average of 120 days 
(p = 1/120). The creation of new cells simply replaces older cells as they die off. 
Unparasitised cells are converted into parasitised cells, y, by combining with a 
merozoite (m). The probability that such contact results in the formation of a parasitised 
cell is /3. This means that parasitised cells are created at a rate of itc(t)m(t). Parasitised 
cells rupture 48 hours after being created. This is incorporated into the model by giving 
them an average lifetime of 2 days (a = 1/2). When a parasitised cell ruptures it creates 
a number of merozoites, r (usually r is between 8 and 32). The merozoites cannot live 
very long outside of a red blood cell and so either go on to invade another red blood cell 
or die with an average lifetime of 20 minutes (incorporated by setting S = 72). 
Simulations of this model show damped oscillations towards an equilibrium level for 
the populations of both parasitised and unparasitised cells. Gravenor et. al. (Gravenor et 
al., 1995) used this model to conclude that the direct parasitisation and thus clearance of 
red blood cells contributes significantly to anaemia, a conclusion that has been 
contradicted by other models (Jakeman et al., 1999). The discrepancy can be explained 
by the fact that Gravenor et. al. reach their conclusions by considering the equilibrium 
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concentrations of parasitised and unparasitised cells. They do not consider that earlier in 
infection catastrophic anaemia can be encountered that is disproportionate to the 
number of parasitised cells at equilibrium. 
Addition of acquired immunity 
Extensions of the basic model to include acquired immunity have been considered by a 
number of groups (Anderson et al., 1989, Hetzel and Anderson, 1996, McKenzie and 
Bossert, 1997, McKenzie and Bossert, 1998, Hellriegel, 1992). The type of immunity 
included and the form of its acquisition and decay varies widely between the models 
(Molineaux and Dietz, 1999). This can be explained by the fact that the exact form of an 
acquired immune response to malaria is as yet unknown and thus any inclusion of it in a 
model is at best an educated guess. 
Inclusion of gametocytes 
Another extension introduces gametocytes, the sexual stage of the parasite, as a new cell 
population (McKenzie and Bossert, 1997, McKenzie and Bossert, 1998, Hellriegel, 
1992). This inclusion allowed McKenzie and Bossert to conclude that increased 
conversion to gametocytes gives rise to lower peak asexual densities (McKenzie and 
Bossert, 1998). Thus there appears to be a trade off between infectivity (due to 
increased gametocytogenesis) and morbidity from the disease (correlated with peak 
asexual densities). 
Competition between genotypes 
In addition to including gametocyte production Hellriegel (Hellriegel, 1992) considered 
the interaction between different strains of the parasite. This was also considered by 
McQueen and McKenzie in their model (McQueen and McKenzie, 2006) which is 
discussed below in section 2.10.3. The models showed that in general the more infective 
strain will dominate, however in the presence of immunity the two strains can co-exist. 
Both models found that disease dynamics depended strongly on the timing of the two 
infections. This is consistent with experimental findings on the dynamics of co-infection 
with different strains of P. chabaudi in mice. These dynamics were strongly influenced 
by which strain was injected first (de Roode et al., 2005, Wargo et al., 2007). 
2.10.2 Allowing for parasitised cell rupture to occur after a fixed time 
In all of the above models parasitised cell rupture is assumed to be a continuous process 
that occurs an average of 2 days after invasion. Merozoites are then released at a 
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uniform rate and can invade new cells immediately after being released. In actual fact 
parasitised cells rupture and release merozoites exactly 48 hours after becoming infected 
(or after 72 hours in the case of P. malariae). Since the distribution of parasite lifetimes 
is captured by an exponential distribution, a significant number of parasitised cells will 
rupture "early" (i.e. before a 2 day period has elapsed since their invasion). The 
discrepancy between the model and reality leads to over-inflated growth rates in the 
basic model and is the subject of a discussion between Saul and Gravenor (Saul, 1998, 
Gravenor and Lloyd, 1998). 
In 2000 Hoshen published a modification of the basic model which addressed this issue 
by including a time delay for parasitised cell rupture (Hoshen et al., 2000). This resulted 
in a delay differential equation model. Due to the addition of the delay term Hoshen was 
able to achieve a measure of periodicity in his model which looks similar to that seen in 
experimental data. 
Jakeman et. al. (Jakeman et al., 1999) approached this issue differently by using a 
discrete compartmental model. By allowing their model to have a two day time step 
they eliminated the possibility of merozoites being released early and thus incorporated 
a fixed two day incubation period for parasitised cells. 
2.10.3 Incorporation of additional clinical effects into the models 
There are a handful of models which incorporate some additional clinical effects 
observed during a malaria infection. These alter the model equations to allow for the 
inclusion of effects such as an increased red blood cell response to anaemia, age 
restricted merozoite invasion and fever. 
Increased red blood cell production in response to anaemia 
The majority of malaria models allow red cells to be replenished at a constant rate, A, 
that is calculated to allow for the replacement of older cells dying due to senescence. 
These models do not allow for increased red blood cell replacement in response to the 
(sometimes severe) anaemia which can develop. This situation is rectified in the models 
of both Jakeman et. al. (Jakeman et al., 1999) and McQueen and McKenzie (McQueen 
and McKenzie, 2004, McQueen and McKenzie, 2006). Jakeman et. al. allow the red 
blood cell response to be constantly upregulated at haemoglobins below 95% of normal, 
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while McQueen and McKenzie increase the response gradually with increasing anaemia 
up to a maximum of twice the basal rate (2A). Whilst neither of these are exact models 
of the red cell response to anaemia (Mackey, 1997) they present a step towards 
including this response in a model. 
Preferential invasion of red blood cells of different ages 
It is known that the different strains of malaria exhibit preferences for invading cells of 
specific ages. The models of McQueen and McKenzie (McQueen and McKenzie, 2004, 
McQueen and McKenzie, 2006) are the only models of which we are aware of that 
address this issue. They allow merozoites to invade only red cells of a specific age, and 
consider the effect this has on the course of infection. Their conclusions show that 
infections (such as P. malariae) which exclusively invade older cells are generally mild, 
but those invading only younger cells can still be severe. This is because the 
parasitisation and subsequent rupture of young cells can cut off the supply of older cells 
by destroying them early on. 
Fever 
Kwiatkowski, Nowak and Gravenor (Kwiatkowski and Nowak, 1991, Gravenor and 
Kwiatkowski, 1998) created a model with negative feedback to assess the effect of fever 
on parasite growth. By allowing fever to increase the destruction of late-stage 
parasitised cells they show that the induction of a febrile response to parasite rupture 
can cause synchronisation of the parasites. It can also assist as an immune response to 
halt the exponential phase of parasite growth. 
2.10.4 Malaria Modelling Series 
In 2006 a series of papers modelling different aspects of malaria was published in a 
supplement to the American Journal of Tropical Medicine and Hygiene. This 
supplement aimed to address the impact that intervention strategies (such as 
vaccination) would have on the disease. The models focused both on epidemiological 
and within-host effects of malaria. 
In one (deterministic) model Dietz et. al. consider the initial wave of parasitaemia 
(Dietz et al., 2006). They are able to establish that the initial parasite peak is strongly 
dependent on the innate immune response and that there is a large host dependent 
variability in the effects of vaccination. Their calculations are based primarily on the 
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parasite multiplication factor, the number of merozoites and the innate and adaptive 
immune responses, but are not dependent on the number of cells available for 
parasitisation. A separate paper addresses the impact of malaria on chronic anaemia 
(Carneiro et al., 2006) using a statistical model. The model assesses the increased risk of 
both severe and mild anaemia that can be attributed to a malaria infection. 
With the exception of the above mentioned models, the majority of the within-host 
models presented in this series are stochastic models, and therefore not directly 
comparable with the other models we have presented, nor with the modelling attempted 
in this thesis (Smith et al., 2006, Ross et al., 2006, Maire et al., 2006a, Maire et al., 
2006b). 
2.10.5 Stochastic vs. Deterministic Modelling 
Throughout this thesis we have focused on deterministic models of malaria rather than 
stochastic models. This type of modelling has the advantage that it is often easy to 
numerically solve the models in a short amount of time and also that there is a rich 
repertoire of tools available to analyse deterministic models. Stochastic modelling also 
has advantages, most obviously that such models are often more realistic for 
considering small populations and can also give a better idea of variability in outcomes 
than can deterministic models. For all but the simplest stochastic models, however, we 
cannot solve the models directly and can only simulate them, which can be extremely 
time consuming. In order to achieve good statistics on the model a very large number of 
simulations must be run which can take significant computing time. In addition, it can 
be very difficult to fit stochastic models to experimental data and so determine 
parameter values. 
Chapter 3 
Preferential invasion of reticulocytes during late- 
stage Plasmodium berghei infection accounts for 
reduced circulating reticulocyte levels 
3.1 Overview 
Insufficient circulating reticulocytes have been observed during severe malarial anaemia 
during both human and murine infection, and are often attributed to reduced production 
of red cell precursors. However, a number of Plasmodium species display a preference 
for invading reticulocytes rather than erythrocytes. Thus, the reduction in circulating 
reticulocyte numbers may arise as a result both of increased parasitisation and lysis of 
reticulocytes, as well as decreased production. We have analyzed both circulating 
reticulocyte numbers and the percentage of infected reticulocytes during murine 
P. berghei infection. We found a large reduction in circulating numbers when compared 
to an equivalent chemically induced anaemia. However, mathematical analysis of 
parasite and red cell numbers revealed the preference of P. berghei for reticulocytes to 
be —150 fold over that for erythrocytes, leading to increased destruction of reticulocytes. 
Although erythropoietic suppression is evident during the first week of P. berghei 
infection, this preferential infection and destruction of reticulocytes is sufficient to 
mediate ongoing reduced levels of circulating reticulocytes during the latter stages of 
infection, following compensatory erythropoiesis in response to haemolytic anaemia. 
-53- 
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3.2 Introduction 
Severe malarial anaemia (SMA) is a major complication associated with malaria and is 
thought to result from a number of processes, which include the destruction of red blood 
cells (RBC) due to direct invasion and rupture by parasites, and the destruction of 
uninfected RBCs, which may result from oxidative damage or increased phagocytic 
activity (Ekvall, 2003, Evans et al., 2006, Schofield and Grau, 2005). 
An insufficient number of circulating reticulocytes has been observed in humans with 
P .falciparum malaria (Phillips et al., 1986, Kurtzhals et al., 1997, Abdalla et al., 1980) 
as well as in murine models of malaria (Chang et al., 2004a) when compared with other 
non-malarial anaemias. It has been suggested that erythropoiesis is suppressed during 
malaria infection and this could in fact be a host protective effect limiting the number of 
red blood cells available for parasitisation (Chang et al., 2004b). Reduced RBC 
production cannot directly induce the onset of SMA, since the long lifetime of red blood 
cells (approximately 120 days in humans (Finch et al., 1977)) ensures that a drop in red 
blood cell production could not immediately cause an anaemic episode. However 
inadequate production of RBCs could impair recovery from anaemia, which may lead to 
fatality. Insufficient RBC production has been attributed to a number of factors 
including (i) bone marrow suppression (Abdalla, 1990) (ii) decreased erythropoietin 
production (el Hassan et al., 1997), and / or (iii) impairment of the maturation of 
erythroid precursors into erythrocytes (Villeval et al., 1990). All of these would lead to 
a reduction in the number of reticulocytes observed in circulation. Suppression of 
reticulocyte production has previously been studied in rodent models, particularly 
during P. chabaudi (Chang et al., 2004a, Chang et al., 2004b) infection. Erythropoietic 
suppression has also been observed starting at day 1 and peaking at day 5 in acute 
P. berghei infection, as evidenced by decreased transcription of erythroid specific genes 
in the spleen and bone marrow (Sexton et al., 2004). In this chapter we investigate 
instead the dynamics of reticulocyte production and destruction in the latter stage of 
P. berghei infection to examine the compensatory erythropoiesis in response to 
haemolytic anaemia and high parasite burdens. 
The observed level of reticulocytes in peripheral blood is the net result of the production 
of reticulocytes in the bone marrow and spleen and their subsequent maturation or 
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destruction in circulation. Therefore, the insufficient observed number of reticulocytes 
in P. berghei infected animals could result from their increased destruction and not just 
from a reduction in their production. In particular, a preference for infection of 
reticulocytes over erythrocytes has been observed in P. vivax (Garnham, 1966, Kitchen, 
1938), P. berghei (Singer, 1953, Ladda and Lalli, 1966, Zuckerman and Yoeli, 1954, 
McNally et al., 1992) and to a lesser extent P. falciparum (Pasvol et al., 1980, Clough et 
al., 1998), and this invasion bias would cause increased destruction and decreased 
circulating levels of reticulocytes. 
We investigate the reticulocyte response to anaemia during the latter phase of acute 
P. berghei infection and compare this with the reticulocyte response observed during an 
equivalent non-malarial anaemia caused by treating mice with phenylhydrazine (PHZ). 
We develop a mathematical model of malaria infection to analyse the dynamics of RBC 
production, infection and destruction. We provide the first quantitative estimate for the 
reticulocyte preference of P. berghei, approximately a 150 fold preference for parasite 
invasion of reticulocytes versus erythrocytes. Once we account for this strong invasion 
preference, the observed reduction in the number of circulating reticulocytes in response 
to anaemia during the latter stage of a P. berghei infection can be explained by P. 
berghei's preference for younger cells. 
3.3 Materials and Methods 
Experimental data for RBC and parasite kinetics following experimental P. berghei 
infection and PHZ treatment of BALB/C mice has been previously described, and we 
refer to the original paper for detailed methods of these procedures (Evans et al., 2006). 
This data was generously provided to us by the original authors. The experimental data 
obtained from mice infected with P. berghei provides estimates of total erythrocytes and 
reticulocytes, as well as the proportion of each that are parasitised, measured every two 
days during infection. Since haematorcit (Hct) and Hb measurements were tightly 
correlated, Hct measurements were calculated by assuming an initial Hct of 6x109 cells 
/ ml and utilising measurements for the percentage changes in haemoglobin. We 
develop a mathematical model of malaria infection to analyse the dynamics of 
reticulocyte production and destruction. In the model we capture continuous turnover 
processes such as the production and death (clearance) of RBCs as well as the discrete 
process of destruction due to parasite rupture. The model allows us to directly estimate 
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(i) the relative infection rates of erythrocytes and reticulocytes, and (ii) the bone marrow 
production rate of reticulocytes based on the observed levels of circulating reticulocytes 
in peripheral blood. 
3.3.1 Model Description 
Within our model, cells are assigned an age, which defines them as either a reticulocyte 
or an erythrocyte, and a parasitisation state, which determines whether they are 
unparasitised or parasitised. Cells change their state according to allowable interactions. 
These interactions are: (i) Cells are produced as reticulocytes according to a production 
function (described below) which is dependent on the RBC levels two days earlier. (ii) 
Cell mature from reticulocytes into erythrocytes after one reticulocyte lifetime (4). 
Estimates for Ir range from 1 day in healthy non-anaemic mice (Ganzoni et al., 1969) to 
3 days in severely anaemic mice (Ganzoni et al., 1969, Noble et al., 1989). We set 4. = 2 
days, in the centre of the suggested range. (iii) Unparasitised cells can become 
parasitised. (iv) All cells are cleared according to an exponential decay function. 
Different decay rates are allowed for parasitised and unparasitised cells. (v) Parasitised 
cells rupture one parasite lifetime (/ p) after becoming infected (1p = 1 day (Deharo et al., 
1996)). 
Our model is loosely based on previous differential equation models (Anderson et al., 
1989, Gravenor et al., 1995, Hetzel and Anderson, 1996); however it differs in three 
main ways. (i) The discrete process of parasite rupture is captured. This requirement has 
been the subject of previous discussion (Saul, 1998, Hoshen et al., 2000, Jakeman et al., 
1999). (ii) Compensatory erythropoiesis (Singer, 1954a, Abdalla et al., 1980, Chang et 
al., 2004b) is included during an anemic episode based on observed reticulocyte levels 
(Jakeman et al., 1999, McQueen and McKenzie, 2004). (iii) The potentially different 
preference of the parasite for cells of different ages is taken into account. 
3.3.2 Formal definition of the model 
In order to express a model encompassing the interactions described above we introduce 
two auxiliary functions, s(a, t) and c(a,ap, t) of two and three variables respectively. The 
function s(a,t) represents cells of age a that till present and unparasitised at time t. The 
function c(a,ap,t) represents the number of cells of age a parasitised for a length of time 
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equal to ap and still present at time 1. Note that c(a,0,t) is a proportion of the cells s(a,t) 
i.e. the cells of age a and still present and thus available to become parasitised at time t. 
A cell cannot be present before it is born, and hence s(a, t) and c(a, v, t) are only defined 
for a> 0. Similarly, parasitised cells only remain in circulation for a maximum of one 
parasite lifetime (before they either decay or rupture) so c(a, ap, t) is undefined for 
ap > /p. The quantity s(0, t) represents cells at the moment of their birth. Such cells are 
born unparasitised and cannot be parasitised at the exact time they are born. Thus 
c(0, ap, t) = 0 for all t and all ap. For a > 0 we must take account of cells that have 
decayed and, in the case of s(a, t) we must consider cells that have become parasitised. 
Unparasitised cells will decay at a rate of 8,1(t) and parasitised cells decay at a rate of 
5(t). 
As unparasitised cells age, they can either decay, with an exponential decay rate, or 
become parasitised. Therefore, the equation governing the change numbers of 
unparasitised cells is: 
as(a, t) as(
d
a, t) — 	4,(t) s(a, t) - c(a, 0, t) 	 (3.1) 
da 	t 
As parasitised cells age, they too decay according to an exponential decay function, and 
so the equation governing their change is: 
ac(a, a p , 	ac(a, a p , t) ac(a, a p ,t) 
	 — 	4,(t) c(a,ap, t). 	 (3.2) 
da 	da 	dt 
Since parasitised cells can only become parasitised after they are born, and rupture after 
one parasite lifetime, we only allow c(a, ap, t) to be defined for a>0 and 0 < ap < /p. 
Equation 3.1 is a very standard age structured model, and has been used extensively 
throughout the literature (see for example (McKendrick, 1926, Von Forster, 1959, 
Cushing, 1998, Metz and Diekmann, 1986, Gurtin and MacCamy, 1974)). Equation 3.2 
is a natural extention of the standard age structured equation to contain two age 
variables. 
To fully define the model we need to specify the boundary conditions for s and c. These 
conditions specify firstly the number of new cells (reticulocytes) being born and 
secondly the number of cells of age a becoming parasitised. It is in the boundary 
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conditions that the novelty of this model lies. These conditions are fairly complicated, 
and we define them later in section 3.3.3. In order to define the boundary conditions, we 
require a few extra definitions, as well as an expression for c(a, ap, t). These are given 
below. 
We can apply the method of characteristics to equation 3.2 to determine an expression 
for c(a, ap, t). Let w be a parameter which parameterises a, ap, and t, and let w be 
defined so that c(w) = c(a(w), ap(w), t(w)) and 
dc 	 ac da ac da p ac dt = 	--+ __ ± _ _ 
dw as dw as p dw at dw 
= 	—Sp c(a, ap, t) 
= 	gp c(w) 	 (3.3) 
a 
Setting —da = d = —dt = 1 in equation 3.3 above provides the necessary conditions 
dw dw chv 
for w. Solving these differential equations gives a = w + a(0), ap= w + ap(0), 
t = w + t(0). We let the initial conditions for w = 0 occur at the time when a cell 
becomes parasitised. This implies that ap(0) = 0, a(0) = ao = a — ap and 
t(0) = to = t — ap. Solving equation 3.3 in terms of w gives 
c(w) 	= 	c(0) e -6. 
	
(3.4) 
Let us now consider the characteristic curve (a(w), ap(w), t(w)) passing through the 
point (ao, 0, to). Then we take ap(w) = w and c(0) = c (a(0), ap(0), t(0)) = c(a—ap, 0, t—ap) 
= c(ao, 0, to). Equation 3.4 then becomes: 
c(w) 	= 	c(a(w), ap(w), t(w)) 
= 	c(a, ap, 1) 
= 	c(a—ap, 0, t—ap) e 8 Pa P 
And so we have an expression for c(a, ap, t) as: 
c(a, ap, t) = c(a—ap, 0, t—ap) e 5 Pa P 	 (3.5) 
We define the total number of parasitised cells, P(t) (where P stands for parasites) at 
time t by integrating c over all cell ages. Therefore: 
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P(t) 	= 	c(a, ap, t) dapda 	 (3.6) 
0 a,, 
And define the total number of reticulocytes, RT07-(t) by integrating s and c up to age /„ 
therefore: 
1,, 1, 
RT07-(t) = 	s(a, t) da + 
f 
J c(a, ap, t) dadap 	 (3.7) 
0 	 o ap 
Total cell numbers H(t) (where H stands for haemoglobin) are given by integrating both 
s and c over all cell ages. Therefore: 
Ip co 
H(t) 	= 	$ s(a, t) da + 	c(a, ap, t) dadap 	 (3.8) 
0 	 o ap 
The initial conditions used for this model are given in the appendix to this chapter. The 
definitions presented in equations 3.1 and 3.2 as well as the initial conditions of 
presented in the appendix will allow a comparison between this model and the model of 
the next chapter. 
3.3.3 Boundary conditions of the model 
Unparasitised cells, s(0, t) 
Within this model, we allow two different boundary conditons for s(0, t). This is to 
capture two different experimental conditions, which are discussed fully in section 3.3.9 
Both boundary conditions utilise a sigmoid family of functions tp(z) (defined in 
equation 3.36) where z is taken to be the total number of red cells that were present r 
days ago. A formula for the family of functions, y.(z), is given in section 3.3.8. 
In the simplest case, s(0, t) is directly by fitting the family of functions, ip(z), to 
experimental data relating reticulocyte levels to the total RBC counts rdays ago (see 
Figure 3.3). The fitted function is expressed as f(H(t-1)), and is treated as a production 
function. This boundary condition is useful when the experimentally measured 
reticulocyte levels corresponds closely to reticulocyte production (i.e. there is not a 
significant amount of cell death). We then have 
s(0, t) 	= 	f(H(t-z)). 	 (3.9) 
dP — —+ 
dt 
dP 
dt 
+ c(v — 1p ,O,t — 1 p )e-6P IP dv + 5pP(t) 
c p(t) c(v,1 p ,t)dv + 5pP(t) 
rupturing cells 
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Alternatively, we can let the boundary condition for unparasitised cells be determined 
by once again fitting the family of functions ip(z) to (different) experimental data 
relating the total number of circulating reticulocytes, to the RBC levels days r ago. In 
this case we express the fitted function as g(H(t-z)), and have RT07(t) = g(H(t-r)). We 
then calculate the value of s(0, t) indirectly from these R7-07(t) in order to maintain the 
correct total level of reticulocytes. This boundary condition is useful when the 
experimentally measured circulating reticulocyte levels may not correlate well with the 
production of reticulocytes and is used when there is significant amounts of cell 
destruction. We then define s(0, t) as: 
s( 0, t) 
dR„),. 
dt 
+ s(1,, + c(1„ a p , t)da p —
0 
maturing reticulocytes 
 
f
c(a, l p , t)da 
  
rupturing reticulocytes 
1, 
—5p is(a,t)da — p f fc(a, a p ,t)dada 
0 	 o a, 
decaying reticulocytes 
(3.10) 
Parasitised cells, c(a,0, t) 
Determining the initial conditions for c(a, 0, t) cannot be done from other variables in 
the model, as this is a non-autonomous model. Instead, c(a, 0, t) is determined using an 
experimental input function, which calculates the total number of parasitised cells 
present at each point in time. We call this function P(t), and use it's derivative to 
calculate the total number of parasitised cells produced at time t, cp(t). cp(t) can be 
determined in a similar fashion to equation 3.10 above as: 
(using equation 3.5) 
And so we have 
cp(t) dP — + 	+ 5pP(t) 
dt 
(3.11) 
The actual value of c(a, 0, t) can then be deduced from equation 3.11 as being given by: 
c(a, 0, t) 	= 	
q(a)s(a,t) 
cp(t) 	 (3.12) 
fq(a)s(a,t)da 
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where 
0 for a 	0 
q(a) p 
1 
for 0 < a 	. 
for a > 1, 
(3.13) 
When numerically simulating the model (section 3.6.2) we require that c(a, 0, t) < s(a, t) 
as we cannot parastise more cells of age a than are present. 
3.3.4 Experimentally focused representation of the model 
The definitions given above for unparasitised and parasitised cells allow a formal 
definition of the model. However, the quantities s and c are not ones that can be 
measured experimentally. Therefore, we now present an alternative representation of the 
model, which is more closely related to the experimental data under analysis. Our 
numerical simulations will be based on this alternate representation. In addition, the 
model is currently represented in an infinite dimensional space, determined by the 
functions s and c. It would be convenient to derive a finite state space representation of 
the model. This has been done previously for age structured models using, for example, 
linear chain trickery (Cushing, 1998, Metz and Diekmann, 1986). We will address this 
in more detail in section 3.3.6 when we present an delay differential equation version of 
this model, using the classes of cells defined in this section. 
The experimentally focused definition of the model contains four classes of cells: 
unparasitised reticulocytes, Ru(t), unparasitised erythrocytes, Eii(t), parasitised 
reticulocytes, Rp(t), and parasitised erythrocytes, Ep(t), all of which can be measured 
experimentally (for details see (Evans et al., 2006)). Equations 3.1 and 3.2 can also be 
represented as interactions between the four classes of cells, and a state diagram 
describing these interactions is shown in Figure 3.1. Equations describing the transitions 
of the model are given below in section 3.3.5. 
In considering the changes in levels of each species in the model we must account for 
each of the arrows in Figure 3.1 heading into or out of a species. Some of the arrows 
depict interactions which, although simple to describe verbally, are somewhat more 
complicated to depict mathematically. In order to facilitate the model description we 
introduce some additional variables, which are defined in Table 3.1. 
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Symbol Description (at time t) 
H(t) Total Red Blood Cells (H for Haemoglobin) 
Ru(t) Unparasitised reticulocytes 
Ru,para(t) Unparasitised reticulocytes becoming parasitised 
Ru,mat(t) Unparasitised reticulocytes maturing into erythrocytes 
Rp(t) Parasitised reticulocytes 
Rp,mat(t) Parasitised reticulocytes maturing into parasitised erythrocytes 
Rp,rupt(t) Parasitised reticulocytes rupturing 
Eu(t) Unparasitised erythrocytes 
Ep(t) Parasitised erythrocytes 
Ep,rupt(t) Parasitised erythrocytes rupturing 
Eu,pam(t) Unparasitised erythrocytes becoming parasitised 
Table 3.1 Variables used in the model 
Using the definitions of s and c given above, we can define the quantities in Table 3.1 as 
shown below. Note the order of integration an dlimits that are required, as a cell cannot 
be parasitized before it is born. 
Ru(t) 
Eu(t) 
s(a, t) da 
f s(a, t) da 
(3.14) 
(3.15) 
RAO c(a, ap, t) dadap r t 
p 
(3.16) 
Ep(t) c(a, ap, t) dadap (3.17) 
R„,mat(t) = s(1,, t) (3.18) 
c(1„ ap, t) dap (3.19) 
R„,para(t) c(a, 0, t) da (3.20) 
Eu,para(t) c(a, 0, t) da (3.21) 
Rp,rupt(t) c(a, 1p, t) da (3.22) 
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Ep,rupt(t) = 	f0 c(a, 1p, da 
	 (3.23) 
3.3.5 Differential equations describing Cell Populations 
We can now describe the changes in the species populations that correspond to the 
arrows in Figure 3.1 intuitively by differentiating the expressions in equations 3.14 -
3.17. We arrive at the differential equations in 3.24 - 3.27. We will assume throughout 
that the functions are sufficiently smooth to allow the exchange of limits. 
Unparasitised Reticulocytes 
The differential equation governing the unparasitised reticulocyte population, Ru(t), is: 
d dR,, 	
—
dt 0 
s(a, t) da 
dt 
1, 
J 
0 
as(a, I)  
da 
at 
 
 
as(a,t) da 
o as 
/, 	 /, 
f
—82,(0s(a,t) da — f c(a,O, t) da 
— s(1„ t) + s(0, t) — gu(t)Ru(t) — Ru,para(t) 
s(0, t) — 	— Ru, para(t) — gu(t)Ru(t) 
	
(3.24) 
The first term in the last line above represents reticulocytes that are being produced. The 
second term, Ru,ma/(t),  represents reticulocytes that are maturing into erythrocytes. This 
depends on the past history of the system. The third term describes reticulocytes that are 
becoming parasitised. It depends on the infection rate of parasites in reticulocytes, the 
number of merozoites present to invade cells and the number of reticulocytes present. 
The final term encompasses reticulocytes that are decaying due to bystander processes 
and is given by 8„(t)R„(t), were 8u(t) is the decay rate of unparasitised cells at time t. 
Unparasitised Erythrocytes 
The by a similar calculation to that in equation 3.24 above, the expression governing the 
change in erythrocyte population is: 
d.E„ = 
—
d 	
s(a, t) da 
dt 	dt 
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. 	. 
= 	-1. as(a,t)  da — $ —5,(t)s(a,t) da — J c(a,0 , t) da 
	
J 	as 1 ir 	 1, 
0 + 	1) — gu(t)Eit(t) — Em para(t) 
Ru,mat(t) — Eu,para(t) — 8,(t)E,(t) 	 (3.25) 
We can compare the three terms in the last line above with the three arrows connected 
to the unparasitised erythrocytes in Figure 3.1. The unparasitised erythrocyte population 
Eu(t) is affected by three processes - the maturation of reticulocytes, the parasitisation of 
erythrocytes and the decay of erythrocytes. As in the case of the reticulocytes, the 
number of erythrocytes becoming parasitised depends on the growth rate of the parasite 
inside erythrocytes, the merozoite population and the number of erythrocytes present. 
The decay term is similar to the one for reticulocyte decay, and is given by 8„(t)Eu(t). 
Parasitised Reticulocytes 
The change in numbers of parasitized reticulocytes is determined by differentiating 
equation 3.16 
dRp = d 1 1, 
" 	c(a, ap, t) dadap 
dt 	dt 0  ap 
ac(a,ap, 
at 
	da dap 
IP 	aC(a,a ,t) 
c 
—8p(t) c(a, ap, t) dadap — P 	da dap 
aa 
r D 
 - f a*, a P 't)  dadap i 
0 a, 	aa 
tP 
= 	—gp(t)Rp(t) — 	(c(1 r , ay, t) — c(0, ap, t)) dap 
( 
$
a 
as 	
ic(a,a p,t)da + c(a p ,a p ,t) dap 
P \,ap 	 =0 
t, 
= —gp(t)Rp(t) — 	c(lr, ap, t) dap — 	c(a, 1P, t) da 
0 
+ 	c(a, 0, t) da (since c(0, u, t) = 0) 
0 
0 a p 
0 a p 	 0 a p 
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= R„,para(t) — Rp,mat(t) — Rp,rupt(t) — Sp(t)Rp(t) 	 (3.26) 
(using equations 3.19, 3.20 and 3.22 and the fact that c(0, u, t) = 0) 
There are therefore four contributors to the change in the population of parasitised 
reticulocytes, Rp(t). The population is boosted by the reticulocytes that are becoming 
parasitised, and is depleted by the following three events. Firstly, the maturation of cells 
into parasitised erythrocytes, Rp)„t(t), and we assume that as in the case of unparasitised 
reticulocytes, parasitised reticulocytes also mature one reticulocyte lifetime after they 
were produced. Secondly, parasitised reticulocytes are depleted by rupture, Rp,rupt(t). 
Finally, there is the decay of parasitised reticulocytes which occurs at a rate gp(t). The 
model allows the decay of parasitised cells to be different from that of unparasitised 
cells, however we have not made use of this flexibility in the current work. 
Parasitised Erythrocytes 
An almost identical derivation to the one given above for equation 3.26 can be used to 
determine the change in parasitised erythrocytes with time. 
, 	00  
a f 
dt 	dt 0 ri 
ac(a, a p , t) da dap  
01, 	at 
,, co ,, co 
=f f —8p(t) c(a, ap, t) dadap — f f  °c(a'  as P
't) dada 
ac(a
' 
a t) 
dada 
0 1, 	as 
rp 	 p 
= —gp(t)Ep(t) 	c(a, ap, t) dap + f c(Ir , ap, t)) dap 
0 	 0 
a (.0 
— — aa fc(a,a p,t)da dap 
0 	P 
r p rp 
= —gp(t)Ep(t) 	c(a, ap, t) dap + f c(Ir, ap, t) dap 
0 	 0 
00 00 
— c(a, 1p, t) da + 	c(a, 0, t) da 
dE p 
c(a, ap, t) da dap 
0 1, 	 0 1, 
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Now, s(0, t) is bounded above, as it is determined from a sigmoid function (equation 
3.9). Let us label the upper bound of s(0, t) by K. Then, s(a, t) < K and in fact from 
equation 3.1 we can deduce that s(a, t) < 	. Now c(a, 0, t) must also be bounded 
above by K e s.a as we cannot parastise more cells of age a than actually exist. Finally, 
from equation 3.2 we have that c(a, ap, t) < c(a, 0, t). Therefore c(a, ap, t)—> 0 
exponentially as a —> co for a fixed t. This shows us that: 
lim 	c(a, ap, t) dap = 0. 
Therefore, we have: 
CO 	 CO 
d; 
= —Sp(t)Ep(t) f c(lr, ap, t) dap — f c(a, 1p, t) da + f c(a, 0, t) da 
Eu,para(t) +Rp,math) — Ep,rupt(t) 	gp(t)Ep(t) 	 (3.27) 
(using equations 3.19, 3.21 and 3.23) 
The transitions governing parasitised erythrocytes, Ep(t), are similar to those governing 
parasitised reticulocytes. Parasitised erythrocytes are produced by unparasitised 
erythrocytes, E,„(t), becoming parasitised, and are removed by rupture or decay with the 
decay term being given by 8p(t)Ep(t). The main difference is that maturing parasitised 
reticulocytes, Rp,„,„,(0, also contribute to the numbers of parasitised erythrocytes. The 
rupture term, Ep,rupt(t), is similar to that for reticulocytes. 
3.3.6 Delay Differential Equation expression of the model 
We now present a closed form expression of the model of equations 3.1 and 3.2 which 
results in the model being expressed as a delay differential equation (DDE). The closed 
form model contains four compartments. These are unparasitised reticulocytes, Ri,(t), 
unparasitised erythrocytes, Eu(t), parasitized cells, P(t) and merozoites, M(t). 
Note we have combined parasitised reticulocytes and erythrocytes into one class of 
parasitised cells. This does not affect the model results, nor the conclusions we are able 
to draw from the model, however it does simplify the closed form expressions as we no 
longer need to find an expression for the maturation of parasitised reticulocytes into 
erythrocytes (which is a non-trivial task). 
Expressions for R,,(t), E„(t) and P(t) have been given previously in equations 3.14, 3.15 
and 3.6. The derivatives of Ru(t) and E„(t) are given above in equations 3.24 and 3.25 
0 	 1, 
1, 
f . 
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respectively (repeated below in a slightly different format for completeness) and we can 
rearrange equation 3.11 to arrive at an expression for dP I dt. Therefore we have: 
= 	s(0, t) — s(lr , t) — f c(a, 0, t) da — 8„(t)R,i(t) 	(3.28) 
0 
= 	s(lr, t) — f c(a, 0, t) da — gli(t)Ei,(t) 
I, 
= 	cp(t) — cp(t—lp) e-aPiP — 4,(t)P(t) 	 (3.30) 
In order to proceed with the model closure we require closed form expressions for 
r, 
Air, t), the number of unparasitised reticulocytes maturing at time t and f c(a, 0, t) da 
o 
co 
and f c(a, 0, t) da, the number of unparasitised reticulocytes and erythrocytes 
/, 
becoming parasitised at time t. 
Expressions for the number of cells becoming parasitised are given by integrating 
equation 3.12 over the appropriate limits. We have: 
i, 
fq(a)s(a, t) 
c(a, 0, t) da 	= 	o 	cp(t) 
fq(a)s(a,t)da 
o 
And similarly 
PR. (t)  
1, 	 cp(t) 
p fs(a,t)da + is(a,t)da 
0 	1, 
pRu (t)  
at) 
pRu (t)+ Eu(t) c' 
(3.31) 
f
c(a, 0, t) da 	= 	
Eu (t) 	
cp(t). 
1, 	 pRu (t)+ Eu (t) 
It remains to determine an expression for the number of maturing unparasitised 
reticulocytes, s(/,, t). 
dRu  
dt 
dEu  
dt 
dP 
dt 
(3.29) 
00 
(3.32) 
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We integrate along the characteristics of equation 3.1, which are given by a=t—tb (where 
tb represents the time of birth of a cell). We fix tb and define 
w(a) = s(a,a+tb) 
Then on a characteristic of equation 3.1, w(a) satisfies the differential equation 
dw(a) — suw(a) 
da 
q(a)c p(a + tb ) 
= —5„w(a) 	 w(a) 
pRu (a + t b )+ Eu (a + tb ) 
( pc p(a + tb ) 	)14)(a) 
pRja + tb ) + Eu (a + tb )) 
(since we are interested in s(/,, t) then a <1, and so q(a) = p) 
Integrating this using the variation of constants method gives 
• c p(z+1,) 
	 dz 
5 a 	P  pk(z+tb)+Ep(z+tb) w(a) = e- " e °  
and hence given t and /, we set tb = t—lr to give 
s(1,,t) = S(lr,lr+tb) 
• w(1,) 
c(a,O, a+ tb) 
w(0) 
cp (z+t-1,) 
- e _5 — e ° 
P 	(z+1-1,)+Ep(zia-1,) 
dz 
w(0) 
c (z) 
_.(5 -P pk(:)+E,,(z)th  
- e 	e 	 s(0, t-1,) 
	
c,(z) 	dz 
= fR(H(t-1,- T)) e 	e 
Pf
t'
pk(z)+E.(z) 
(3.33) 
(assuming that reticulocytes are created using the direct 
calculation formula given in equation 3.9) 
We can combine equations 3.28 - 3.33 to arrive at a closed form expression for the 
model of chapter 3 as: 
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dRu 
= 	
pR
u
(t) 	
cp(t) fR(H(t— 1-)) 
	
dt pRu (t)+ Eu (t) 
_p 	cp(z) 
—fR(H(t—lr—r)) e-gd, e 	
PR,,(z)+E,,(,)`fr 
au(t)Ru(t) (3.34) 
dE 	 5 	P 1 pRu  
dt 
(z)  
fAll(t-1- 
(zP)-1-17„( )61z E 
r .L1 e ure 	
z 	u (t) 
pRu (t)+ Eu(t)cP(0 gu(OEu(t) 
(3.35) 
dP 
at 
= cp(t)— e 	cp(t—lp) — 42(t)P(t) 	 (3.30) 
This expression depends only on the terms Ru(t), E„(t), P(t) and the experimentally 
calculated quantity, cp(t). This shows us that we can think of the model of equations 3.1 
and 3.2 as a DDE wth a distributed delay. 
Parameter Value Source 
reticulocyte lifetime (4) 2 days Ganzoni et. al. (Ganzoni 
et al., 1969) 
Parasite lifetime (/p) 1 day Deharo et. al. (Deharo 
et al., 1996) 
decay of unparasitised cells (SH) 0.0095 / 0.123 per day regression from data 
reticulocyte function (S(t)) sigmoid function 
(details specified in 
section 3.3.8) 
curve fit to data 
Preference for reticulocytes (p) 153 optimization fit to data 
Table 3.2 Parameters used in the model 
Parameter values and functions used in the model and their sources. 
Unparasitised 
reticulocytes 	unparasitised 
produced 	reticulocyte 
clearance 
Reticulocytes 
Parasitised 
parasitised 
reticulocyte 
clearance 
reticulocytes 
becoming 
parasitised 
parasitised 
reticulocytes 
rupturing 
unparasitised 
reticulocytes 
maturing 
parasitised 
erythrocytes 
rupturing 
Erythrocytes 
unparasitised 	 parasitised 
erythrocyte erythrocyte 
clearance 	 clearance 
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Figure 3.1 Model of RBC infection 
A mathematical model of RBC infection that accounts for the parasitisation, lysis and 
rupture of reticulocytes as well as the parasite's preference for invading reticulocytes is 
developed. Newly produced red cells enter at top left as uninfected reticulocytes (Ru). 
These reticulocytes may be cleared (by the reticuloendothelial system), parasitised (and 
become parasitised reticulocytes), or may mature into uninfected erythrocytes (Eu). 
Parasitised reticulocytes (Rp) may similarly be cleared, destroyed due to parasite 
maturation and rupture, or may mature to become parasitised erythrocytes (Ep). 
Uninfected erythrocytes (bottom left) may be cleared or parasitised, and finally infected 
erythrocytes may be cleared, or die due to parasite mediated rupture. Further details of 
the model are provided in the rest of this section and in the appendix. 
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A table specifying all the parameters in the model as well as how they are determined is 
given in Table 3.2. We use Matlab® version 7, The MathWorks, Inc, MA to calculate 
numerical solutions to the model. The majority of the parameters in our model can be 
estimated from the literature or directly from the experimental data (Table 3.2). We use 
the experimental data to estimate the number of parasitised cells present in each mouse 
and use our model to generate simulations of red blood cell (RBC) and reticulocyte 
numbers. We use the Matlab® optimization toolbox (command = 1 sqnonl in) to 
estimate the magnitude of the parasite preference for invading reticulocytes from the 
proportion of parasitised reticulocytes and erythrocytes (Figure 3.5B). 
3.3.7 Estimation of Decay Rates 
It is widely accepted that there is considerable destruction of uninfected erythrocytes 
during malaria infection (Price et al., 2001, Jakeman et al., 1999, Evans et al., 2006) as 
the loss of RBCs often exceeds the percentage of parasitised cells by up to 10 fold. We 
account for this "bystander death" through the parameter 6H, (the rate of killing of 
uninfected erythrocytes). We estimate this rate by fitting the observed decay in 
haemoglobin levels (Hb). Hb decay does not begin until at least 6 days p.i., so initially 
(51-1 is small enough to maintain a constant Hb levels (5H = 0.0095/day). For the 
remainder of the infection, Hb data from days 6-10 post infection (p.i.) is used to 
estimate OH (using linear regression of the natural log transformed data (Figure 3.2)). By 
using data from times of low parasitaemia (all mice have <0.6% parasitaemia on day 6) 
the contribution of parasitised cell rupture to the decay estimate of uninfected cells is 
minimised. This leads to a mean (±S.E.) OH of 0.123 (±.007)/day (95% confidence 
interval of mean = .1058 - .1396), (ty, = 5.7±0.3 days 95% confidence interval of mean = 
5.0-6.5 days). We allow (5H to increase steadily from 0.0095 to 0.123 between days 6 
and 7 p.i. to parallel the observed change in RBC kinetics in infected animals. 
In parallel with (5H we have Op, the natural clearance rate of parasitised cells 
(independent of parasite mediated rupture). Since the rate of parasite mediated rupture 
of these cells is much greater than 0H, we assume for simplicity Op = OH. This is a 
conservative assumption for our purposes, as a higher rate of parasite clearance would 
have increased estimates of reticulocyte production. The number of parasitised cells is 
estimated from a smoothed version of the observed numbers of parasitised cells in 
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individual mice. Estimation of the other parameters in our model is discussed in the 
modelling results sections. 
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Figure 3.2 RBC decay during P. berghei infection 
RBC levels (as a percentage of normal) for individual mice for days 6-10 p. i. were 
plotted on a log scale (symbols). The "bystander death rate" of uninfected cells was 
estimated using linear regression of the natural log transformed RBC level data from 
days 6-10 p. i. Dotted lines show linear regression for each mouse. Thick line is the 
average slope for all mice. 
3.3.8 Relationship between RBC levels and reticulocyte levels during 
P. berghei induced anaemia 
Anaemia induced reticulocyte production at any given time should correlate with the 
level of RBCs at some earlier time point, as this is the stimulus which leads to 
erythropoiesis. The correlations between absolute reticulocyte numbers and RBC count 
at three different time points — four days previously, two days previously and 
concurrently are shown in Table 3.3 with their correlation coefficients (Spearman). For 
each group of mice the correlation is strongest and the r-squared value largest when 
comparing the reticulocytes with the RBC count two days earlier (Table 3.3). This two 
day delay between the onset of anaemia and the observed reticulocyte response is 
consistent with literature estimates (Chapel et al., 2000, Veng-Pedersen et al., 2002) and 
suggests that it takes approximately two days for reticulocytes to be produced by the 
bone marrow and released in response to anaemia. The reticulocytes we see in 
v(z)= baseR + y(1 	
1  
1+ e-w( z-x ) )  
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circulation will all have been produced over the last two days, and most will have been 
produced in the last 24 hours. When comparing reticulocyte levels in the P. berghei 
infected and PHZ treated mice we observe a decreased level of circulating reticulocytes 
in the P. berghei infected mice compared to PHZ treated mice for corresponding RBC 
counts (Figure 3.3). 
The correlation between reticulocytes and RBC levels two days previously is shown in 
Figure 3.3. A suitable function relating these quantities should have three key features: 
(i) There should be some baseline reticulocyte production level for RBC counts close to 
normal (see right hand side of Figure 3.3) (ii) It should increase steadily for RBC levels 
less than 80% of normal (see left hand side of Figure 3.3). (iii) It should reach a plateau 
as the RBC level tends towards 0. This is an intuitive assumption that the circulating 
reticulocytes should not increase without check. The sigmoidal family of functions yi(z) 
of equation 3.36 matches these constraints whilst being a smooth family of functions. 
(3.36) 
Each of the four parameters in the sigmoid function has a biological interpretation. The 
baseR parameter essentially defines the baseline reticulocyte count, in the absence of 
any anaemia. The maximum reticulocyte level is given by baseR + y. This is the 
reticulocyte level which would be observed when erythropoiesis is at its maximum 
level. The other parameters (x and w) determine (respectively) the red blood cell level at 
which reticulocyte levels begin to increase (around 80% of normal) and the slope of the 
linear section of the reticulocyte curve. Any curve describing the relationship between 
reticulocyte levels and red blood cell levels two days earlier must include parameters to 
account for these four features of the curve. The sigmoid function is a smooth function 
with the necessary four parameters and is often used in biological modelling. A similar 
curve has previously been used in models of erythropoiesis (Loeffler et al., 1989, 
Mackey, 1997). 
Fits to both sets of data are shown in Figure 3.3. The sigmoid function fitted to the data 
from P. berghei infected mice specifies the number of reticulocytes currently in 
circulation and allows us to indirectly calculate the production rate of reticulocytes (see 
section 3.3.9). These observed levels of reticulocytes are the steady state result of 
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reticulocyte production and ongoing parasitisation, lysis and rupture of the newly 
produced reticulocytes. In contrast, PHZ causes oxidation of the erythrocyte membrane, 
resulting in the hemolysis of cells and a chemically induced anaemia. The observed 
reticulocyte levels in PHZ treated mice represent the actual numbers of reticulocytes 
produced. This is true for two reasons. First, reticulocytes have a lifetime of 2 days, 
equal to the interval between measurements, so all cells are counted exactly once. 
Second, since PHZ has only a transient effect, reticulocytes produced after PHZ 
administration should not experience ongoing clearance. Thus, there are two possible 
explanations for the reduction in observed reticulocytes in P. berghei infected mice: 
either decreased reticulocyte production (compared to PHZ treated mice) or increased 
reticulocyte destruction. 
3.3.9 Determining Reticulocyte production rates 
Indirect calculation of reticulocyte production rate in P. berghei infected mice 
The production of reticulocytes in P. berghei infected mice can be estimated indirectly 
from the observed cell numbers and the destruction rate of reticulocytes. This 
corresponds to the boundary condiction for s(0, t) defined in equation 3.10. We fit the 
relationship between the RBC level two days earlier (H(t-2)) and the level of circulating 
reticulocytes (RroT (t)) to the sigmoid family of functions defined in equation 3.36. We 
fit the parameters of p(H(t-2)) to the reticulocyte counts in all P. berghei infected mice, 
and set then set &O7(t) = g(H(t-2)), where g(z) is the fitted function. We would get 
similar results if we allowed R7-07(t) to be estimated directly from the data for individual 
mice (not shown). The best fit estimates for the parameters of equation 3.36 in P. 
berghei infected mice are: baseR = 1.793, x = 51.06, y = 18.84 and w = 0.09412. 
We then calculate the number of reticulocytes which would have had to have been 
produced in this time period (Rprod(t) = s(0, t)At) to maintain the observed levels of 
reticulocytes in circulation. We do this using a discretised version of equation 3.10 
(once the other quantities have been determined). 
Rp„d(t) = R7-07-(t)—RroT(t-At)+ R ,(t) + R a,(t)+ Atg a(t)Ra (t)+ Atg r(t)Rp(t) +Rp,rupt(t) 
maturing reticulocytes 	 decaying reticulocytes 
(3.37) 
• PHZ treated 
A P. berghei 
fit to PHZ 
fit to P. berghei 
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Correlations 
(reties vs Hb) P. berghei Phenylhydrazine 
H(t) -0.737* -0.624* 
H(t-2) -0.882* -0.920* 
H(t-4) -0.732* -0.287 
Table 3.3 Spearman Correlation coefficients for the number of circulating 
reticulocytes vs the RBC counts during P. berghei and phenylhydrazine induced 
anaemia. 
The correlation between current reticulocyte levels and Hb on the same day (H(t)). 
2 days prior (H(t-2)), and 4 days earlier (H(1-4)) are shown. 
*p<0.001 
2 
1.8 
• 1.6 
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Figure 3.3 Reticulocyte counts vs. RBC counts two days previously 
Reduced levels of circulating reticulocytes in response to anaemia are seen in 
P. berghei (blue triangles) infection compared with PHZ treatment (red circles). A 
strong correlation is evident in both data sets and can be modelled by a sigmoidal 
relationship. Lines are sigmoidal curves fitted to the data using Matlab®  curve fitting 
software and the methods described in section 3.3.9. Dotted line is the fit to the 
P. berghei data, dashed line is the fit to the PHZ data. 
Chapter 3: Preferential Reticulocyte Infection during P. berghei 	 - 76 - 
Direct calculation of reticulocyte production rate in PHZ treated mice 
The relationship between RBC levels and circulating reticulocyte levels for PHZ treated 
mice is estimated in the same way as for P. berghei infected mice, viz: 
However this time we fit the function to data from PHZ treated mice. A simple fit of the 
observed reticulocyte levels and the RBC counts two days earlier to the PHZ data, using 
the sigmoid function gives best fit estimates for the parameters of: baseR = 1.941, 
x = 64.68, y = 27.53 and w = 0.1603. We label this fitted function as f I (H(t-2) 
For the PHZ treated mice, the observed level of reticulocytes closely mirrors their 
production rate (as discussed in section 3.3.8), and we allow the production of new 
reticulocytes to be given by the circulating levels divided by the reticulocyte lifetime. 
The reticulocyte production function is therefore given by f(H(t-2)) = f(H(t-2))11,, and 
the condition for reticulocyte production is the same as that of equation 3.9. Thus, the 
production rate can be estimated from a simple fit of the observed reticulocyte levels 
and the RBC counts two days earlier, using the same sigmoid function and parameters 
fit to the PHZ data. This time we have: 
R prod(t) = s(0, t)At = f(H(t-2)). 	 (3.39) 
To investigate whether the experimentally observed decrease in circulating reticulocytes 
in P. berghei infected mice (Figure 3.3) results from preferential infection of 
reticulocytes, we use the model to estimate the underlying reticulocyte production rate 
in P. berghei infected mice, and compare that with the production rate seen in mice with 
chemically induced anaemia. We also simulate infections where the reticulocyte 
production rate in P. berghei infected mice is set to be equivalent to that observed in 
PHZ treated mice, and estimate the number of reticulocytes we should observe in 
circulation (given the destruction rate of reticulocytes). 
1 
RT07(t)= v)(H(t-2))= baseR +y(1 	  1+ e -w(H0-2)-x) • (3.38) 
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3.4 Results 
3.4.1 Kinetics of parasitaemia, RBC levels and reticulocyte levels during 
P. berghei infection 
Naive mice infected with P. berghei develop patent parasitaemia 4-8 days post infection 
(p.i.). Parasitaemias increase steadily, and reach up to 60% of circulating cells by day 
16 p.i. (Figure 3.4A). There is a sharp decrease in RBC levels, to 65% of baseline, 
between day 6 and 10 p.i., with a further drop to around 30% of original levels by day 
16 p.i. The drop in RBC levels is accompanied by a significant increase in the level of 
circulating reticulocytes beginning on day 10 p.i. 
The erythropoietic response to a P. berghei infection can be divided into two distinct 
phases (Figure 3.4A). During the initial phase of infection (day 0-8 p.i.) there is a 
decrease in the level of circulating reticulocytes prior to the onset of severe anaemia. In 
our study, no parasite invasion of reticulocytes was detected in this phase, and RBC 
count did not decrease significantly. It is possible that the early decrease in circulating 
reticulocytes is due to erythropoietic suppression (Sexton et al., 2004), however this 
phase of the infection was not the subject of this study. The latter stage of infection, 
from day 8 onwards, sees the onset of haemolytic anaemia due to increasing levels of 
parasitaemia, which results in marked increases in circulating reticulocytes. 
Reticulocyte counts rise steadily from day 10 p.i. and account for up to 60% of 
circulating cells at 14-16 days p.i. Despite increases in observed reticulocyte levels, it is 
unclear whether there is erythropoietic suppression or whether the reticulocyte response 
is adequate for the level of anaemia. 
3.4.2 Effects of phenylhydrazine administration 
Mice treated with PHZ experience a sharp decrease in RBC levels between days 0 to 3 
post-PHZ treatment (Figure 3.4B). Compensatory reticulocyte production leads to an 
increase in RBC count from day 3 onwards and results in a restoration of baseline RBC 
levels by 7-9 days after administration of PHZ. 
3.4.3 Preferential infection of reticulocytes during P. berghei infection 
It has previously been suggested that P. berghei has a preference for invading 
erythrocytes in early infection (Sexton et al., 2004) and for reticulocytes in the latter 
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stages of infection (Singer, 1954a). Our experimental collaborators examined the 
proportion of parasites found inside reticulocytes and erythrocytes by microscopy 
throughout the course of the infection and found that at low parasite burdens the 
majority of parasites are found inside erythrocytes, and it is not until parasite counts 
reach above 2x108 cells (2% of original red blood cells) that parasitised reticulocytes 
dominate (Figure 3.5A). However, early in infection there are significantly more mature 
red blood cells than reticulocytes (>98% of cells are erythrocytes) and so naturally we 
would expect the parasitised cell distribution to reflect this ratio. At higher parasite 
counts the percentage of both circulating reticulocytes and parasitised reticulocytes 
increases. Figure 3.5B considers the number of infected cells of each phenotype as a 
percentage of the total number of cells in that age group, thereby taking into account 
relative population sizes. We see that at almost all parasite counts there are higher 
percentages of infected reticulocytes than erythrocytes. This agrees with previous 
observations that P. berghei has a preference for invading reticulocytes (Singer, 1953, 
Ladda and Lalli, 1966, Zuckerman and Yoeli, 1954, McNally et al., 1992) but it is only 
apparent at higher levels of parasitaemia when there are more reticulocytes available to 
invade. 
3.4.4 Modelling the preference of P. berghei for reticulocytes 
Using the mathematical model of infection (described in section 3.3.1) and parameters 
estimated from the data (Table 3.2), our initial attempts to fit the experimental data were 
based on equal infection of erythrocytes and reticulocytes (p = 1 in equation 3.13). They 
provide adequate fits to the RBC levels and reticulocyte data. (Figure 3.6A), but fail to 
adequately account for the observed proportion of infected reticulocytes (Figure 3.6B). 
Therefore we deemed it necessary to allow the parameter p (where p stands for 
preference) to be greater than one, and allow parasites to be p times more likely to infect 
reticulocytes than erythrocytes. This parameter is essentially the number of reticulocytes 
which would be parasitised per invaded erythrocyte in a system with equal numbers of 
each cell type. In our system there will not be equal numbers of each phenotype, and so 
the proportion of parasites which enter reticulocytes and erythrocytes will depend both 
on p and on the relative proportions of each cell type. This is formulated explicitly in 
equations 3.31 and 3.32. 
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Figure 3.4 Reticulocyte production in response to anaemia 
A) Average SE) RBC count (pink triangles, left hand axis), reticulocyte (yellow 
circles, left hand axis) and parasitaemia (blue squares, right hand axis) levels for P. 
berghei infected mice (n=6) showing the natural course of a P. berghei infection. 
B) Average SE) RBC count (pink triangles) and reticulocyte (yellow circles) curves 
for PIIZ treated mice (n=6). SE bars are often smaller than the size of the symbols and 
so are hard to see. 
In both panels SE bars are often smaller than the size of the symbols and so are hard to 
see. 
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To estimate the P. berghei preference for invading reticulocytes, we allow p to vary 
from 1 to 500 and use the Matlab® non-linear optimisation function (1 sqnoral in) to 
fit the percentage of infected reticulocytes and erythrocytes to the experimental data 
(Figure 3.7). Modelling across the cohort gave an estimate ofp = 153+8.7 
(mean ± S.E.), with 95% confidence intervals on the mean ofp of 130-174, indicating 
that parasites are around 150 times as likely to invade a reticulocyte as an erythrocyte. 
The results of fitting a typical mouse with p=153 can be seen in Figure 3.7A (RBC 
count and reticulocyte curves) and Figure 3.7B (proportion of infected reticulocytes) 
showing good fits. A value ofp=153 is used in subsequent modelling to estimate the 
underlying production rate of reticulocytes. 
3.4.5 Reticulocyte production during P. berghei infection 
The levels of reticulocytes that we observe during P. berghei infection are a balance of 
production and destruction. For a given level of infection and destruction we estimate 
the number of reticulocytes that need to be produced to maintain the observed 
circulating levels (using equation 3.37). Allowing for reticulocytes to be 153 times as 
likely to become parasitised as erythrocytes, the estimated production of reticulocytes in 
P. berghei infection is comparable to that during PHZ treatment (Figure 3.8A). That is, 
once we include the preference of P. berghei for reticulocytes in the model the 
relationship between RBC levels and reticulocyte production following P. berghei 
infection and PHZ treatment are almost identical. 
To complete our analysis we also address the question by assuming the production of 
reticulocytes is "normal" in P. berghei infected mice (i.e. the relationship between 
reticulocyte production and RBC count is the same as in PHZ treated mice and that 
reticulocyte production is determined by equation 3.38) and then estimate what the 
observed level of circulating reticulocytes should be. That is, if production is the same 
as in PHZ treated mice and given increased destruction due to the preferential infection 
of reticulocytes, what net level of reticulocytes would we expect to see in circulation? 
Figure 3.8B illustrates the predicted level of absolute reticulocytes in circulation (green 
line) and is in close agreement with the experimental data from P. berghei infected mice 
(dashed blue line). 
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Figure 3.5 Preferential infection of reticulocytes during P. berghei infection 
A) Percentage of total parasites found either inside erythrocytes (green triangles) or 
inside reticulocytes (red diamonds). At low parasite burdens, the majority of parasites 
are found inside erythrocytes. As parasitaemia increases, more than 80% of parasites 
are found inside reticulocytes. 
B) Proportion of erythrocytes (green triangles) and reticulocytes (red diamonds) that 
contain parasites (note that this is the same data as in (A), but represented as 
"parasitaemia of erythrocytes" and "parasitaemia of reticulocytes'). At all levels of 
parasitaemia, relatively more reticulocytes contain parasites than do erythrocytes. For 
parasite burdens of greater than 2 x 108 cells more than 50% of reticulocytes are 
parasitised, while the percentage of parasitised erythrocytes never exceeds 20%. 
B 100% - 
80% - 
Tv u 0 
mo 1:1  60% • 
0 w. 
45  - 40% • o Q o 
6: 	20% • 
Chapter 3: Preferential Reticulocyte Infection during P. berghei 	 - 82 - 
- - 'RBC count (model) 
Haematocrit (expt)  
Reticulocytes (model) 
Reticulocytes (expt) A 
71 
6 .11 
cn < 5. 
-?-<- 4 • 
E 3  
tia 
15 2 - 
0 
0 2 4 6 8 10 12 14 16 
reticulocytes (exp) 	—reticulocytes (model) 
erythrocytes (exp) 	- - 'erythrocytes (model) 
•• • • 	441, • • • 
• • • • • • 
• 
• 	 aSa 
G 
A 	• 
0% laa — 
0 
• 
0.5 
	
1.5 
Figure 3.6 Modelling without including preferential infection of reticulocytes 
Model fits for a typical P. berghei infection with p =1 (equal invasion of reticulocytes 
and erythrocytes). Panel A shows goodfits to RBC count and reticulocyte data, however 
panel B shows a very poor fit for the percentage of infected cells of each phenotype. 
That is, when there is equal infection of reticulocytes and erythrocytes there is no way 
one can obtain the large observed difference in parasitaemia in reticulocytes vs. 
erythrocytes. 
A) Model fits to RBC counts (pink) and reticulocyte counts (yellow). Experimental data 
for a representative animals is shown as closed symbols and solid lines, and model fits 
for this animal are given as broken lines. 
B) The percentage of reticulocytes and erythrocytes containing parasites estimated from 
the model (lines) overlayed on the experimental data (symbols) (this is a fit to the data 
in Figure 3.5B). Model simulations depicted by lines overlayed on experimental data 
(symbols). The level of parasite invasion of erythrocytes (green triangles, dotted lines) 
and reticulocytes (red diamonds, solid lines) are shown for all animals, and the fits are 
shown for the same animal used in panel A. 
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Figure 3.7 Modelling the preferential infection of reticulocytes 
Model fits for a typical P. berghei infection with p = 153 (reticulocytes 153 times more 
likely to accept a parasite than erythrocytes). Increasing p to 153 means that panel A 
shows good fits to RBC count and reticulocyte data, and panel B also shows a good 
simulation of the percentage of infected reticulocytes and erythrocytes. 
A) Model fits to RBC counts (pink) and reticulocyte counts (yellow). Experimental data 
for a representative animals is shown as closed symbols and solid lines, and model fits 
for this animal are given as broken lines. 
B) The percentage of reticulocytes and erythrocytes containing parasites estimated from 
the model (lines) overlayed on the experimental data (symbols) (this is a fit to the data 
in Figure 3.5B). Model simulations depicted by lines overlayed on experimental data 
(symbols). The level of parasite invasion of erythrocytes (green triangles, dotted lines) 
and reticulocytes (red diamonds, solid lines) are shown for all animals, and the fits are 
shown for the same animal used in panel A. 
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3.5 Discussion 
The development of anaemia during malaria infection is multi-factorial and a 
suppression of the erythropoietic response to anaemia is thought to contribute to 
decreased haemoglobin levels. A suppressed erythropoietic response can hinder the 
appropriate recovery from anaemia, and cause red blood cell levels to remain depressed 
for far longer than in other non-malarial anaemias. If sustained over rather protracted 
time scales, erythropoietic suppression might also be sufficient for the development of 
anaemia in the absence of accelerated destruction of RBCs. An insufficient number of 
circulating reticulocytes has been observed in P. falciparum (Phillips et al., 1986, 
Abdalla et al., 1980, Kurtzhals et al., 1997), P. vivax (Wickramasinghe and Abdalla, 
2000) and P. chabaudi (Chang et al., 2004a) infection. This reduction in circulating 
reticulocytes is commonly attributed to reduced RBC production, however it has also 
been suggested that preferential infection and destruction of reticulocytes may 
contribute to low numbers in circulation (Collins et al., 2003). Thus although there is 
evidence for authentic erythropoietic suppression in human, simian and murine 
malarias, additional mechanisms may contribute to the phenomenon of reduced 
peripheral reticulocyte levels. 
We analyse the reticulocyte response to anaemia induced by high parasite burdens 
during the latter stage of acute P. berghei infection, when initial erythopoietic 
suppression is overcome and compensatory erythropoiesis is underway. We find that 
there are decreased levels of circulating reticulocytes during acute malarial anaemia as 
compared to non-malarial anaemia. We quantify the preference of P. berghei for 
reticulocytes and estimate that in the presence of equal numbers of erythrocytes and 
reticulocytes P. berghei is around150 times more likely to infect a reticulocyte. 
In the presence of preferential parasitisation of reticulocytes, increased erythropoiesis 
will not translate into a comparable increase in observed reticulocyte numbers and RBC 
levels. Newly created reticulocytes simply serve as targets for parasitisation, and once 
parasitised they rupture one day later without contributing to the RBC count for an 
extended period. Indeed, our results argue that increased reticulocyte production may 
"add fuel to the fire" of parasite growth, because of the higher susceptibility of 
reticulocytes to infection. This conclusion is supported by studies of P. berghei 
infection in rats and mice (Zuckerman, 1957, Ladda and Lalli, 1966, Singer, 1953), 
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Figure 3.8 Normal reticulocyte response to anaemia during P. berghei infection after 
accounting for preferential invasion of reticulocytes. 
A) The experimental data (symbols) for the relationship between circulating 
reticulocyte numbers (y-axis) and RBC levels two days prior (x-axis) illustrated for 
P. berghei infection (blue triangles) and phenylhydrazine treatment (red circles). The 
dashed blue line indicates the curve fit for the relationship between circulating 
reticulocyte levels and RBC levels during P. berghei infection. The dashed red line 
indicates the curve fit for the relationship between circulating reticulocyte levels and 
RBC levels following PHZ administration (in the case of PHZ treated mice this is also 
the level of reticulocyte production). The solid blue line indicates the estimated level of 
reticulocyte production in P. berghei infection in the presence of preferential infection 
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of reticulocytes calculated using the model (p=153). Once the preferential infection of 
reticulocytes is taken into account, the estimated production of reticulocytes in the 
P. berghei infected mice rises (as indicated by the blue arrow) to the observed 
reticulocyte levels in the PHZ treated mice 
B) A similar result is obtained when we allow the reticulocyte production in P. berghei 
infected mice to be the same as that in PHZ treated mice (dashed red line), and then 
estimate what levels of reticulocytes would be observed in the P. berghei mice (solid 
green line). Once we have accounted for preferential infection of reticulocytes, the 
predicted circulating reticulocyte numbers (solid green line) are reduced (green arrow) 
to the same level as seen in the P. berghei infected mice (dashed blue line). 
where decreased reticulocyte production (as a result of polycythemia and bone marrow 
irradiation) led to a delay in patency and reduced peak parasitaemia, and increased 
reticulocytosis (as a result of bleeding) led to more severe disease. A similar 
phenomenon has also been observed in P. yoelii infection in mice (Vigario et al., 2001) . 
Once preferential invasion of reticulocytes is taken into account, the erythropoietic 
response to anaemia in P. berghei infected mice after the first week appears equivalent 
to that in PHZ treated mice. It is only the ongoing preferential parasitisation and rupture 
of immature red blood cells which causes the observed suppression in the number of 
reticulocytes in circulation during the period of anaemia. The fact that this conclusion 
arises from detailed modelling and kinetic analysis may raise concern that this is merely 
an artefact of the methodology. To address this, we can also return to the data to see 
whether we can intuitively understands the conclusions reached through modelling: 
This can be done by piecing together several observations: (i) during the period of 
anaemia the level of circulating reticulocytes in P. berghei infected mice is around half 
that seen in PHZ treated mice (Figure 3.3), (ii) almost 100% of reticulocytes are 
infected at this time (combining Figure 3.5B and Figure 3.4A), (iii) the lifetime of an 
infected reticulocyte is around half that of an uninfected reticulocyte (since the parasite 
lifetime is one day vs. the two day maturation of an uninfected reticulocyte). Thus, 
putting together (ii) and (iii) leads to the conclusion that reticulocytes are living on 
average half as long as normal. On this basis it is expected that, for any given level of 
reticulocyte production, the steady state level of reticulocytes seen in the blood should 
also be half the normal level. Thus, even this relatively crude analysis supports the 
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conclusion that if reticulocytes are produced at an identical rate in P. berghei infected 
and PHZ treated mice, we should see (as stated in (i) above) around half the level of 
circulating reticulocytes in P. berghei infection due to their preferential infection. 
At first sight this result would seem to contradict earlier observations of suppression of 
erythropoiesis during P. berghei (Sexton et al., 2004) and other forms of malaria 
infection. However, care needs to be taken to differentiate the impact of erythropoietic 
suppression at different stages of infection. In early infection, parasite and / or immune 
mediated suppression of erythropoiesis is evident, indicated by decreased reticulocytes 
(Figure 3.4A) and decreased erythroid gene expression (Sexton et al., 2004). Given the 
increased susceptibility of reticulocytes to infection, this may well represent an adaptive 
response to reduce the early growth of parasites. We believe that as haemolytic anaemia 
develops later in this murine malaria infection, this suppression of erythropoiesis is 
overridden by the need to increase red blood cell levels, and the erythropoietic response 
to anaemia is then normal. Given the available data, we cannot exclude that some minor 
reduction in erythropoiesis still occurs during the period of anaemia. However, since 
preferential infection of reticulocytes can fully account for the observed reduction in 
their numbers, any contribution of reduced reticulocyte production to the observed 
reticulocyte 'deficit' must be at best slight. This conclusion must also be tempered by 
the observation that unlike in humans where erythropoiesis occurs exclusively in the 
bone-marrow, murine erythropoesis can occur in two distinct organs, namely bone-
marrow and spleen, and each organ may be differentially regulated. Thus following 
early erythropoietic suppression, compensatory 'stress' erythropoesis may proceed in 
one site while erythropoietic suppression is maintained elsewhere. 
In human malaria, P. vivax has been shown to exhibit a strong preference for invasion 
of reticulocytes (Garnham, 1966, Kitchen, 1938), while P. falciparum can efficiently 
invade RBC of all ages (Garnham, 1966, Bruce-Chwatt, 1948) However, even in 
P. falciparum a 2 — 14 fold preference for invasion of reticulocytes has been observed 
both in vitro (Clough et al., 1998) and in vivo (Hegner, 1938, Pasvol et al., 1980). These 
estimates were obtained simply by dividing the proportion of reticulocytes infected by 
the proportion of mature RBC infected. Use of the same method here would have 
estimated an average of only around a 20 fold preference for reticulocytes, because this 
estimation technique does not take into account the probability of encountering 
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reticulocytes or the dynamics of infection. The 2-14 fold preference for reticulocytes in 
P. falciparum infection is likely to be a significant underestimate of the true preference 
for reticulocytes, since (i) it was observed in patients with relatively low levels of 
reticulocytes (1-10%), and (ii) the longer parasite lifetime means that many infected 
reticulocytes may mature into erythrocytes, and thus some parasitised erythrocytes will 
actually have been infected as reticulocytes. 
Our analysis suggests that caution needs to be used when relying solely on decreased 
circulating reticulocyte levels as evidence for erythropoietic suppression, as the 
preferential infection and destruction of reticulocytes may confound the analysis 
(Srichaikul et al., 1969). In the light of our observations concerning P. berghei and the 
effect its preference for reticulocytes has on the levels of circulating reticulocytes, it 
seems likely that a parasite species' propensity to infect younger red blood cells may 
contribute in varying degrees to the reduced reticulocyte levels in human malaria. 
Although the quantitative analysis of infection kinetics used in this study was designed 
for P. berghei infected mice, it could easily be adapted to investigate the dynamics of 
RBC infection and replacement in humans, as we see in the next chapter. Certain 
modifications would be necessary to account for the differences in host parasite 
interactions and kinetics of infection, however the model is broad enough to include 
these and be used to shed further light on the issue of erythropoiesis in human malaria. 
Further studies should aim to investigate the rates of infection and destruction of 
reticulocytes in P. falciparum and P. vivax infections in order to understand the role of 
preferential infection of reticulocytes in the pathogenesis of severe malarial anaemia. 
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3.6 Appendix 
3.6.1 Initial Conditions of the model 
The initial conditions of the model were determined from the experimental data. The 
initial haemoglobin levels, H(0) were determined individually, from the experimental 
data for each mouse. Since in many mice haemoglobin levels oscillated between day 0 
and the beginning of RBC loss, a feature not captured by our model, the initial 
haemoglobin levels, H(0) were taken to be the haemoglobin levels immediately prior to 
initiation of RBC loss (See Figure 3.6 for an example). The average value of H(0) was 
107% (range 104%-112%). 
The initial level of reticulocytes is also determined from the average initial reticulocyte 
level in Naive mice. We therefore set R(0) = 2%. 
The initial parasite levels were determined from the experimental conditions described 
in (Evans et al., 2006), as P7-07(0) = 1.0695 x104%. In order to determine the number of 
rupturing cells over the first parasite lifetime, we assume that parasitised cells were 
injected with an exponential distribution of ages, with a greater number of recently 
parasitised cells. This approach is adopted to give a smooth curve for the number of 
rupturing cells. Thus, we define: 
ceP 
ep(t) 	= 	T
e' 	for—/ <t< 0 
	
1— e`" 	P 
where ot = 1.33 is a constant chosen to give smooth curves. 
We set the initial values of Rp(0) and Ep(0) so that Rp(0) + Ep(0) = PT07-(0) and we set 
Rp(0) = 0.02 Ep(0) (Since reticulocytes initially make up 2% of the normal RBC levels). 
3.6.2 Numerical Simulation of the Model 
In this section we explore how the model was numerically simulated. In order to 
simulated the model we divide the time into discrete periods of length At and consider 
how the variables of Table 3.1 change over one time step. 
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We let t, be the current time step. The next time step is given by t, + At = ti± j. In the 
model simulation we set At = 0.05 day. Thus our time steps were small compared to the 
time scale of the parasite dynamics. Decreasing the value of At showed no significant 
effect on the model simulations. 
In our numerical simulations the basis of the model is the four classes of cells we 
consider; reticulocytes (Ru(t)), parasitised reticulocytes (Rp(t)), erythrocytes (Eu(t)) 
and parasitised erythrocytes (Ep(t)). 
The transitions between different cell classes (corresponding to the arrows in Figure 
3.1) have been described for the continuous model in equations 3.24 - 3.27. We now 
form a Euler discretisation of these as: 
Ru(t) = Ru(t—At) + At s(0, t) — AtRu,mat(t) 	AtRu,para(t) 	8u(t)At Ru(t) (3.40) 
Rp(t) = Rp(t—At) + AtRu,para(t) 	AtRAmat(t) — AtRp,„pt(t) — 42(t)At Rp(t) (3.41) 
Eu(t) = E„(t—At) + AtRu,mat(t) — AtEu,para(t) — 8u(t)AtEu(t) (3.42) 
Ep(t) = Ep(t—At) + LXtRp,mat(t) + AtEu,para(0—  AtEp,rupt(t) — op(t)At Ep(t) (3.43) 
The total number of reticulocytes (RT07(t)) is given by the sum of parasitised and 
unparasitised reticulocytes: 
RT0T(t) = Ru(t) + Rp(t). 	 (3.44) 
The total number of parasites (PT0T(t)) is given by the sum of parasitised reticulocytes 
and parasitised erythrocytes. 
PTQJ(t) = Rp(t) + Ep(t) 	 (3.45) 
We now consider how each of the quantities of Table 3.1 appearing in equations 3.40 -
3.43 are numerically calculated. 
3.6.2.1 Maturing reticulocytes (Ru,mat(t) and Rp,,,,„t(t)) 
Reticulocytes mature into erythrocytes one reticulocyte lifetime (4) after they are 
produced. This is of course assumes that they have not been cleared and have not 
ruptured before their scheduled maturation time. If a cell has not become parasitised as 
a reticulocyte it will mature into a normal erythrocyte, and if it has become parasitised it 
will mature into a parasitised erythrocyte. 
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The number of reticulocytes maturing at time t is a fraction of the number of 
reticulocytes that were produced at time t-/„. We consider first the number of 
unparasitised reticulocytes that mature at time t and then consider the maturing 
parasitised reticulocytes. 
We denote the reticulocytes produced one reticulocyte lifetime ago, at time t — lr , by 
s(0, t — /r). By t — lr +At a proportion of them (At8H(t — lr + At) s(0, t — 4.) ) have been 
cleared and a proportion of them have become parasitised. The proportion that become 
parasitised at any time t is the ratio of all the reticulocytes becoming parasitised that 
time period (Ru,para(t)) and the total number of unparasitised reticulocytes (Ru(t)). We 
call this quantity the parasitised reticulocyte percent at time t and denote it by y/(t). We 
define ip(t) by: vi(t) = Ru,para(t) (R,(0+ Ru,para(t)). Using the ratio yi(t) we can define 
the number of reticulocytes produced at a time to and becoming parasitised over the 
time interval to to to +At by s(0, to)tp(to +At). 
Maturation of unparasitised reticulocytes (Ru,mat(t)) 
We require a method to calculate Rionat(t), the number of unparasitised reticulocytes 
scheduled to mature. We note that using equation 3.18, Ru,mat(t) = s(lr , t). We note that 
s(kAt, to+ kAt) represents the number of unparasitised reticulocytes produced at time to 
and still present and unparasitised at time to + kAt (and so having age kAt). Using the 
discussion above, we find that s(At, to+At) is given by 
s(At, to+At) = s(0, t)(1 — At 8H(t + At) — tAt + At) ). 	 (3.46) 
Similarly the number of reticulocytes produced at time t and still present as 
unparasitised reticulocytes after two time periods (s(2At, t)) is given by 
s(2At, to+2A0 = s(At, to+ At) (1— Mt() + 2At)At - (to + 2At)). 	(3.47) 
and the number of reticulocytes produced at time t and still present as unparasitised 
reticulocytes after k time periods (s(kAt, t)) is given by 
s(kAt, to+kAt) = s((k-1)At, to+(k-1)At) (1— gu(to + kAt)At - 1p(to + kAt)) 
= S(0, to) n 	- 8u(to + jAt)At - y)(to + j At) ) . 
j=i 
(3.48) 
We apply this process starting from time t — Ir and continuing throughout the 
reticulocyte lifetime to arrive at an equation for Ru,mat(t), the number of reticulocytes 
that mature into unparasitised erythrocytes at time t. This equation is: 
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yAr 
Ru, =KO = s(lr, t) = s(0, t — /r) H ( 1 — 811(t — lr  + jAt)At - tp(t —1, + j At)) . (3.49) 
Maturation of parasitised reticulocytes (Rp,,,,„t(t)) 
An exact definition of Rp,,,,t(t) has been given in equation 3.19. We consider a 
discretised version of this equation (equation 3.50) to calculate Rp,,,,,r(t) numerically. 
Any reticulocytes parasitised less than one parasite lifetime ago, that have not decayed, 
will still be in circulation. These cells will be ready to mature from a parasitised 
reticulocyte into a parasitised erythrocyte. See Figure 3.9 for a diagrammatic 
representation of this process. The quantity c(t-1„ kAt, t) represents the number of 
reticulocytes that were produced at time t — 1,, have been parasitised for a length of time 
equal to kAt (where 1 S kAt < p) and are still present to mature at time t. Then the total 
number of parasitised reticulocytes maturing at time t will be given by the sum over k of 
these quantities. Thus we have: 
/At-1 
Rp,mat(t) 	E 	c(lr, kAt, t). 	 (3.50) 
k=1 
We now determine an expression for the quantity c(1,, kAt, t). First we determine an 
expression for c(1,—kAt, 0, t), the reticulocytes produced at time t —1,, still present and 
unparasitised at time t — kAt (and so having age t — kAt —(t — 10= — kAt) and becoming 
parasitised over the next time interval. These are given by s(1,—kAt, t—kAt) y,(t — kAt). 
These reticulocytes will decay at a rate of 8P(t) once they have become parasitised. 
Thus, c(1,, kAt, t), the number of reticulocytes that were produced at time t — 1„ became 
parasitised at time t — kAt and are still present to mature at time t, is given by: 
k-1 
c(1,, kAt, t) = s(1,—kAt, t—kAt)v(t — kAt) n (1— Sp(t — j At) ). 	(3.51) 
J=0 
3.6.2.2 Parasite generation (c(t), rp(t) and ep(t)) 
The total number of parasites (PT0T(t)) in circulation for each mouse at time t is read off 
a smooth curve fitted to the experimental data for the mouse. The curve is a spline curve 
fit to the data using the Matlab® curve fitting package (func t ion= f t , ltype = 
`smoothingspline', smoothingParam=0.7). 
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The number of parasitised cells that need to be produced at each time point (cp(t)) is 
then calculated to preserve the total value, PT07(t). In calculating cp(t) we consider 
changes in parasitised cell populations occurring during this time period. These changes 
could be due to either cells being cleared or cells rupturing. We can combine equations 
3.41 and 3.43 (or discretise equation 3.11) to show that the parasites produced are 
given by the following equation: 
cp(t)= ProT(t)—Pmr(t—A0+ R prupi(t) E p rup, (1) + Atgp(Rp(t)+ E p (t)) . (3.52) 
rupturing cells 	 decaying cells 
We can then use equation 3.12 to establish how many of these parasites are produced in 
reticulocytes and how many in erythrocytes. Equations 3.31 and 3.32 give an exact 
definitions of Ru,para(t) and Eu,para(t) as 
_ 	pRu (t)  
pRu (t)+ Eu(t) cp(t) 
Ru,para(t) _ E
u (t)  elm) 
pRu (t)+ Eu (t) 
However during the numerical calculations we require an expression for Ru,para(t) before 
we can calculate an expression for Ru(t) or Eu(t). Therefore we approximate Ru(t) by 
Ru(t—AO —Ru,mat(t) and Eu(t) by Eu(t—At)+Rumiar(0. We therefore obtain the following 
expression for Ru,para(t): 
p(Ru (t — At) — Ruma,(t)) 
Ru,para(t) 
	
	 cp(t). 
p(Ru (t — At) — Rumat (t))+ (E u (t — At) + Ru,ma, (t)) 
By a similar argument we have 
p(Eu (t — At) + Ru,„,,,(t)) 
Eu,para(t) 	 cp(t). 
p(Ru (t — At) — Ru,„,,,(t))+ (E u (t — At) + Ru ,„,a,(t)) 
3.6.2.3 Parasitised cell rupture (Rp,,,,pt(t) and Ep,rupt(t) ) 
Finally, we consider the parasitised cells that are rupturing in one time period (between 
t— At and t). This group of cells is essentially composed of three subgroups. 
1) Cells that were parasitised as erythrocytes one parasite lifetime ago and have not 
yet decayed. We denote the number of these cells by Ep,ruptE(t). 
2) Cells that were parasitised as reticulocytes one parasite lifetime ago, have not 
yet decayed and have not yet matured into erythrocytes. This group is denoted as 
Rp,rupt(t). 
Ru,para(t) 
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3) Cells that were parasitised as reticulocytes one parasite lifetime ago, have not 
yet decayed and have now matured into erythrocytes. We denote these cells by 
Ep,ruptRW• 
The total number of erythrocytes rupturing (Ep,rupt(t)) is then given by 
Ep,rupt(t) — Ep,mptE(t)+ Ep,mptR(t)). 	 (3.53) 
Rupturing cells parasitised as erythrocytes (Ep,,,,;(t) ) 
The first of these subgroups is the simplest to address. Cells that were parasitised as 
erythrocytes one parasite lifetime ago have been undergoing clearance at a rate of op(t) 
since their parasitisation, and those that are left are now ready to rupture. The equation 
governing the number of such cells remaining is: 
/At-1 
Ep,ruptE(t) = Eu,para(t — 1p) n 	kAt)). 	 (3.54) 
k=1 
Rupturing cells parasitised as eeticulocytes (Ep,,,,NR(t) and Rp,rupt(t)) 
We let Rp,remain(t)  denote the number of cells that were parasitised as reticulocytes one 
parasite lifetime ago and that are still present in some form (either as reticulocytes or as 
erythrocytes) at time t and so are now ready to rupture. As in equation 3.54, we 
calculate Rp,remain(t)  by the following equation: 
/At-1 
Rp,remain(t) = Ru,para(t — 1p) H ( 1— At4,(t — 1p + kAt)). 	 (3.55) 
k=1 
We then calculate how many of the reticulocytes that were present and unparasitised 
one parasite lifetime ago could now have changed state into erythrocytes. Dividing this 
quantity by the total number of unparasitised cells present at the same time provides the 
proportion of Rp,remain(t) that will be rupturing having already matured into an 
erythrocyte. We let the group of reticulocytes which have "changed state" into 
erythrocytes since time t — 1p be denoted by rchstat(t — /p). The ratio 
Rchstat(t —1p)/ Ru(t — 1p) gives the proportion of reticulocytes that were parasitised at 
time t — 1p (one parasite lifetime ago) and have now matured into erythrocytes. Thus, we 
have 
and 
RchSiat( t — p )  
EpfuptR(t) =  Rp,remain(t) Ra(t—lP )  
(3.56) 
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RchStar 	p (t — 1 ) 
Ru (t — p ) 
 
rupt(t) = Rp, remarn(0 (3.57) 
  
The reticulocytes that compose the group RchStat(t — 1p) are those which were present as 
unparasitised reticulocytes one parasite lifetime ago (and so have an age < 1p + 4) and 
that have now matured into erythrocytes (and so have an age > /r). They are thus cells 
that have not been cleared or become parasitised by time t — 1p and so are represented by 
s(a, t— 1p), with lr < a < lr + 1p. Then, using equation 3.48 we can write RchStat(t  1p) as: 
(4+1p )/At 	 1,, /4r-1 
	
RchStat(t 1p)= 	s(a, t— 1p) JJ ( 1 — Ou(t + j At)At - y.(t* + j At)). 
1,[6,1+1 	 j =lc +1 
,+1 p )/ Ar 	 a / At 
= 	E 	s(0, t — 1p a) n (1— 6;(t — 1p — a+ jAt)At - cp(t — 1p — a+ j At)). 
Ar+i J=1 
(3.58) 
reticulocyte 
parasitised 
 
parasitised 
reticulocyte 
ruptures as 
erythrocyte 
   
I 	I 
t- Ir 	 t - 1p 	 t 
reticulocyte 
produced 
reticulocyte 
matures into 
erythrocyte 
Figure 3.9 Timeline describing parasitised reticulocytes which may mature into 
parasitised erythrocytes 
A reticulocyte due to mature at time t was born at time t 	If it becomes parasitised at 
some time point between t — 1p and t then the parasitised reticulocyte will mature into a 
parasitised erythrocyte. The parasitised cell will then rupture some time between time t 
and time t + 1p as an erythrocyte. 
Chapter 4 
Low red cell production may protect against 
severe anaemia during a Malaria Infection — 
Insights from modelling 
4.1 Overview 
The malaria parasite causes lysis of red blood cells, which can result in anaemia, a 
major cause of mortality and morbidity. Intuitively, one would expect the erythropoietic 
response to increase in order to compensate for this loss. However, it has been observed 
that the response is weaker than would be expected. Furthermore iron supplementation 
of iron deficient children in malaria endemic regions can paradoxically adversely affect 
the clinical outcome of malaria infection. A possible explanation may lie in the 
preference that some malaria parasites show for infecting immature red blood cells 
(reticulocytes). In the presence of a parasite preference for immature red cells, a rise in 
red cell production can "fuel the fire" of infection by increasing the availability of the 
parasite's preferred target cell. 
We present a mathematical model of red blood cell production and infection in order to 
explore this hypothesis. We assess the effect of varying the reticulocyte replacement 
rate and preference of the parasite for reticulocytes on four key outcome measures 
assessing anaemia and parasitaemia. 
For a given level of parasite preference for reticulocytes we uncover an optimal 
erythropoietic response which minimises disease severity. This optimal rate is far lower 
than the rate in a healthy individual. Increasing red blood cell production much above 
this optimum confers no benefit to the patient, and in fact can increase the degree of 
anaemia and parasitaemia. These conclusions are consistent with epidemiological 
studies demonstrating that both iron deficiency and anaemia are protective against 
severe malaria, whilst iron supplementation in malaria endemic regions is associated 
with an increased number of malaria related adverse effects. 
- 96 - 
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4.2 Introduction 
Malaria presents a major health burden in the developing world, and is associated with a 
range of clinical symptoms including acute and chronic anaemia. The malaria parasite 
causes lysis of both infected and uninfected red blood cells (RBCs) (Dondorp et al., 
1999, Ekvall, 2003), leading to anaemia, one of the most significant clinical outcomes 
of the disease. Intuitively, one would expect a host to respond by increasing the 
production of RBCs to compensate. Instead it has been observed that in both human 
(Abdalla et al., 1980, Abdalla, 1990) and animal (Maggio-Price et al., 1985, Egan et al., 
2002, Chang et al., 2004a) malarias the RBC replacement rate may be suboptimal, and 
baseline reticulocyte levels have been observed regardless of the degree of anaemia 
during most cases of both P. falciparum and P. vivax infections (Srichaikul et al., 1967, 
Srichaikul et al., 1969). It is usually thought that this suppression of the erythropoietic 
response to anaemia may be an unfortunate side effect of the inflammatory response to 
infection. One would expect this to exacerbate and prolong the anaemia and hence 
potentially have an adverse effect on the prognosis. It has been postulated that an 
inadequate erythropoietic response contributes to disease severity and death. 
This apparent paradox is reinforced by observations that in regions where malaria is 
endemic, iron supplementation for iron-deficient children may have significant 
detrimental consequences on mortality and morbidity during malaria infection (Smith et 
al., 1989, Sazawal et al., 2006, English and Snow, 2006). This is despite the fact that 
iron supplementation improves haematological and iron status. In regions where malaria 
is not endemic, iron supplementation has no adverse effects (Oppenheimer, 2001, 
Iannotti et al., 2006). 
A separate study (O'Donnell et al., 2007) has investigated the relationship between 
anaemia and erythropoietin (EPO) production and demonstrated that younger children 
have higher EPO production for a given level of anaemia. Since severe malarial 
anaemia (SMA) is more common at early ages when there is a high level of EPO 
produced in response to anaemia, this suggests that high RBC production may have a 
paradoxical negative effect on anaemia during P. falciparum malaria, and may also 
explain why severe P. vivax malaria is more common in very young children (Genton et 
al., 2008). 
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A possible explanation comes from the preference exhibited by many species of malaria 
for immature RBCs (reticulocytes) compared to mature RBCs (erythrocytes). This 
preference is estimated to be as high as 34-180 fold in P. vivax (Mons et al., 1988a, 
Mons et al., 1988b, Mons, 1990), and in the range 2-14 fold for P. falciparum (Hegner, 
1938, Wilson et al., 1977, Pasvol et al., 1980). In the presence of such preference, a 
high reticulocyte replacement rate (RRR) could serve to provide large numbers of the 
parasite's preferred target cell. This could significantly boost parasitaemia and increase 
the severity of the disease. Iron supplementation in iron-deficient individuals would be 
likely to increase reticulocyte production leading to similar effects. 
On the other hand, a high RRR will also serve to replace those RBCs destroyed by the 
parasite, serving to alleviate anaemia and hence having a positive effect on the outcome 
of the infection. The picture is further complicated by the results of experiments that 
manipulated reticulocyte production in mice (Singer, 1954b) and rats (Zuckerman, 
1957) infected with P. berghei, and more recently in mice infected with P. chabaudi 
(Chang et al., 2004b). An increase in reticulocyte production early in infection can 
significantly increase parasitaemia and reduce survival rates. On the other hand, an 
increase in reticulocyte production at an appropriate stage of the infection led to reduced 
mortality (Chang et al., 2004b). 
The overall effect of an increase in the reticulocyte replacement rate thus depends on the 
balance and timing of these positive and negative interactions and on the degree of the 
parasite preference for reticulocytes, which varies from species to species. It is 
impossible to infer the integrated outcome of all these factors by intuition alone. It may 
thus be that erythropoietic suppression is simply an inadvertent consequence of 
inflammation and has negative consequences for the host, or it may be a host protective 
effect to reduce the availability of preferred target cells. 
Similar counter-intuitive phenomena that cannot be understood through conventional 
experimental approaches are routinely encountered in biological systems. One common 
reason why intuition may be insufficient to understand such behaviour is the presence of 
regulatory mechanisms acting in opposing directions. The outcome of these 
mechanisms will depend on the fine balance between competing pressures (in this 
example the response to anaemia competes with the production of preferred targets), 
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and this balance may be a complex function of a wide range of other interactions. The 
only way to predict and explain the behaviour of such systems is to quantify the key 
interactions and analyse them within the framework of a mathematical or computational 
model (Stark and Hardy, 2003, Hardy and Stark, 2002, Hastings and Palmer, 2003). 
The majority of models of pathogen growth within a host are straightforward ordinary 
differential equation (ODE) models, where target cells are treated as homogeneous. To 
model a preference for target cells of a certain type, one must incorporate into the model 
the variable for which the pathogen shows its preference. Thus, in this instance we must 
structure our model by red blood cell age. The model developed here does this through 
the use of a continuous age variable, and has a similar structure to the model presented 
by (Antia et al., 2008) which discuss the role of RBC resourse limitation in rodent 
malaria. Such a continuous age variable. This has the effect of turning the model into a 
complex integro-differential equation. This is in contrast to an earlier age structured 
model by McQueen and McKenzie which uses discrete age compartments and is 
applied to analyse the difference between the dynamics of various strains of malaria 
(McQueen and McKenzie, 2004). The detailed differences between the two models are 
discussed in the materials and methods section of this chapter. 
Our mathematical model allows us to distinguish between competing pressures and to 
explore the effects of changing key parameters such as the parasite's preference for 
reticulocytes and the rate of reticulocyte production. This allows us to understand the 
circumstances under which decreased reticulocyte production is either beneficial or 
harmful to the host. In the absence of any preference of the parasite for reticulocytes an 
elevated RRR is always beneficial to the host, since it allows rapid replacement of 
destroyed RBCs. However, we confirm that in the presence of a preference of the 
parasite for younger cells, a high RRR is not always advantageous. In fact, for a given 
reticulocyte preference there is a threshold RRR beyond which an increase in the RRR 
becomes detrimental. This threshold RRR is usually far below the normal RRR in 
response to anaemia, suggesting an important benefit of erythropoietic suppression. 
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4.3 Materials and Methods 
The model used here is based on that in chapter 3, but has been expanded to incorporate 
the dynamics of merozoite release and invasion. The age-structured time evolution 
equations are identical in both models, however the boundary conditions are altered in 
this chapter. The model still captures the continuous birth and death processes of cells 
as well as the discrete process of parasite rupture, but differs from the earlier model in 
the way that parasitised cells are produced. The model of chapter 3 is a non-autonomous 
model, which requires an experimentally determined input function giving the number 
of parasites as a function of time. In this chapter we introduce a continuous process to 
describe parasite growth, and hence provide a self contained model of the cell 
populations during a malarial episode. This can be used to make predictions about the 
course of an infection. In the previous model we considered the physiological 
relationship between reticulocyte replacement rate and red blood cell levels. In this 
model we allow the reticulocyte replacement rate to vary from its baseline production 
up to a normal erythropoietic response. This allows us to investigate the effects of 
reticulocyte production in response to anaemia. 
The model describes the population dynamics of classes of parasitised and unparasitised 
cells, separated into reticulocytes and erythrocytes. An overview of the model is 
depicted in Figure 4.1. Cells move between the groups according to the following 
interactions: 
i) Reticulocytes are produced according to a production function that is dependent 
on the RBC levels 6 days earlier (Belair et al., 1995). 
ii) Reticulocytes mature into erythrocytes after one reticulocyte lifetime, 
= 2.8 days (Colijn and Mackey, 2005). 
iii) Unparasitised reticulocytes and erythrocytes can become parasitised and move 
into their respective parasitised classes. The rate of infection of cells is determined 
by the number of available merozoites and the preference of merozoites for 
erythrocytes or reticulocytes. The infection rate of the parasite in mature 
erythrocytes is g and infection rate in reticulocytes is gp where p is the 
reticulocyte preference. 
Un-parasitised Parasitised 
Ep 
Reticulocytes 
reticulocytes 	unparasitised 
produced 	reticulocyte 
clearance;  
parasitised 
reticulocyte 
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rupturing 
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Figure 4.1 Model of malaria infection kinetics. 
Processes included in the model are red blood cell production, parasitisation and 
destruction as well as merozoite creation, invasion and death. Reticulocytes (Ru) enter 
the system from the top left in an uninfected state. These cells can either be cleared due 
to natural processes, become parasitised (Rp) through contact with a merozoite (m), or 
mature into an erythrocyte (Eu). Erythrocytes can also become parasitised (Ep) through 
contact with a merozoite. Parasitised cells rupture, producing merozoites, which then 
either decay, or go on to parasitise more cells. 
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iv) All cells are cleared according to an exponential decay function with the natural 
decay rate required for baseline turnover of RBCs that equates to an average RBC 
lifetime of 120 days (Belair et al., 1995). 
v) Parasitised cells rupture one parasite lifetime, 1p = 2 days (Garnham, 1966), after 
becoming infected, releasing a number (16) of free merozoites, which have a short 
lifespan (20 minutes) unless they infect another cell (Anderson et al., 1989). 
This model contains two major advantages over other published models. The first is the 
explicit inclusion of a time varying reticulocyte replacement rate that depends on 
previous RBC levels. Most other models of malaria do not address the fact that 
reticulocyte production during a malaria infection may be increased to compensate for 
anaemia (Gravenor et al., 1995, Hellriegel, 1992, Hoshen et al., 2000, Anderson et al., 
1989). Models that do include an elevated response only increase production by a 
maximum of two-fold from baseline (Jakeman et al., 1999, McQueen and McKenzie, 
2004), the problems with which are discussed below. The second advantage is that our 
model incorporates the effects of altering the preference of the malaria parasite for 
younger cells. The only other model to address this is one by McQueen and McKenzie 
(McQueen and McKenzie, 2004) and is discussed below. 
Our model has some similarities to that of McQueen and McKenzie (McQueen and 
McKenzie, 2004). Their model incorporated age restricted parasite invasion (parasites 
exclusively invade cells of a certain age) and an elevated red cell response to anaemia. 
However, there are also a number of differences between the two models. We allow for 
parasites to have a (variable) preference for reticulocytes rather than being simply 
restricted in their invasion to cells of a specific age, as was the case in the McQueen and 
McKenzie model. Such a preference is similar to what has been reported in in-vivo and 
in-vitro studies (Pasvol et al., 1980, Mons, 1990) and enables us to consider disease 
severity as a function of parasite preference for reticulocytes. A second difference lies in 
the reticulocyte replacement functions used. McQueen and McKenzie used only two 
replacement rates (basal production and an increase up to twice the basal rate), and did 
not attempt to model a "physiological" response to different levels of anaemia. Previous 
work has shown that an increase up to 10 times the basal rate is possible during severe 
anaemia (Mackey, 1997). In this paper we consider a range of different erythropoietic 
responses up to this maximum level. The significant flexibility that our model allows 
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both in terms of parasite preference and reticulocyte production means that we are able 
to consider disease progression as a function of these two variables. The three 
dimensional plots shown in Figure 4.8, Figure 4.7 and Figure 4.10 indicate the power of 
our model, and would have been difficult to generate using the model of McQueen and 
McKenzie. 
In addition to the differences described above, there is also a conceptual difference 
between our model, and that of McQueen and McKenzie. In their model they allow 
cells to pass through different age compartments at a certain rate. At each point in time 
there is a probability that a cell will age from one compartment into the next Although 
this can give the correct average lifetime of cells, a finite number of cells will move 
through the compartments infinitely fast, and so age instantaneously. Using their model 
it would therefore be possible (and probable) that some newly created cells would 
immediately pass through the reticulocyte stage, and so not be subject to preferential 
infection. 
Within the framework of our model cells age in a deterministic fashion. All cells must 
spend a specified amount of time as a reticulocyte (and so be the subject to preferential 
infection) before they age into an erythrocyte. Since a main priority of this paper is to 
accurately capture the preference of the parasite for newly created cells we felt that the 
potential instantaneous aging of cells in the McQueen and McKenzie model could 
impact on our results. We therefore chose to implement a model in which cells age in a 
deterministic fashion. 
The model can be understood through six basic equations (equations 4.19, 4.5 and 3.24 
-3.27). These include one equation to describe the production of newly formed 
reticulocytes (equation 4.19) and five differential equations to describe the changes in 
populations of the five species in the model (equations 4.5 and 3.24 - 3.27). Each term 
in equations 4.5, and 3.24 - 3.27 is associated with the arrows of Figure 4.1. 
Parameters of the model are listed in Table 4.1, and the variables are the same as those 
listed itn eh previous chapter in Table 3.1. 
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4.3.1 Formal definition of the model of chapter 4 
The model of this chapter is very similar to that of chapter 3. In both models, 
unparasitised cells either decay or become parasitised, and parasitised cells decay and 
then rupture after a fixed time. The main difference between the models is in the 
boundary condition for the the production of parasitised cells, c(a, 0, t). The model of 
chapter 3 is non-autonomous, and relies on an experimentally determined input function 
to define the level of parasitised cells (equations 3.11 and 3.12). In contrast, in the 
model of this chapter, the number of parasitised cells is determined using equation 4.4, 
which relies only on other model parameters. 
Therefore, the formal definition of the model of this chapter is identical to that given in 
equations 3.1 and 3.2, and the boundary condition for unparasitised cells, s(0, t) is given 
by equation 3.9 (rewritten below for completeness). Therefore the time evolution 
equations for s and c are: 
as(a, t) + as(dt , t) _ g(t) s(a, t) - c(a, 0, t) 	 (4.1) 
da  
ac(a, a p ,t)ac(a, a p ,t) + ac(a, a p ,t) 
Sp(t) C(a,ap, 1). 	(4.2) 
da + dap 	dt 
and the boundary condition for s(0, t) is: 
s(0, t) = AH(t- v)). 	 (4.3) 
We now define a new boundary condition for c(a, 0, t) in terms of other model 
parameters. 
The term c(a, 0, t) is simply the rate at which cells are parasitised, given by combining 
the infection rate parameter g with the current preference of the parasite for cells of age 
a, the number of merozoites M(t) and the number of unparasitised cells present, s(a, t). 
Thus the boundary condition for c(a, 0, t) is: 
c(a, 0, t) 	= 	g q(a)M(t)s(a, t) 
	
(4.4) 
where q(a) is defined as in equation 3.13, i.e. 
0 	for a 0 
q(a) 	= 	p 	for 0 < a 1, 
1 for a > 1, 
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In order to complete the model definition for this chapter, we define a formula for M(t), 
the number of merozoites in circulation. M(t) is affected by merozoites that are created, 
those that are used up when parasitizing new cells, and those that decay. It is in the 
definition of M(t) that the novelty of our model lies, as this is not a standard definition 
for an age structured model. 
Merozoites are created by rupturing parasitised cells. Each parasitised cell releases a 
number of merozoites upon rupture, denoted by mr (taken to be 16 in this work). A 
rupturing cell is a parasitised cell of any age, which has been parasitised for a length of 
time equal to /p, and therefore the total number of rupturing cells is given by 
c(v, 1p, t)dv, and the number of merozoites released is given by mr J c(v, 1p, t)dv. 
'p 
Merozoites are used up in the creation of parasitised cells. Each merozoite creates one 
parasitised cell, and so the number of merozoites used up is given by the total number of 
cells (of any age) becoming parasitised at this time. The number of such cells is given 
00 
by J c(v, 0, t) dv. Finally, merozoites decay at a rate 8,n(t ). Thus we have: 
0 
dM 
dt 
Mcreated(t) — Mused(t) — Mdecay(t) 
co CO 
mr J c(v, 1p, t)dv — 	c(v, 0, t)dv — M(t) 
0 
4.3.2 Closed form expression and DDE formulation of the model 
We now present a closed form expression for the model of this chapter. We first discuss 
some methods from the literature for determining ODE models from age-structured 
models, and then proceed to develop a DDE model for this chapter. 
Linear Chain Trickery 
A common method for determining an ODE model from an age-structured partial 
differential equation model is known as "Linear Chain Trickery" (Cushing, 1998, Metz 
and Diekmann, 1986, Bucharov and Hadeler, 2000). In the absence of parasitisation and 
delays, our model can be written as: 
as(a, t) as( a, t) _ s(a, t) 	 (4.6) 
da 	dt 
(4.5) 
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s(0, t) = f( cs(a,t)da) 	 (4.7) 
And we can rewrite an ODE for the total number of cells, H(t), using the linear chain 
trick as 
dH U(H) — Mt)] H(t) 
dt 
(4.8) 
However, the model of this chapter is far more complicated than the model presented 
above in equations 4.6 and 4.7. There are delay terms both in the boundary condition of 
s(a, t) (equation 4.3) and in the rupture of parasitised cells. It is possible that we could 
incorporate these delays and still apply linear chain trickery (MacDonald, 1978b, 
MacDonald, 1978a), however there additional factors which this method more difficult 
to apply. In our model there are three interacting populations, s(a, t), c(a, ap, t) and M(t). 
The time evolution equation for s(a, t) is more complicated than equation 4.6 (see 
equation 4.1) and the boundary condition for c(a, ap, t) does not match the criteria 
required for applying linear chain trickery (equation 4.4) since (i) it is dependent on two 
other populations and (ii) the birth rate is age dependent in a complicated fashion. In 
addition, the incorporation of a preference, whereby cells of different ages are 
parasitised at different rates means that the "decay" of unparasitised cells (i) depends on 
another population (M(t)) and (ii) is complexly age-dependent. Therefore we believe 
our model to be too complex to apply the standard linear chain trick to convert it to a 
system of ODEs.We now discuss an alternate derivation of a closed form expression for 
our model. 
Alaternate forms of model closure 
We proceed as we did for the model of chapter 3 and present a closed form expression 
for the model of this chapter which contains four compartments. These are unparasitised 
reticulocytes, Ru(t), unparasitised erythrocytes, Eu(t), parasitized cells, P(t) and 
merozoites, M(t). Note that once again we have combined unparasitised reticulocytes 
and erythrocytes into a single class. 
Matching Equilibrium Results 
Recently a method has been suggested for approximating a physiologically structured 
model by a stage structured ODE model which ensures that under equilibrium 
conditions the two models give identical results (de Roos et al., 2008). One option 
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would be for us to apply this method to the model of chapter 4, utitlising the equilibrium 
age distributions of cells which we derive later in section 4.6.3. It transpires, however, 
that it is actually possible to present a closed form expression for the model of chapter 4 
which equates at all time points (and not just at equilibrium). The result is a system of 
delay differential equations which correspond exactly to our model, and are derived 
below. 
DDE formulation of the Model 
Expressions for R„(t), Eu(t) and P(t) and their derivatives have been given in chapter 3 
in equations 3.14, 3.15 and 3.6 respectively and equations for their derivatives have 
been given in equations 3.28, 3.29 and 3.30 respectively. The equation governing the 
derivative of M(t) has been given in equation 4.5. The derivative equations are repeated 
here for completeness. 
dR, 
• s(0, t) — 	t) — J c(a,0 , t) da — nu(t)R„(t) 	(3.28) 
	
dt 	 0 
t) — J c(a, 0, t) da — 6.„(t)E„,(t) 	 (3.29) 
dt 
dP 	 -5 
• CP  (t) - CP  (t-1P  )e 	— 5p(t)P(t) (3.30) dt 
dM 
- m,. J c(v, 1p, t)dv — J c(v, 0, t)dv — 	M(t) 	 (4.5) 
0 
In order to proceed with the model closure we require closed form expressions for 
s(lr , t), the number of unparasitised reticulocytes maturing at time t, cp(t), the total 
number of cells becoming parasitised at time t, and J c(a, 0, t) da and J c(a, 0, t) da, 
0 
the number of unparasitised reticulocytes and erythrocytes becoming parasitised at time 
t. 
Expressions for the number of cells becoming parasitised are given by integrating 
equation 4.4 over the appropriate limits. We have: 
J c(a, 0, t) da = J g q(a)M(t)s(a,t) da 
0 	 0 
CO 
dt 
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= pgM(t) J  s(a, t) da 0 
= pgM(t)R„(t) 	 (4.9) 
And similarly 
c(a, 0, 1) da = 	g q(a)M(t)s(a, t) da 
1, 
gM(t) J s(a, t) da 
1, 
gM(t)E„,(t) 	 (4.10) 
Combining equations 4.9 and 4.10 gives an expression for cp(t) as: 
cp(t) = 	c(a, 0, t) da 
= 	J c(a, 0, t) da + 
0 1, 
c(a, 0, t) da 
= pgM(OR,i(t) + gM(t)E„(t) 	 (4.11) 
We see that expressions for the number of unparasitised cells becoming parasitised are 
functions of Ru(t), Eu(t) and M(t). 
It remains to determine an expression for the number of maturing unparasitised 
reticulocytes, s(lr, t), in terms of Ru(t), Eu(t), P(t) and M(t). We integrate along the 
characteristics of equation 4.1, which are given by a=t—tb (where tb represents the time 
of birth of a cell). We fix tb and define 
w(a) = s(a,a+tb). 
Then on a characteristic of equation 4.1, w(a) satisfies the differential equation 
dw(a) — juw(a) — c(a,0, a+tb) 
da 
= — auw(a) — gq(a)M(a+tb)w(a) 
= —(8„ pgM(a+ tb))w(a) 
(since we are interested in s(ir, t) then a < 1r  and so q(a) = p) 
Integrating this using the variation of constants method gives 
-8 a —pg jM(z+th )clz 
w(a) = e 	e ° 	w(0) 	 (4.12) 
and hence given t and 1, we set tb = t — 4 to give 
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S( lr,t) = S(1r, 1r±tb) 
W(10 
- pg J  M(z4t-1,)61z 
e e 
	 w(0) 
- pg JM(z)dz 
e e s(0, t —1r ) 
-pg JM(z)dz 
= fR(11(t—lrr)) e-(5.4 e (4.13) 
which is a function of Ru(t), Eu(t), P(t), and M(t). Note that the integral for Monly 
requires values up to time t and hence is a just a distributed delay. Therefore we have 
found a closed form expression for s(4., t). Note also, that by equation 4.12 and the fact 
that g, q(a) and M are non-negative we have shown that s(a, t) —*0 at least exponentially 
as a —*oo. 
We can now substitute equation 4.13 into equations 3.28 and 3.29 above to get closed 
form expressions for dRu I dt and dEi, 1 dt as: 
dRu 	 -pg JM(z)dz 
= fR(H(t— r)) — pgM(t)R,i(t) —fR(H(t-1,— r)) 	e 	— 8,(t)10) 
(4.14) 
dE
.45, 	-pg t fi Al(z)dr 
dt 
1")) e — e 	— gM(t)Ru(t) — S(t)E1(t) 	(4.15) 
Remembering that cp(t) is a function of means that 3.30 is a closed form representation 
of dP 1 dt and finally, we can substitute 	c(a, 0, t) da = cp(t) into equation 4.5 to give 
0 
an expression for dM I dt as: 
dM 
= mre P IP cp(t—lp)— cp(t)— om M(t) 
dt 
(4.16) 
Equations 3.30 and 4.14 - 4.16 therefore give a set of four coupled delay differential 
equations which define Ru(t), Ei,(t), P(t) and M(t) in terms of themselves. 
4.3.3 Similarities and Differences between this model and that of Chapter 3 
The similarities and differences between this model and the model of chapter 3 can be 
seen by comparing both the formal definitions of the models and the DDE formulations 
of the models. Note that in this section we assume that the boundary condition for s(a, t) 
in the model of chaper 3 is given by equation 3.9. Both models are formulated in an 
dt 
Chapter 4: Low RBC production may protect against SMA 	 - 110 - 
identical fashion (equations 3.1, 3.2 and 3.9 are identical to equations 4.1, 4.2 and 4.3) 
however the difference between them lies in the creation of parastisied cells (equation 
3.12 is different from equation 4.4). In the model of chapter 3 the generation of 
parasitised cells is via an experimentally determined input function. In contrast, the 
model of this chapter is autonomous and the generation of parastities cells is determined 
using other model variables. 
The similarities between the models can also be observed by comparing their closed 
form representations. Equations 3.34 and 4.14 describing the change in numbers of 
unparasitised reticulocytes are identical except for the term which defines the number of 
reticulocytes becoming parasitised, and this term differs only in the integral of the 
exponential. In the model of chapter 3, the integral depends on the experimental input 
function for cp(t), while in the model of this chapter it depends on integrating M(t). 
Similarly equations 3.29 and 4.15 escribing the change in numbers of unparasitised 
erythrocytes are identical except for the parasitisation term. Finally the DDE 
representation for the model of this chapter includes an extra equation (equation 4.16) 
defining the change in numbers of merozoites. This comparison highlights the fact that 
the key difference between the two models is in the way parasitised cells are generated, 
and aside from this difference the models are identical. 
4.3.4 Altering the Preference for Reticulocytes 
By changing the value of the reticulocyte preference, p, we alter the probability that a 
free merozoite will invade a reticulocyte rather than an erythrocyte. A preference of 5 
indicates that a merozoite is 5 times as likely to invade a reticulocyte as an erythrocyte. 
4.3.5 Altering the Reticulocyte Replacement Rate (RRR) 
The production of reticulocytes in response to reduced RBC levels is described by the 
function fR(H(t-r)). The normal RRR is similar to that used in the earlier model of 
chapter 3, but has been altered slightly to agree with literature estimates in other animals 
(Mackey, 1997). It is a sigmoid curve that is dependent on the RBC level six days 
earlier (Belair et al., 1995). This RBC level is represented by the sum of all RBC 
populations H(t). We use a sigmoid function, that is similar to the one outlined in 
chapter 3 and whose use is supported in (Mackey, 1997). 
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Mackey (Mackey, 1997) proposed the following function for the erythropoietic 
response in rabbits 
on 
fR(H(t- r)) = 	H0 H(t — r)" + 0" 	
(4.17) 
with Ho = 23% day-1, 0 = 74.85% day 1, n = 7.6 and r = 5.7 days. We have scaled the 
values of these constants to give fR(t) in terms of the percentage of the normal RBC 
compartment per day rather than in terms of cells kg -1 day 1.  H0 is the maximum normal 
production rate at very low red blood cell concentrations. 
In this work we use the same function, but modify the constants H0 and r to appropriate 
values for humans. Justification for not altering the other Hill parameters between 
rabbits and humans can be found in the literature (Colijn and Mackey, 2005, Belair et 
al., 1995). 
In rabbits the lifetime of an RBC is 43.5 days, whereas the lifetime of a human RBC is 
120 days (Belair et al., 1995). This means that RBCs in humans must be produced at a 
slower rate. We therefore scale the production function by 
lifetime of rabbit RBC 43.5 	= 0.3625. 	 (4.18) 
lifetime of human RBC 120 
This is equivalent to setting H0 = 23 *0.3625 day-1. In humans the delay in reticulocyte 
production after RBC loss is 6 days (Belair et al., 1995) and so we set r = 6. Note that 
the results presented here are not particularly sensitive to our choice of parameters for 
fR(t). We have run the model using parameters appropriate for rabbits, mice and humans 
and see the same qualitative behaviour in all cases. 
We modify the reticulocyte production function to represent reduced reticulocyte 
replacement rates, yielding the sigmoid curves shown in Figure 4.2. A normal RRR has 
a maximum production rate of 10 times the baseline rate, attained when RBC levels 
drop to low values (Mackey, 1997). Each modified RRR is defined by reducing the 
maximum production rate at low RBC numbers (Figure 4.2), expressed as a fold change 
relative to the baseline rate. 
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Symbol Description Value Source 
ir Reticulocyte lifetime 2.8 days Colijn et. al. (Colijn and 
Mackey, 2005) 
l, Parasite lifetime 2 days Garnham (Garnham, 1966) 
r Delay in reticulocyte 
production 
6 days Belair (Belair et al., 1995) 
au Decay rate of unparasitised 
cells 
.083 day' Established from erythrocyte 
lifetime of 120 days (Belair et 
al., 1995) 
gp  Decay rate of parasitized 
cells 
.083 day"' Same decay as for 
unparasitised cells. 
gm Decay rate of merozoites 1/72 day' Anderson et. al. (Anderson et 
al., 1989) 
g Invasion rate of parasites 
into erythrocytes 
0.06 Established to give similar 
parasitaemias to those seen in 
humans. 
P Preference for reticulocytes 1-20 Similar to range of values seen 
in P.fakiparum (Pasvol et al., 
1980, Wilson et al., 1977, 
Hegner, 1938) 
mr Number of merozoites 
released per rupturing 
parasite 
16 Estimated range is 8-32 
merozoites (Garnham, 1988) 
Table 4.1 Parameters used in the model. 
The behaviour of the model does not depend on the precise parameter values used in the 
model and essentially the same results are observed for a wide range of parameters. 
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Figure 4.2 Examples of intermediate RRR curves. 
Curves show reticulocyte replacement rate curves for various intermediate values 
between baseline and normal production. Curves show number of reticulocyte produced 
per ml of blood volume in a single day, given different levels of anaemia. Baseline 
production is a flat line. Normal RRR is given by the highest curve (maximum of 10 
times baseline). Reduced RRR show intermediate maximum production rates at low 
RBC numbers. 
Fold Increase From Baseline k 
8 2.06 
6 3.94 
4 5.73 
2 7.48 
1 (Baseline) 8.33 
Table 4.2 Values of k for representative RRR functions 
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When modifying the reticulocyte replacement rate we used an almost identical function 
to that suggested by Mackey (Mackey, 1997), however we altered it slightly to ensure 
that there is always a stable baseline production rate when the red blood cell count is at 
100% of its original level. This corresponds to the ordinary production of reticulocytes 
to account for the senescence of older cells. We call this baseline production rate BL, 
and set BL = 100%/(erythrocyte lifetime) = 100%/120 = 0.83%. We use a sub-script of I 
to indicate "intermediate" values of the parameters and let H0,1 represent the maximum 
production rate at low RBC levels for intermediate parameters denoted by I. Thus the 
modified production function f',1 (t) becomes: 
fR,I(H(t-r)) = 11*,1 
01"? 
+ 	 (4.19) 
H(t — 	+19/1' 
The maximum reticulocyte production forfR,f (t) is thus given by H0,1= H*,1 + B.J . The 
value of I gives the fold increase in the maximum reticulocyte production Hey compared 
to baseline (BL ) and thus 
11„,i + 
	
0,1 	 (4.20) 
BL BL 
and for a given value of / we have 110 j = IBL. The parameter By is selected to be a 
baseline shift parameter that ensures that the reticulocyte production is equal to BL when 
the RBC level is 100% of the normal red blood cell concentration. Setting 
n? 
H*,1 	 
loon' + 19/11 
(4.21) 
ensures this. The parameter H.,1 is defined by H0,1= M,I+ B*,1, i.e.  11*,1= Hof — Bv, SO 
that the maximum production rate at very low red blood cell levels equals I/0j. Clearly 
these definitions of H*1  and By are dependent on each other, and so we use an iterative 
root finder (described below) to determine their actual values. 
To calculate the parameters needed to generate the stacked curves of Figure 4.2, we first 
use I to calculate the desired value of H0,1. We then introduce a reduction constant k1 
and let H*,1= Ho — kb 01= 0— k110.3625 and ni= — 1c1/3.625. Finally we define B.; from 
Equation 4.21 above. The value of k1 is determined through an iterative root finding 
process which ensures that Ho,/ = H*,1+ B.,1 and representative values are shown in 
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Table 4.2. Note that the results presented in this chapter are not sensitive to the precise 
definition of the reticulocyte replacement rate function fR,r(t) (not shown). 
4.4 Results 
4.4.1 Reticulocyte preference can adversely affect the outcome of infection 
We first examine the effects of changing the reticulocyte preference in the presence of a 
normal reticulocyte response (Figure 4.3A). In the absence of any reticulocyte 
preference, our model leads to target cell limited growth of the parasite (Phillips, 1996). 
Parasite numbers increase until the uninfected RBC count drops low enough to reduce 
the reproductive ratio of the parasite below one. Parasite levels then drop and RBCs are 
replaced until they reach a level where parasite growth and death are in equilibrium 
Figure 4.3A. 
In the presence of a preference for reticulocytes, two competing parasite growth 
functions (occurring in erythrocytes and reticulocytes) contribute to a more complicated 
dynamic. Early in infection the proportion of reticulocytes is low, so the parasite and 
RBC curves are similar to those seen without a preference, and lead to an early peak of 
parasites in erythrocytes (green curve in Figure 4.3B). However, the depletion of RBCs 
during this time leads to increased production of the parasite's preferred target 
(reticulocytes). Thus, a second wave of parasite growth emerges, occurring 
predominantly in reticulocytes (red curve in Figure 4.3B). This wave of parasite 
invasion may lead to higher parasitaemias than can be achieved by infection of older 
RBCs alone (compare Figure 4.3A and B). 
4.4.2 High reticulocyte production increases severity of infection 
The above scenario describes how an increased preference for reticulocytes can drive 
higher parasitaemias and lower RBC levels when combined with normal reticulocyte 
replacement rates. A similar scenario emerges when the reticulocyte replacement rate is 
varied in the presence of a fixed preference for reticulocyte invasion (Figure 4.4). 
For low RRRs, the dynamics are primarily determined by the infection rate of the 
parasite in erythrocytes (since few reticulocytes are present at any given time) and we 
essentially see target cell limited growth of parasites in erythrocytes (Figure 4.4A). 
Initially, the reproductive ratio of the parasite is greater than one and parasitaemia 
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increases. As target cells are depleted the reproductive ratio of the parasite drops to 
below one, and the parasite levels begin to decrease again. A minimum in the number of 
uninfected RBCs is followed by a slow recovery to an equilibrium level. 
At higher reticulocyte production rates, the presence of increased numbers of the 
preferred target later in infection can force the reproductive ratio of the parasite above 
one and lead to a second wave of reticulocyte infection, resulting in higher 
parasitaemias and lower uninfected RBC levels (Figure 4.4B). Under certain 
circumstances this can lead to a biphasic appearance in the total parasite number 
(Figure 4.4C), similar to what is observed during experimental P. berghei infection 
(Figure 4.4D) (25, 32). Note that the time scales for the two plots are different since 
Figure 4.4C is a simulation of human infection, whilst Figure 4.4D depicts data from 
mice. This hump in parasite number has previously been attributed to the onset of 
acquired immunity (Singer, 1954a) or a shortage of reticulocytes (Janse and Waters, 
2005), but here we show that it could simply be a result of reticulocyte replacement and 
preference. 
We next investigate the combined impact of different levels of reticulocyte preference 
and reticulocyte production on the outcome of malaria infection. We focus on four key 
outcome measures: the lowest attained level of uninfected cells (minimum RBC, Figure 
4.5, Figure 4.7A and Figure 4.6B), the long term uninfected RBC level (equilibrium 
RBC, Figure 4.7A and Figure 4.6A), the maximum parasitaemia (Figure 4.7B and 
Figure 4.6D), and the long term (equilibrium) parasitaemia (Figure 4.7B and Figure 
4.6C) during an infection. The minimum uninfected RBC level is a marker of the degree 
of SMA generated by infection, a major cause of death during crisis. Maximum 
parasitaemia can serve as a marker of hyper-parasitaemia, again another cause of severe 
morbidity. The equilibrium levels of uninfected RBCs and of parasitaemia are 
indicative of the long term effects of infection, and can serve as markers for long term 
morbidity. In order to minimise the negative effects of disease, it would be 
advantageous to have both high minimum RBC levels and and high equilibrium RBC 
levels, as well as low parasitaemias. 
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Figure 4.3 Graphs showing the course of infection for different reticulocyte 
preferences in the presence of normal reticulocyte replacement. 
Pink curves are plotted on left hand axes and show RBC counts as a percentage of 
normal RBC. Parasite curves are plotted on right hand axes and give number of 
parasitised cells/ml. Total parasite numbers (blue) are a sum of parasitised 
reticulocytes (red) and parasitised erythrocytes (green). Note the different scaled of 
theright hand axes in panels A and B. 
A) Normal reticulocyte production and equal invasion of erythrocytes and reticulocytes 
by the parasite. 
B) Normal reticulocyte production and a 15 fold preference of the parasite for invading 
reticulocytes. Initial parasite growth is in erythrocytes (green curve), leading to a peak 
in erythrocyte parasitaemia. This is followed by a wave of parasites in reticulocytes 
(red curve) once sufficient numbers of them have been produced. 
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Figure 4.4 Graphs showing effect of altering RRR in the presence of a preference 
for reticulocytes. 
Legend is as for Figure 4.3, however parasite curves are plotted using the left hand axis 
in Figures C and D. 
A) Baseline reticulocyte production and a 15 fold preference of the parasite for 
invading reticulocytes. Since there are never a large number of reticulocytes present for 
the parasite to invade, the preference of the parasite for reticulocytes does not cause a 
significant rise in parasitaemia; 
B) Elevated reticulocyte production (6 fold increase from baseline) and a preference 
value of p=15 of the parasite for invading reticulocytes. This scenario is similar to the 
one shown in B, but we can see a hump in parasitaemia which arises as we switch from 
seeing more parasites in erythrocytes to seeing more parasites in reticulocytes; 
C) Enlargement of the section in Figure 4.4B centred at the hump in parasitised RBCs; 
D) Data for P. berghei infected mice adapted from Chapter 3. 
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4.4.3 In the presence of reticulocyte preference, lower RRR leads to better 
outcomes 
In the absence of a preference for reticulocytes (p = 1), increasing the RRR does not 
affect the equilibrium levels of uninfected RBCs (Figure 4.6A). This is to be expected, 
as the equilibrium level of target cells is not affected by the production rate of targets 
(Nowak and Bangham, 1996). However, perhaps somewhat counter-intuitively, once 
the parasite has even a slight preference for reticulocytes, an increase in RRR always 
leads to lower equilibrium levels of uninfected RBCs. This relationship can be seen in 
the dotted line in Figure 4.7A for a preference value ofp = 5. We see that as the RRR is 
increased, equilibrium RBC levels are decreased. We can also see this relationship 
clearly in Figure 4.6A and on the right hand side of Figure 4.9. 
Raising the RRR causes a larger pool of reticulocytes to be created. Since the parasite 
has a preference for invading reticulocytes, this provides a large pool of the preferred 
target and hence boosts the number of parasitised cells. The result is that a large 
percentage of the newly created reticulocytes become parasitised and then rupture a 
short time later, without contributing to the overall RBC numbers. Furthermore, the 
increase in the number of parasitised cells results in more merozoites being produced 
which invade both mature RBCs and reticulocytes. Thus, not only are the newly created 
reticulocytes destroyed, but so are many older RBCs. The net result is that increasing 
the RRR in the presence of a preference of the parasite for reticulocytes leads to both an 
increase in equilibrium parasitaemia and a decrease in equilibrium levels of uninfected 
RBCs (Figure 4.7A and B). Therefore, in the presence of a reticulocyte preference it 
appears to be beneficial to have an RRR that is lower than normal. 
4.4.4 There is a threshold RRR that minimises RBC loss in acute infection 
When there is no preference of the malaria parasite for reticulocytes (p = 1) then an 
elevated RRR allows cells to be replaced as they rupture, and so the minimum RBC 
level rises with increasing RRR. Once a preference of the parasite for reticulocytes (p> 
1) is introduced then increasing the RRR no longer necessarily increases the minimum 
RBC levels (Figure 4.5). However, unlike the equilibrium RBC level, the minimal RBC 
level does not change monotonically with the RRR. In particular, there is an optimal 
RRR, which we call the threshold RRR, at which the minimum RBC level reaches its 
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highest value (Figure 4.5 and Figure 4.7A). This threshold divides the range of possible 
RRRs into two intervals, the first from the baseline RRR to the threshold, and the 
second from the threshold to the normal RRR. We observe qualitatively different types 
of behaviour in these intervals. 
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Figure 4.5 Effect of RRR and reticulocyte preference on minimum levels of 
unparasitised cells. 
For a fixed reticulocyte preference initially the minimum RBC level attained increases 
with increasing RRR. It reaches a maximum at the threshold RRR, marked with a black 
dotted line and thereafter, further increases in RRR lead to a rapid drop in the minimum 
unparasitised RBC level. The blue starred line indicates a reticulocyte preference of 5 
and corresponds to the plot in Figure 4.7A. 
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Figure 4.6 The effect of reticulocyte preference and RRR on four clinical features. 
Black lines in each plot mark the threshold RRR. Blue curves indicate a reticulocyte 
preference of 5 and varying RRRs. It is these lines that are reproduced in two 
dimensions in Figure 4.6. 
A) Equilibrium unparasitised RBC levels. 
B) Minimum unparasitised RBC levels. (This is the same as Figure 4.5) 
C) Equilibrium parasite levels. 
D) Peak parasite levels. 
Note that in plots C and D the x and y axes are rotated in order to show the shape of the 
three dimensional surface. We see in (D) that the critical RRR at which the peak 
parasite level starts to grow significantly as a function of the RRR is generally higher 
than the threshold RRR (marked in black). 
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Baseline to Threshold: The minimum RBC level increases slowly with increasing 
RRR (solid curve, left of Figure 4.7A). This region gives similar behaviour to that 
seen in the absence of a reticulocyte preference. It corresponds to the profile of 
infection depicted in Figure 4.4A and the dotted curve in Figure 4.9. Uninfected 
RBC levels decline to a minimum, which occurs close to the time that 
parasitaemia reaches a peak. Since the RRR is still relatively low, there is only a 
small pool of target reticulocytes at this time point. Parasite levels are therefore 
controlled by a lack of availability of target cells. Gradual reticulocyte 
replacement then allows the RBC levels to increase from the minimum, while the 
parasite levels remain controlled. Increasing the RRR in this phase allows newly 
created reticulocytes to raise minimum RBC levels. 
Threshold to Normal: An increase in RRR actually causes a decrease in the minimum 
RBC levels. The profile of an infection in this phase is depicted in Figure 4.4B 
and the dashed curve in Figure 4.9. RBC levels decrease due to the initial rise in 
parasitaemia. As the RBC levels decrease large numbers of reticulocytes are 
generated due to the elevated RRR. These reticulocytes provide new targets for 
the parasite to invade, and fuel the fire of infection from this point onwards. 
Almost all generated reticulocytes then become parasitised and thus cannot 
mature into erythrocytes and cannot contribute to raising the RBC levels. This 
causes the RBC levels to decrease further (and the parasite levels to rise) to a 
lower minimum RBC level. There is no recovery of the RBC level and the 
minimum value now coincides with the equilibrium. In this range of RRR patients 
therefore reach an equilibrium with chronically high levels of reticulocyte 
production and parasitaemia, and low levels of RBCs. Increasing the RRR during 
this phase only adds more target cells and further decreases the minimum RBC 
levels. 
In order to maximise the minimum RBC level during the infection it is optimal to be at 
the threshold RRR, on the boundary between these two intervals. The threshold RRR 
will vary with different reticulocyte preferences p. The minimum RBC level attained at 
this threshold RRR for each p is shown by the black curve in Figure 4.5. As the 
reticulocyte preference p increases the threshold RRR drops towards the baseline RRR 
and the corresponding minimum RBC level also falls. Similar behaviour is seen for 
other infection rates g (compare the "slices" in Figure 4.8 with Figure 4.5). 
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Figure 4.7 Effect of altering RRR on four key features. 
Dashed lines are equilibrium cell levels, solid lines are minimum level of unparasitised 
cells (A) and maximum level of parasitised cells (B). 
A) Minimum and equilibrium unparasitised RBC levels for a reticulocyte preference of 
5 and varying RRRs. The minimum RBC curve corresponds to the starred line marked 
in Figure 4.5. Also indicated is the threshold RRR and the corresponding minimum RBC 
level. 
B) Maximum and equilibrium parasitaemias for a reticulocyte preference of 5. Also 
indicated is the critical RRR for maximum parasitaemia. 
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Figure 4.8 Minimum RBC level for different infection rates g when altering RRR 
and reticulocyte preference. 
The three surfaces are for three different growth rates. The upper surface has g = 0.05, 
the middle surface has g = 0.06 (value used in the rest of this chapter) and the lower 
surface has g = 0.07. We can see that the general shape of the surfaces is the same 
regardless of the growth rate we pick, only the values change. 
4.4.5 Effect on parasitaemia levels 
In the absence of a preference for reticulocytes (p = 1), an early rise in parasitaemia is 
achieved due to the presence of a large number of erythrocytes in early infection (seen 
in the left of Figure 4.3A). An equilibrium RBC level is then reached where the density 
of RBCs allows the parasite numbers to be in equilibrium. In the presence of a 
preference for reticulocytes (p> 1) a similar early peak in parasitaemia occurs, driven 
predominantly by the infection of erythrocytes, since reticulocyte numbers are low. This 
is seen as the initial peak in parasitised erythrocytes in Figure 4.3B and Figure 4.4A and 
B. Parasite numbers then decline as infected cells are destroyed. 
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If there are insufficient reticulocytes produced to push the basic reproductive rate of the 
parasite back above one, parasite numbers will continue to decrease, and the infection 
will be controlled (as is the case in Figure 4.4A). In this scenario the RRR does not have 
a significant effect on the peak parasitaemia (flat section on left of solid curve in Figure 
4.7B), which is far more sensitive to the reticulocyte preference and the natural rate of 
infection. However, in the presence of a high RRR a burst of reticulocyte production 
occurs to replace the RBCs lost due to infection. If the RRR is elevated sufficiently so 
that a large pool of highly susceptible reticulocytes accumulates, then the reproductive 
ratio of the infection is pushed above 1, and parasite numbers begin to increase again, 
driven by newly produced reticulocytes. This can be seen in the second half of Figure 
4.4B which shows a second rise in parasite numbers, driven predominantly by the 
parasitisation of reticulocytes. This is also seen on the left of the solid curve in Figure 
4.7B where peak parasitaemia starts to increase much more rapidly in response to rising 
RRR. 
The critical RRR in terms of the peak parasitaemia is the one which pushes the basic 
reproductive ratio of the parasite back above 1 after the initial peak in parasites is 
controlled. This critical RRR is indicated in Figure 4.7B for a reticulocyte preference 
p = 5 and can be estimated for a range of different prefrences from Figure 4.6. This 
reveals that except for very low preferences, the critical RRR for parasitaemia is higher 
than the threshold RRR for the minimum RBC level. Hence, as long as the RRR is less 
than or equal to the threshold, unacceptably high parasitaemias are not attained. This 
further reinforces the importance of having an RRR below the threshold. 
Note also that the peak parasitaemia obtained during an infection is highly sensitive to 
the parasite preference for reticulocytes. A high preference leads to a much higher peak 
parasitaemia for a given RRR. The peak parasitaemia is also very sensitive to the rate of 
infection of the parasite in erythrocytes, with higher infection rates leading to higher 
peak parasitaemias (data not shown). 
4.4.6 Estimating the optimal Reticulocyte Replacement Rate 
The optimal RRR is one which maximises equilibrium red blood cell levels, minimises 
equilibrium parasite numbers and does not force the patient to endure unacceptably low 
transient RBC levels or exceedingly high parasite levels. It will thus depend on what 
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RBC level is classified as "unacceptably low", and how long a person can withstand 
lowered RBC levels during acute infection without succumbing to SMA. If a patient is 
able to withstand a lower RBC level for a period of time, then an RRR closer to baseline 
will be optimal as it will lead to increased equilibrium RBC levels and lower 
equilibrium parasitaemias. However, optimizing equilibrium RBC levels is not 
important if the patient is unable to survive the early transient period of severe anaemia 
caused by a low RRR. It is also unclear whether such an equilibrium state will ever be 
reached, since modifying factors such as immunity (which is only briefly considered by 
our model in section 4.4.7) may help control long term infection. Thus, the optimal 
RRR lies somewhere between the threshold level (that produces the highest minimum 
RBC level) and baseline production (that produces highest equilibrium RBC level). 
An RRR just below threshold is often the best solution that restricts the acute minimum 
level of RBCs and also the time spent at this minimum, while still allowing a relatively 
high equilibrium level of RBCs. This is highlighted in Figure 4.9. Here the solid curve 
represents the course of infection with an RRR equal to the threshold value. The dotted 
curve, however, shows the course of infection using what is potentially the optimal 
RRR. We can see that RBC levels drop slightly below their threshold value for a short 
time, but the gain in terms of equilibrium RBC (and parasitaemia levels) is substantial. 
4.4.7 Incorporating an Immune Response 
Thus far we have not included an immune response during the analysis of our model. 
This is because the nature and timing of such a response is an area of continued research 
(Filipe et al., 2007) and as such we felt that the inclusion of an immune response would 
add unnecessary complexity and uncertainty to our model. Interesting modelling 
observations have been made previously (McQueen and McKenzie, 2004, Jakeman et 
al., 1999) by considering simplified models that do not include immune responses. 
Nevertheless, we verify that we would obtain qualitatively similar results when 
including an immune response. We assume that an immune response is initiated once 
the number of parasitised cells has increased to a reasonable level and that the immune 
response causes parasitised cells to be destroyed at a faster rate than unparasitised cells. 
We allow the immune response to begin midway through day 30 after infection (as this 
is when most numerical simulations of the model begin to show clear levels of 
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Figure 4.9 Unparasitised RBCs as a percentage of the original RBC count for three 
reticulocyte replacement rates and a reticulocyte preference of 5. 
The unparasitised cell levels for the threshold RRR are shown by the solid line. The 
dotted line shows the unparasitised cell levels obtained for what is potentially the 
optimal RRR. This RRR is slightly below the threshold RRR and therefore is associated 
with a slightly lower minimum RBC level, but a higher equilibrium RBC level. The 
dashed line shows the unparasitised cell levels for an RRR greater than the threshold 
RRR. Both the minimum and equilibrium levels of unparasitised cells are lower than 
when the threshold RRR is used. 
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Figure 4.10 Effect of incorporating a delayed onset immune response 
The effect of altering reticulocyte preference and RRR on four clinical features while 
incorporating a delayed onset immune response. These plots are generated from our 
model using the same parameters as those used to generate Figure 4.7, however we 
have allowed (Sp to increase from 6H to 156 H between t=29.5 and t=30.5 and to remain 
at 1.56H for the remainder of the simulation. This should simulate a delayed onset 
immune response. 
Note that in plots C and D the x and y axes are rotated in order to show the shape of the 
three dimensional surface. 
A) Equilibrium unparasitised RBC levels. 
B) Minimum unparasitised RBC levels. 
C) Equilibrium parasite levels. 
D) Peak parasite levels. 
We see that the shapes of these plots are similar to those seen in Figure 4.6, indicating 
that the inclusion of an immune response gives qualitatively similar results to when it is 
omitted. 
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parasites) and allow parasitised cells to be destroyed at 15 times the rate of 
unparasitised cells once this response had been activated (i.e. we allow Sp to increase 
from 8H to 158H between 1=29.5 and t=30.5 and to remain at 155H for the remainder of 
the simulation). The results of simulations using these parameters are shown in Figure 
4.10. The shapes of the plots are very similar to those of the plots in Figure 4.7. This 
highlights the fact that incorporating an immune response into the model yields 
qualitatively similar results to when it is omitted. Figure 4.10B still shows a "ledge" 
indicating a threshold RRR. Increasing the RRR above the threshold RRR still causes a 
sharp decrease in the minimum level of unparasitised cells and also in the equilibrium 
levels of unparasitised cells (Figure 4.10A and B). Altering the timing or the extent of 
the immune response does not alter the general shape of the plots in Figure 4.10. 
4.5 Discussion 
The erythropoietic response to anaemia during a malaria infection is not completely 
understood. It is often assumed to be suppressed below what would be expected in an 
uninfected individual, although the precise mechanism for this remains unclear. 
Numerous studies of infected individuals have shown both dyserythropoiesis and 
suppressed reticulocyte levels during infection, regardless of the degree of anaemia 
(Abdalla, 1990, Srichaikul et al., 1967, Srichaikul et al., 1969, Phillips et al., 1986). It 
has been shown that following clearance of the parasite, reticulocyte counts rise rapidly, 
sometimes by up to 10 fold, to combat the anaemia (Abdalla et al., 1980). A priori, it 
would seem that erythropoietic suppression would hinder the recovery from anaemia 
and would contribute to its pathogenesis. However, in the presence of a preference of 
the parasite to infect reticulocytes, both the reticulocyte replacement rate and 
preferential invasion of reticulocytes strongly influence the outcome of an infection. 
Studies involving iron have shown that incidence of malaria is lower among iron 
deficient children (Nyakeriga et al., 2004). We propose that a key reason for this is that 
the lower haemoglobin levels associated with iron deficiency can act as a protection 
against malaria related anaemia and parasitaemia. In the presence of a strong preference 
for reticulocytes newly created cells provide a target for infection and serve to boost 
parasite numbers. A strong reticulocyte response combined with a strong reticulocyte 
preference can lead to catastrophic anaemia and hyperparasitaemia. Conversely, 
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however, not producing enough new cells to replace cells dying due to parasitisation 
and rupture will lead to anaemia in its own way by depleting the host of all target cells. 
In this chapter we have investigated the circumstances under which a suppressed 
reticulocyte response may in fact be advantageous to the host. We find that in the 
presence of a preference of the parasite for reticulocytes there is a threshold RRR that 
balances the effects of target cell generation and host cell depletion to provide the most 
beneficial outcome to the patient. The threshold RRR maximises the minimum RBC 
level that the patient is forced to suffer and having an RRR above this threshold value 
confers no benefit to the patient. However (assuming the threshold RRR is not already 
equal to the baseline value) lowering the RRR still further below the threshold value can 
help increase equilibrium RBC levels, and lower long term parasitaemias. Thus the 
optimal reticulocyte replacement rate is one which is less than or equal to the threshold 
value. 
We find that in the presence of a mild preference of the parasite for reticulocytes, such 
as that seen in P. falciparum (2-14 fold preference) the threshold RRR takes on an 
intermediate value that is close to (but slightly above) the baseline RRR. This 
intermediate RRR balances the effects of target cell generation and host cell depletion to 
provide the most beneficial outcome to the patient. Increasing the RRR above this 
relatively low threshold value actually leads to more severe anaemia and 
hyperparasitaemia. Thus the lowered reticulocyte replacement rates observed in many 
P. falciparum subjects (Abdalla et al., 1980, Abdalla, 1990) could be a host protective 
effect, with the host effectively seeking out the optimal reticulocyte replacement rate to 
minimise disease progression. In addition, the slightly elevated (but still sub-optimal) 
reticulocyte counts seen in some P. faldparum subjects (Srichaikul et al., 1969) may 
actually represent this intermediate optimal RRR. 
In the presence of an even stronger preference of the parasite for reticulocytes, such as 
is seen in P. vivax infections, we find that the threshold RRR is equal to baseline 
reticulocyte production. This supports the results of studies that have shown that in 
patients infected with P. vivax malaria, reticulocyte counts are not increased from 
baseline levels (Srichaikul et al., 1967, Srichaikul et al., 1969) and is in agreement with 
the results of (McQueen and McKenzie, 2004) which also showed that for parasite 
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species that invade only reticulocytes compensatory erythropoiesis can increase 
parasitaemia. 
We have not included an immune response of the host to the parasite in the majority of 
this analysis. It is still possible to gain valuable insights into infection dynamics while 
excluding an immune response, as has been shown in HIV (Phillips, 1996). However if 
we were to include an immune response, it is reasonable to assume that such a response 
would take one of two forms. It would either lower the overall growth rate of the 
parasite or increase the clearance rate of infected cells. The trends discussed here are 
still seen even if the rate of infection were lowered due to an immune response (Figure 
4.8). The only factors that change with a modification of infection rate are the actual 
values of the threshold and optimal RRR. In addition, allowing for a delayed onset 
adaptive immune response that increases the clearance of infected cells also gives 
qualitatively similar results (Figure 4.10). 
Erythropoietic suppression during malaria infection is often considered an inadvertent 
outcome of severe infection and inflammation, where inflammatory mediators produced 
in response to parasitaemia suppress bone marrow function and worsen anaemia 
(Abdalla, 1990, Kwiatkowski et al., 1990, Clark and Chaudhri, 1988). However, we 
suggest that under most circumstances the reduction in reticulocyte production observed 
in vivo paradoxically serves to maintain RBC levels by preventing the accumulation of 
large numbers of reticulocytes and an explosive second wave of infection in these cells 
(Figure 4.4). It is interesting to speculate whether prolonged exposure to infection and 
chronic anaemia in endemic areas may serve to damp down the erythropoietic response 
to anaemia, an effect that may ultimately contribute to non-specific resistance to 
infection. 
A number of studies involving iron supplementation of children in developing countries 
have shown an increase in malaria related adverse effects and malaria risk (Smith et al., 
1989, Sazawal et al., 2006), reviewed in (Oppenheimer, 2001, lannotti et al., 2006). In 
addition, incidence of malaria is reportedly lower in mildly anaemic (Michon et al., 
2007) and iron deficient (Nyakeriga et al., 2004) children. Different reasons for the 
relationship between iron status and disease have been postulated: i) Lower iron levels 
limit parasite growth (Raventos-Suarez et al., 1982, Fritsch et al., 1987); ii) A defect in 
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immunoglobulin production results from iron deficiency which protects against malaria 
(Nyakeriga et al., 2004); iii) Iron can block the synthesis of nitric oxide which in turn 
would contribute to pathogen death (Sazawal et al., 2006); iv) Iron supplementation 
causes increased levels of reticulocytes which are preferentially infected (Nyakeriga et 
al., 2004). The modelling results presented here lend support to this final hypothesis. 
Increased red blood cell production as a result of iron supplementation could lead to an 
increase in parasitaemia and anaemia. In contrast, the lower RBC production rates in 
iron deficient or mildly anaemic children could result in an RRR closer to the optimal 
RRR presented in this chapter, and so protect them from severe malarial episodes. 
Additional support for the conclusion that a lower RRR can be protective against severe 
malarial anaemia resulting from P. falciparum infection is found in a study showing that 
SMA is most prevalent in children at ages when the EPO response to anaemia is highest 
(O'Donnell et al., 2007). A high EPO response to anaemia should correlate with a high 
RRR. Therefore early in life children have a high RRR and this is when SMA is its most 
severe. As children mature their RRR decreases, and so does their susceptibility to 
SMA. This may also explain why severe malaria associated with P. vivax infection is 
more common in very young children (Genton et al., 2008). Since P. vivax has a very 
strong preference for reticulocytes, the high EPO response and hence presumably high 
RRR of young children could lead to more severe disease. 
The arguments presented above do not explain why P. falciparum, rather than P. vivax, 
is generally associated with SMA (WHO, 2000, Newton et al., 1997). P. vivax malaria 
has a stronger preference for reticulocytes, and so by the arguments presented in this 
chapter should be associated with more severe anaemia than P. falciparum. Indeed, 
recent reports have indicated that P. vivax may give rise severe anaemia more often than 
has traditionally been believed (Genton et al., 2008, Tjitra et al., 2008). 
There are a number of potential reasons why P. falciparum may be the strain of malaria 
connected with SMA. (i) P. falciparum infection may lead to increased clearance of 
both parasitised and unparasitised cells, resulting in more severe anaemia. This 
clearance could be due to the reduced deformability of both infected and uninfected 
RBCs during P. falciparum infection (Dondorp et al., 1999). (ii) P. falciparum infection 
may lead to a faster increase in parasitaemia due to the fact that P. falciparum releases 
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more merozoites per schizont (Field and Shute, 1956) cited in (Price et al., 2007) due to 
the fact that its merozoites may be more capable of infecting RBCs once they are 
released. Faster parasite growth could then lead to a more severe infection, and 
associated increased parasitised cell rupture. (iii) The stronger inflammatory response of 
P. vivax at lower levels of parasitaemia (Hemmer et al., 2006) may be protective against 
severe malarial anaemia. (iv) Patients infected with P. vivax malaria may have a lower 
RRR than those infected with P. falciparum. Studies of patients infected with both of 
these strains have shown that reticulocytosis was not associated with any cases of P. 
vivax, although it was present in some P. falciparum infections (Srichaikul et al., 1967, 
Srichaikul et al., 1969). It is possible that, as predicted by the results of this chapter, the 
complete lack of compensatory erythropoiesis during a P. vivax infection is protective 
against severe malarial anaemia. Additional research is needed to determine which, if 
any, of these hypotheses can explain why P. falciparum, more than P. vivax, is 
associated with SMA. 
Further experimental work is required to study the erythropoietic response to anaemia in 
infected and uninfected individuals in malaria endemic areas, and understand both 
reticulocyte production and its effects on parasitaemia and disease outcome. 
Measurement of haemoglobin, reticulocyte and parasite levels during some of the iron 
supplementation studies could give the necessary data to validate the results obtained 
here through modelling. 
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4.6 Appendix 
4.6.1 Initial Conditions of the model 
It remains to specify the initial conditions of the model. We define: 
H(t) 	= 	100 	for t < 0 
where the value 100 represents 100% of the normal RBC level. Thus we have 
fR(H(t)) = BL 	for t < 0 
We also define 
s(a,0) = 	BL for t < 0 
	
(4.22) 
and so the initial condition for s(0, 0) is given by 
s(0,0) = BL  
and use equation 3.14 to define R(0). We then set E(0) = 100 — R(0), where again 100 
represents 100% of the normal RBC level. 
The initial conditions of c(a,ap,O) are motivated by the work presented in chapter 3 and 
in (Cromer et al., 2006). We assume that parasitised cells were "injected" into the host 
at time t = 0, and that the injected cells were parasitised erythrocytes (This means that 
c(0, 0, 0) = 0). We assume that a total of PT parasites were injected, where 
PT =1.07 x 104% of the total RBC level and was chosen to be similar to the percentage 
of parasitised cells injected into the mice in the work in chapter 3. We assume that 
parasitised cells were injected with an exponential distribution of ages, with a greater 
number of recently parasitised cells. This approach is adopted to give a smooth curve 
for the number of parasitised cells. Thus, we define: 
c(a, ap, 0) dv 
and therefore we have 
f c(a, ap, 0) da = 
0 
5e-6  Pa aPT eaaP  { 	  
e-5Pir. 1— e'dP 
0 
l aPrea a P  
1 
for a, 
for a, > —/, 
for a,< —/, 
for a, > 
where a = 1.33 is a constant chosen to give smooth curves. The initial value Rp(0) is set 
to zero, and equation 3.17 is used to define Ep(0). Evaluating this in fact yields Ep(0) = 
PT. Finally we set H(0) = Ru(0) + Rp(0) + Eu(0) + Ep(0). 
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4.6.2 Solving the Model 
The model presented above is a complex integro-differential delay equation describing 
an age-structured population. There are some exsiting methods for numerically solving 
physiologically structured population models. For example, the Escalator Boxcar Train 
method (Roos, 1998) is a numerical integration method for solving partial differential 
equations governing the time evolution of the population density of individuals in 
different states. 
More specific methods also exist for solving age-structured models, which are a specific 
form of the physiologically structured models, many of which are reviewed in (Abia et 
al., 2005). The model of this chapter is similar to the age structured model proposed by 
McKendrik (McKendrick, 1926), often refered to as the McKendrik model, however it 
utilises some of the alterations proposed by Gurtin and McCamy (Gurtin and MacCamy, 
1974) which allow birth (and death) rates to be dependent on the total population size. 
Numerical methods for solving this model using an eulerian scheme have been 
proposed (Sulsky, 1993). 
It is important to note there are two key differences between our model and that of 
Gurtin and McCamy. The first is that we have two interacting populations —
unparasitised and parasitised cells, both of which are structured by age, as opposed to 
only one age-structured population. The second difference lies in our birth functions, or 
boundary conditions, which are both more complex functions than that proposed by 
Gurtin and McCamy. A model which allows for a more general birth function (and 
which would incorporate our birth function for unparasitised cells only) was analysed 
using a first-order upwind scheme (Lopez-Marcos, 1991), an extrapolated box method 
that is second-order accurate (Fairweather and Lopez-Marcos, 1994) and difference 
schemes based on Runge-Kutta methods (Abia and LOpez-Marcos, 1995). 
Antia et. al. (Antia et al., 2008) solve a very similar age-structured model by dividing 
the age ranges of cells into compartments and solving a sytems of coupled ODEs. This 
produces what they term a "mean field" model of cell dynamics, and results in gamma 
distributed cell lifetimes and rupturing times. The means of the gamma distributions 
correspond to the correct values. 
and 
as(a,t) 	as' atb 	as, at _ 	+ 
aa 	at b aa at as 
	
=_i 	=, 
as' 
(4.24) 
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We chose to develop a custom numerical solution scheme to solve our model as we did 
not feel that the complexity associated with a more sophisticated numerical scheme 
would greatly enhance the results. In section 4.6.3 we show an agreement between our 
custom numerical scheme and analytical equilibrium age distributions and so validate 
our scheme. 
When solving equations 4.1 and 4.2 each characteristic represents a cohort of cells that 
are born at the same time, tb, where tb = t — a, and become parasitised at the same time, 
tp, where tp = t — ap. If we work in terms of a and ap then at each update in time, both a 
and ap must be incremented, leading to additional book-keeping and potential for error. 
On the other hand, by working in terms of tb and tp, the characteristics have tb and tp  
constant, thereby simplifying the programming logic. 
We therefore implement a change of variables, letting tb(a, t) = t — a and 
tp(ap, t) = t — ap. We now consider how this change of variables affects the equations 
governing s and c. We let s'(tb(a, t), t) = s(a, t) represent the number of unparasitised 
cells born at time tb and present at time t and c '(tb, tp, t) = c(a, ap, t) represent the 
number of cells of age a that have been parasitised for a length of time equal to ap and 
are present at time t. 
Then 
as(a,t) 	as' atb 	as, at = 	+ 
at 	at b at 	at at 
.1 =1 
as' as'  , _ ± _
arb at 
(4.23) 
___ 
atb 
Combining equations 4.23 and 4.24 shows that 
as'as(a,t) as(a,t) = 	+ 
at 	aa 	at 
=—(51,s(a,t)— c(a,0, t) 
= —811 ST (t b , I) — CO' b , t , 0 
By a similar argument we can show that 
(4.25) 
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ac' 
at 
ac(a, a ,t) ac(a, a p ,t) ac(a, a p ,t) 
= 	P  + 	+ 	  
as 	 asp 	at 
= —8 pC(a,a p ,t) 
= —8 pC(t b ,t p ,t) 
(4.26) 
From now on, we will omit the dash from s ' and c ' when the dependent variables are tb, 
tp and t, and will write s(tb, t) = s'(tb, t) = s(a, t) and similarly for c(tb, tp, t). 
We discretise time using a time step e (c = 0.005 is used in all the modelling presented 
in this chapter). Note that s has an identical purpose to At, used in chapter 3. We then 
define the index function i(t) = 1 + t/c. We use the index function to construct two 
"matrices", S and C, corresponding to the functions s and c respectively, which describe 
the cell populations (C is a three dimensional matrix). These matrices are necessary to 
store the previous history of the system, due to the different delay terms which are 
present in the model. The entry S(i(u), i(v)) in matrix S corresponds to s(u, v), and 
similarly for C(i(u), i(v), i(w)). To simplify notation we will drop the index functions 
from now on, and so we will have s(u,v) S(u,v) and c(u,v,w)— C(u,v,w). 
The numerical scheme we have used to implement this model is essentially amounts to 
numerically evaluating the integrals using the method of characteristics, with an Euler 
time-step for the time series evolution. Such a method is commonly used in more 
complicated structured models (Yates et al., 2004), however it is more common to use 
Runge-Kutta for the time series evolution (as was done by Yates et. al.). Using Runge-
Kutta for the time series evolution would likely have allowed us to use a longer time-
step to achieve the same level of accuracy, and so have sped up our simulations. 
However, it would also have considerably complicated the programming logic, which is 
already complex. For this reason we felt that using a Euler time-step was sufficient to 
solve the problem at hand. 
The discrete equations corresponding to equations 4.1 and 4.2 are then given by: 
S(tb, t) 	= 	S(tb, t—E) (1 — Six) — C(tb, t, t) 	 (4.27) 
and 
C(tb, tp, t) 	= 	C(tb, tp, t—c) (1 — 4,c) 	 (4.28) 
With boundary conditions: 
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{ 	0 	for t < tb  
S(tb, t) 
f R  (t)e for t = tb 
C(tb, t, t) 	= 	g q(t—tb) M(t) S(tb, t) E 
(4.29) 
(4.30) 
We define discrete versions of the integrals of equations 3.14 - 3.23 in equations 4.31 -
4.40 as follows. We should note that in this section we have replaced an integral by a 
sum. A more accurate integration scheme would have been to use either the Trapezoidal 
rule, or even more accurate schemes such as Gaussian quadrature. However either of 
these schemes would once again have further complicated the already complex 
programming logic. We decided that adding additional complexity through a more 
complicated integration scheme would be unwise as its main advantage would be to 
allow more efficient simulation, which is not the aim of this work. 
1, --1 E 
Ru(t) 	= 	E s(t_irtig, t) 
i=1 
E 
Eu(t) 	 E sue, t) 
1=1 
-1 
EE 
RAO 	 E E C(t-1,+je, t—lp+ks, t) 
J=t 	J=1 
(4.33) 
113-' -1 .1Z-1 
E E 
Ep(t) 	 E E C(jE, t—lp+ke, t) 	 (4.34) 
1=1 	J.1 
Ru,„t(t) = S(t-1,t) 	 (4.35) 
Ip 
Rp,mat(t) 	 C(t-1„ t—lp+ke, t) 	 (4.36) 
j=1 
Rupara(t) = 	E c(t_irtig, t, 	 (4.37) 
j=1 
t-1, 
Eupara(t) = 	E cus,t,0 	 (4.38) 
1=1 
Rprupt(t) = (4.39) 
j=1 
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Ep,rupt(t) E 	C(je, t—ip,t) 	 (4.40) 
J-1 
It should be clear that both S and C are upper triangular matrices as cells cannot be 
present or parasitised before they are born. 
4.6.3 Analytical age distributions of cells at equilibrium 
At equilibrium the distributions of s(a, t) and c(a, ap, t) aren't changing with time. This 
means that the age profile of the cells in circulation is unchanging, and we have 
at 
= 0 
and 
at 
= 0. In addition, since s(a, t) and c(a, ap, t) aren't changing with time, and 
neither are the decay rates, the variable t can be dropped, and we have that at 
equilibrium: 
as 
= 	s(a) — c(a,0) 
as 
and 
ac ac —+ 	= —4, c(a,ap ) 
as 	aa p  
(4.41) 
(4.42) 
We must now determine the initial conditions for s(a) and c(a, ap). s(0) represents cells 
that are being produced from the bone marrow. If we define H* to be the equilibrium 
level of red blood cells in circulation, then s(0) = f (H* ) (where f Ri (H) is the 
reticulocyte replacement rate function defined earlier). We let f * represent this 
equilibrium replacement rate of RBCs, and so s(0) =f * = f (H* ). 
Note that although f * is a rate (number of cells produced per unit time) and s(0) is a 
density (number of cells aged between 0 and da) the two can be equated as age, a, 
changes at the same rate as time, t. 
We then define m* to be the number of merozoites in circulation at equilibrium (i.e. m* 
is the equilibrium value of M(t)). At equilibrium we then have 
c(a, 0) = g m* q(a) s(a) 	 (4.43) 
And we obtain an initial condition for c(0, 0) as: 
c(0, 0) = g m q(0) 
{ gm* pf*e-(6 .+Pgm* )ze-apa ,  c(z+u, u) = 
0 < z < 1 
gm* pf *  e-(6. PgM*)1 e-( °.+ gm*)( z -4)e'Pa 	z > 1, 
(4.46) 
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4.6.3.1 Determining an expression for s(a) 
Combinining equation 4.41 with the initial conditions for c(a, 0) in equation 4.43 gives: 
as 
as 
= — s(a) 	— g m* q(a)) 
Integrating this and using the initial conditions for s(0) gives: 
f
* e-(8„+pgm*)a 
s(a) = { f * e--(8„+pgm*)1, e-(b+gre)(a-1,) 
0 	a < 1„ 
a > 1, 
(4.44) 
4.6.3.2 Determining an expression for c(a, ap) 
We can substitute the the expression for c(a, 0) defined in equaton 4.43 and the 
expression for s(a) defined in equation 4.44 into the expression for c(a, ap, t) defined in 
equation 3.5 (with the time variable dropped) to give an expression for c(a, ap) as: 
c(a, ap) 	= c(a — a p ,O)e-oPa P 
= gm q(a — a p )s(a — a p )e -°PaP 
 
gm* pf *  e-('n+Pgm*)(a-a de-6 Pa P 	 0 a— a < 1 
gm*  pf* e-('.+Pgin*)I, 	p 	
p  a— a> p  
(4.45) 
OR, alternatively 
 
4.6.3.3 Determining expressions for m* and f* 
The expressions we have derived for s(a) and c(a, ap) both include parameters 
representing the number of merozoites present at equilibrium (m* ) and the equilibrium 
replacement rate of red blood cells ((). We now attempt to develop expressions for 
these quantities. 
Merozoites 
We first consider the rate of change of merozoites, —dM . Using the definition of given 
dt 
in equation 4.5 we have: 
c(a, 1p)da — f c(a, 0)da — S„, m*  
c(a-l p, 0)e-5PC da — f c(a, 0)da — S„, m 
dM 
dt 
	mr 
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Mr e
-8PIP  f gm.q(a-l p)s(a-l p )dv — f gm.q(a)s(a)da — m*  
1 
= 	(Mr e
-(5 
 " — 1) gm*q(a)s(a)da — m* 
dM But at equilibrium — = 0, and so dividing through by m and rearranging gives: 
dt 
Sm q(a)s(a)da 
0 g(mre-6P1P —1) 
= 	 f10 re-(''''*)a 	-(' da + e''±pg"'*)c f - e"+'*)( a-4-)da ( 	+ 	 ) 
f,p(1—e-(6.+Pg"*)4) + e-Gc.+Pg'n% (1— 0) --_-_,  
gu + pgms 	8u+ gm*  
[p(1—e±" + P"M*)1 r) 	e-co.±ppoY,- 
= i  
au+ Pgm* 	5. + gm*  
(4.47) 
or alternatively, 
— e-(8.+ Pgm*)1r) 
	  J 	  g(mre-oP I P -1) 	 Su+ pgm
* 
 
e-(o'+Pgm*)1,1 
Su + gm*  
— 0 	 (4.48) 
The equilibrium production rate,l, depends both on the RRR function, f RI (H), and on 
the equilibrium RBC levels, H* . In order to calculate the total number of cells at 
equilibrium, H* , we must consider both the parasitised and unparasitised cells. 
Unparasitised Cells 
The total number of unparasitised cells at equilibrium is given by: 
STOT 
	f s(a)da 
= 	 f* (f r e -('.+ Pgrn*)a da + e-(6.+Pgin*)1r f e-(`'.+P"*)( a-4)da) 
= 1  
 
1— e-(5.+Pg'n*)1r e +pgm*)1,1 
5u + gm*  
(4.49) 
 
Su + pgrn 
     
Chapter 4: Low RBC production may protect against SMA 	 - 142 - 
Parasitised Cells 
The total number of parasitised cells at equilibrium is given by: 
CTOT 
	
f e(a+ap, ap)dadap 
gm*/ f q(a)s(a)da e-epap dap (Using eq 4.46) 
fP 	e-(°.+Pg-*)1,) e-
(6„ - pgm* )1,  
-5 a gm*/  
(514 Pgin 	C5-u gm*le 
° ° da 
gm * f * (1 — 	 e-(''+PgM*)1' ) 	e-('.+Pgm*)l'l 
	  + 	  
+ Pgm
* 
	+ gm * 
(Using eq 4.47) 
(4.50) 
Total numbers of RBCs,H* 
Combining equations 4.49 and 4.50 gives an expression for the total number of cells at 
equilibrium, H*: 
H*  ".= STOT + CTOT 
1 — e-("Pgm*)4  
Pgm 
e-(o.+Pgm* )1, 
g„ + gm * ) 
_ 1  
gm * f i (1— e-e,(, ) (p(1 — e-(6.÷Pgm*)1, ) 	6,-(o.+Pgmt )1,\ 
pgm
* + 	  
65. + gm 
(4.51) 
We can therefore derive a second relationship between/ and m* as: 
1 = .f., (11*) 	 (4.52) 
with the conditions on H* being defined by equation 4.51. 
We can then combine 4.51 and 4.52 to give: 
	
r( 1— e-("Pg's 	
	
e-(".+Pwn*Y' 
- 	8„+ pgm 	8  	u 	+ gm*  
   
m* f * g,n (1 — e --.'PIP ) 
g p (mre 8P1P — 1) 
  
 
= 0 (4.53) 
   
    
Combining the conditions given by equations 4.48 and 4.53 is enough to determine the 
values off and m*. 
= 
r* ,  
J 
( 1 — e-(6"+Pgms)ir e -0„-f-pgm*)1 r  f * (5.,n (1 — e- °PIP ) 
gn + pgm 
+ 	 + 
 
jm *  
S.+ gm* g p (mre'PlP — 1) 
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4.6.4 Comparing analytical distributions with results of numerical 
simulations 
We can solve the conditions defined by equations 4.48 and 4.53 in Matlab® to 
determine for values of m* and/ and so determine expressions for the age distributions 
of both parasitised and unparasitised cells. We use the Matlab® command 1 sqnoril in, 
which solves non-linear least squares problems to minimise the values associated with 
the left hand sides of equations 4.48 and 4.53. 
4.6.4.1 Equilibrium levels of unparasitised and parasitised cells 
Figure 4.11 shows the predicted equilibrium level of unparasitised and parasitised cells 
by solving these expressions. The level of unparasitised cells is determined by the 
expression in equation 4.49, while the level of parasitised cells is determined by the 
expression in equation 4.50. 
The 3D figures obtained and presented in Figure 4.11A and B look almost identical to 
those in Figure 4.6A and C showing that at equilibrium our numerical simulations give 
results that are qualitatively extremely similar to those calculated analytically. The 
average difference in unparasitised cell levels between the analytical equilibrium 
distribution and the numerical simulations is 1.5% of the normal RBC level (SD = 
0.95%) while the average difference in parasitised cell levels is 0.12% (SD = 0.19%). A 
graph showing how the difference between the models varies with preference and 
reticulocyte replacement rate for both unparasitised and parasitised cells is given in 
Figure 4.12. Although some parameter combinations show greater differences than 
others, the difference between the models is never particularly large. It is interesting to 
note that the difference between the models appears to be greatest along the line of the 
threshold RRR. 
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Figure 4.11 Graphs showing the equilibrium levels of unparasitised (A) and 
parasitised (B) cells predicted by the age distribution model. 
Figure 4.12 Graphs showing the Difference in calculated levels of unparasitised (A) 
and parasitised (B) cells between the age distribution and discrete models. 
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Comparing the results of numerical simulations using different discretisation 
steps 
We next consider how closely the results of our numerical simulations match those of 
the analytical equilibrium age distribution when different discretisation steps are used. 
During all simulations presented previously a time step of s = 0.05 was used, and this is 
also the time step that was used to produce the graphs in Figure 4.12 and Figure 4.14. 
We consider implementations of our numerical simulations with 8=0.01, 0.008 and 
0.005 and compare the results of these implementations to the results of the analytical 
equilibrium age distributions. The results for all values of c are qualitatively similar to 
each other and also to the analytical equilibrium distributions. 
We find that ass is decreased, the difference between the numerical simulations and 
analytical results also decreases, as we would expect. Figure 4.13 shows the difference 
in the anaytical and simulated equilibrium levels of cells for different values of E. We 
observe stacked error surfaces, with the surface corresponding to the largest difference 
(red surface) being associated with the numerical simulation with s = 0.01 and the 
smallest difference (blue surface) being associated with a numerical simulation with s = 
0.005. A numerical simulation with E = 0.008 gives and intermediate difference (green 
surface). 
4.6.4.2 Equilibrium Distributions of Reticulocytes and Erythrocytes 
We can extract the predicted number of unparasitised and parasitised reticulocytes and 
erythrocytes in the age-parameterised model at equilibrium by integrating equations 
4.44 and 4.45 over the appropriate ages. 
The number of unparasitised reticulocytes at equilibrium is given by 
R 	= 	r I e—(°" —Pgm*)a da 
f* 	 
* 
= 	 (1 e-v-Pgin*)1, ) 	 (4.54) gu — pgrn 
and the number of erythrocytes at equilibrium is given by 
E 	= STOT — R. 	 (4.55) 
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Figure 4.13 Difference between equilibrium levels of unparasitised (A) and 
parasitized (B) cells between the analytical age distribution equations and 
numerical simulations, for a range of different values of s. 
Surfaces are shown for e=0.01 (red surfaces), 6=0.008 (green surfaces) and E=0.005 
(blue surfaces). The largest difference occurs when e=0.01 (red surfaces). Intermediate 
differences (green surfaces) are obtained when e=0.008 and the smallest difference 
(blue surface) is achieved when 6-0.005. 
The number of parasitised reticulocytes at equilibrium is given by: 
Rp 	 c(a, ap)dadap  
= 
	p 	C(Z+ap, ap)dzdap (Letting z=a-ap) 
gni* pc r 
gm. pf * 
(1- e-('.+ Pgm*)(1'-u ) )e-sPa p dap  
8u + pgm' 
gm* pf * r 1— 	e-('.+ Pgm*)'' (1— e-("Pgm*''' )/P) 
Su + pgm* P 	8, + pgm* — 
e-(6-+Pgm*) z dz e s'°' da 
(4.56) 
and the number of parasitised erythrocytes at equilibrium is given by: 
Er 	= C TOT — R. 	 (4.57) 
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We can consider how the ratio of both unparasitised and parasitised reticulocytes to 
erythrocytes changes for varying preference and reticulocyte replacement rate values, 
and compare the ratios obtained from the analytical equilibrium distribution with the 
results of our numerical simulations. 
Figure 4.14 compares the ratios obtained using the expressions in equations 4.54 - 4.57 
(blue surface) and those obtained from our numerical simulations (red surface). We 
observe a close correlation between the surfaces, highlighting the fact that the ratios 
obtained from our numerical simulations closely approximate the analytical equilibrium 
ratios of reticulocytes and erythrocytes. Note that Figure 4.14A and B show the ratio of 
reticulocytes:erythrocytes, while Figure 4.14C and D show the inverse ratios of 
erythrocytes:reticulocytes. This is due to the fact that when the ratios are small, they are 
difficult to view on the figure, and so plotting their inverse is more instructive. 
We note also that difference between the analytical and simulated ratios of reticulocytes 
to erythrocytes decreases ass decreases (as we would expect). 
4.6.4.3 Considering the full age distribution of unparasitised cells 
Finally, we consider the full equilibrium age distribution of cells as predicted by the 
analytical solutions, and compare this to the results of our numerical simulations. Since 
it is computationally difficult to extract the full age distribution of cells from the 
implementation of the numerical simulations (memory restrictions mean that we only 
record the exact populations of cells until they mature into erythrocytes, and then treat 
them as a uniform group) in this section we only compare the age distributions of cells 
when they are reticulocytes. Since we have previously shown that the ratio of 
reticulocytes to erythrocytes is conserved, showing an agreement of the age distribution 
of reticulocytes between the two models should be sufficient to conclude that the age 
distribution of our numerical simulation approximates that in the equilibrium age 
distributions. 
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Figure 4.14 Ratio of reticulocytes to erythrocytes (and visa-versa) at equilibrium 
for unparasitised (A and C) and parasitised (B and D) cells 
Panels A and B show the ratio of reticulocytes: erythrocytes for unparasitised (A) and 
parasitised (B) cells. Panels C and D show the ratios of erythrocytes:reticulocytes for 
unparasitised (C) and parasitised (D) cells. Blue surfaces show the results for the 
analytical equilibrium distributions. Red surface plot the results of our numerical 
simulations. A close correlationo can be observed between the blue and red surfaces, 
highlighting the fact that our numerical simulations closely approximate the analytical 
equilibrium distributions of reticulocytes and erythrocytes. 
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Figure 4.15 shows the age distribution for unparasitised reticulocytes predicted by both 
models for various reticulocyte replacements rates and a preference value of 15. We 
observe that as the reticulocyte replacement rate increases, more very young cells are 
present at equilibrium, and less older cells are present. The solid lines depict the age 
distributions predicted by the analytical solutions, and the dotted lines depict the 
distributions predicted by the numerical simulations (with c=0.05). We see a close 
agreement between the two models and the same is true for different preference values 
(not shown). 
Figure 4.15 Change in age distribution of unparasitised cells for a preference of 15 
and an RRR of 1, 2, 4, 6, 8 and 10. 
Solid lines show the age distributions of unparasitised reticulocytes predicted by the 
analytical age distributions, and stars show the age distributions obtained using our 
numerical simulations. A good correspondence is achieved for all reticulocyte 
replacement rates. 
Chapter 5 
Simplified ODE Model of a Malaria Infection 
5.1 Overview 
The model presented in chapter 4 gives rise to some interesting and clinically relevant 
phenomena. In this chapter we analyse a simplified Ordinary Differential Equation 
(ODE) version of the model. This allows us to determine whether the phenomena 
observed earlier were specific to the integro-differential equation model used or whether 
a simplified model can provide similar insight. We do not obtain an exact 
correspondence between the simplified and more complex models, however we observe 
qualitatively similar behaviour. 
The simplified model also allows us to utilise some of the standard tools for analysing 
differential equations and so gain insight into the reason behind the threshold 
reticulocyte replacement rate (RRR) uncovered in chapter 4. 
- 150 - 
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5.2 Introduction 
In the previous chapter we used a structured model to analyse red blood cell populations 
during a malaria infection. The model consisted of a system of integro-differential 
equations constructed to capture the discrete processes of parasite rupture and 
reticulocyte maturation occurring after certain time delays. We computationally solved 
the model to analyse the effects of certain parameter variations on the model's 
behaviour. 
In this chapter we consider a simplified ODE model of infection. This model captures 
the essential features of the full model and allows us to do some more basic analysis. 
The motivation for the analysis of such a simplified model stems from a discussion 
between Saul and Gravenor and Lloyd (Saul, 1998, Gravenor and Lloyd, 1998). In this 
discussion the pros and cons of using an exponential distribution to describe the discrete 
process of parasite rupture and merozoite release are debated. Saul observes that using 
an exponential distribution to describe parasite lifetimes, without correct modification 
of the exponential constant, can lead to errors in model dynamics. Gravenor and Lloyd 
respond by putting forward a more complicated ODE model which introduces a number 
of categories through which a parasite must pass before rupturing. Their new model has 
the effect of narrowing the distribution of parasite lifetimes compared to an exponential 
distribution. They observe that the introduction of such a compartmental model does not 
alter earlier conclusions drawn from the non-compartmental model (Gravenor et al., 
1995). 
Against the background of such discussion, it is our aim to show that the observations 
made in chapter 4 are not artefacts of the model complexity, but are general features 
which can be observed even in a more simplified model. It is only by constructing and 
analysing both the more complicated integro-differential equation model and a 
simplified version of the model that we are able to verify that the observations we make 
are robust features of a malaria infection and are not related to the form of the model. 
We can solve the simplified ODE model presented here to find equilibrium solutions. 
This means that we can analytically examine the effects both of a parasite preference for 
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young cells and of altered reticulocyte production on chronic infection without the need 
to simulate the model for long time periods. It also provides us with a way to verify the 
equilibrium results of the previous chapter using analytical methods. In addition, by 
applying some standard methods for analysing differential equations we are able to gain 
insight into the reason behind the change in model behaviour at the threshold RRR. 
5.3 Model Setup 
We represent red blood cell (RBC) infection during a malarial episode by the following 
differential equations. 
ddt„ = 
	RI (t) cD(H(0) — pgM(t)Ru(t) 	
1 
(5 .1) 
, 
	
dE „ 	R„(t) 	 E „(t)  
	 gM(t)E,,(t) 	 (5.2) 
dt le 
dR p 	 R p(t) 	R p (t) 
pgM(OR,,(t) 	 (5.3) 
dt 1, 	1 p 
dE p 	R p (t) 	 E p (t) 
	 gM(t)E„(t)  	 (5.4) 
dt r p 
dM 	r (Rp(t)+ Ep(t)) 	 M(t)  gM(t)(Eu(t) + pR„(0)  	(5.5) 
dt p 	 1,, 
The symbols describing the cell populations are the same as those used previously. This 
means that Ru(t) and Eu(t) represent unparasitised reticulocytes and erythrocytes 
respectively, Rp(t) and Ep(t) represent parasitised reticulocytes and erythrocytes, and 
m(t) represents merozoites. We use the symbol H(t) (where H stands for haematocrit) to 
represent the total level of RBCs i.e. H(t) = Ru(t) + E„(1) + Rp(t) + Ep(t). All cell 
populations are functions of time, however in future we may omit explicitly stating this 
where the meaning is obvious. 
The majority of the model parameters have been previously discussed but are listed here 
(often with slightly edited notation) for compatibility with the revised model. Note that 
the number of merozoites released per parasite is now denoted by r instead of mr  (which 
was used previously) to simplify later expressions. Some parameters are taken from 
published estimates and are shown in Table 5.1, while those that have not been 
established experimentally are listed in Table 5.2. 
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Parameter value Explanation citation Previous 
notation 
i„, 1/72 Merozoite lifetime of 20 
minutes 
(Anderson et al., 
1989) 
1,7 , 
r 16 Inside estimated range of 
8-32 merozoites released per 
rupturing parasite 
(Garnham, 1988) mr 
/r 2.8 Reticulocyte lifetime of 2.8 
days 
(Colijn and 
Mackey, 2005) 
1, 
/p  2 Parasite lifetime of 2 days (Garnham, 1966) / p  
Ie 120 Erythrocyte lifetime of 120 
days 
(Belair et al., 
1995) 
le 
A .83 Baseline retic production to 
account for an erythrocyte 
lifetime of 120 days 
(Belair et al., 
1995) 
BL  
Table 5.1 Parameter values for known parameters 
The final column of the table gives the notation for the corresponding parameter that 
was used in the model presented in chapter 4. Note that sometimes the notation is 
slightly different in this model. 
Parameter Explanation Previous 
Notation 
g The infection rate of the parasite g 
P The preference of the parasite for reticulocytes. p 
(1)(11) The rate that new reticulocytes enter the blood stream. 
This rate is dependent on the total number of RBCs 
already in the system. 
fR(t) 
Anse The maximum reticulocyte replacement rate increase 
above baseline (attained when total RBC count is zero). 
HO 
Table 5.2 Parameter values for variable parameters 
As in Table 5.1 the final column of the table gives the notation for the corresponding 
parameter that was used in the model presented in chapter 4. 
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5.3.1 Comparison with the model from chapter 4 
Equations 5.1 - 5.5 are closely related to the equations defining the models of chapters 3 
and 4 (equations 3.24 — 3.27 and 4.5). In this section we consider both the similarities 
and differences between the model of this chapter and that of chapter 4. Since equations 
5.1 - 5.5 represent a closed model, it will be intuitive to compare the model of this 
chapter with the closed form expression of the model of chapter 4, developed in section 
4.3.2. To make this comparison we once again combine parasitised cells into a single 
class, P(t) where P(t) = R p(t)+ E p(t). For the model of this chapter this is achieved by 
adding equations 5.3 and 5.4 to give the following expression for dP 1 dt: 
pgM(t)R„(t) + gM(ORu(t) P () 
dt 	 1 p  
Unparasitised Reticulocytes 
The closed form equation giverning the change in unparasitised reticulocytes for the 
model of chapter 4 has been presented earlier in equaton 4.14, and is repeated below: 
-PS 
= f(H(t-z)) — pgM(t)R„(t) — fR(H(t-1,—T)) e-611' e 1-4 	- 6„(t)R„(t) 
(4.14) 
The equation for the change in unparasitised reticulocytes used in this chapter is 
presented in equation 5.1, and is repeated below to allow direct comparison with 
equaton 4.14. 
_ 
dt 	
u 
ct,(H(t)) — pgM(O 	
R1(t) 
R„(t) 
	
	 (5.1) 
, 
The first term of equation 5.1, (1)(H(t)), is equivalent to f(H(t- r)), the production of 
reticulocytes, in equation 4.14, excluding the delay term. In the model of this chapter 
reticulocyte production is dependent on the instantaneous level of RBCs in the system, 
rather than the RBC level at an earlier time point. This makes it simpler to solve the 
model.The second term representing reticulocytes that become parasitised is identical in 
the two equations. 
The difference between equation 4.14 and equation 5.1 lies in the former's final two 
terms. Firstly, equation 5.1 does not include a term corresponding to the decay of 
dP (5.6) 
dR„ 
dt 
A 
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reticulocytes due to senescence, —88(t)Ru(t). This terms is omitted as it is considered to 
be a much slower process than the maturation of reticulocytes into erythrocytes. 
Including it would have added a Ru(t)11, term to equation 5.1. 
The second difference is in the term corresponding to the maturation of reticulocytes. 
For the model of this chapter, a term corresponding to the average lifetime of a 
reticulocyte (in the absence of parasitisation), Ru(t)11„ is used for maturation instead 
of keeping track of cells scheduled to mature (s(/„ t)) as was done in equation 4.14. 
Using the term Ru (t)I1r to represent the maturation of unparasitised reticulocytes 
assumes that there is a uniform age distribution of cells, and those that are scheduled to 
mature are just a proportion of all reticulocytes present (Figure 5.1A). In actual fact 
(even if we ignore the decay of reticulocytes due to clearance) the age distribution of 
cells decays as age increases (Figure 5.1B) due to the parasitisation of cells. This 
decaying age distribution is incorporated into equation 4.14 through the exponential 
- pg M (z)dz 
term e 
Using an average lifetime, Ru(t)I1„ for reticulocyte maturation makes it easier to solve 
the differential equations and also makes the model comparable with the basic model 
for malaria infection previously discussed in section 2.10.1 (see section 5.3.2 below). 
age 	 0 	age 
Figure 5.1 Age distributions of reticulocytes assumed in the models of chapter 5 
(panel A) and chapter 4 (panel B). 
dP 
dt 
C (i) 
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Un pa rasitised Erythrocytes 
The closed form equation giverning the change in unparasitised erythrocytes for the 
model of chapter 4 has been presented earlier in equaton 4.15, and is repeated below: 
dE u 
dt 
-pg J M(z)dz 
fAH(t—lr — z)) e- ,' e — gM(t)Eu(t) — 8,(t)Ru(t) (4.15) 
The equation for the change in unparasitised erythrocytes used in this chapter is 
presented in equation 5.1, and is repeated below to allow direct comparison with 
equaton 4.15. 
dE u 	Ru (t) 	 E u (t)  gM(t)E„(t) 	 (5.2) 
dt 
The first term of both of these equations, the maturation of reticulocytes, has already 
been discussed above. The second term, the parasitisation of erythrocytes is identical in 
both equations, and the final term, the decay of erythrocytes due to senescence is also 
the same for both equations, with 8u(t) = 1/le in this chapter. 
Parasitised Cells 
The closed form equation giverning the change in unparasitised reticulocytes for the 
model of chapter 4 has been presented earlier in equaton 3.30, and is repeated below: 
	
— cp(t—/ p) e-s°1° — 8p(t)P(t) 	(5.7) 
The equation for the change in parasitised cells used in this chapter is presented in 
equation 5.6, and is repeated below to allow direct comparison with equaton 4.14. 
dP 	 P(t) = 	(pgM(t)Ru(t) + gM(t)Ru(t)) 	 (5.6) 
aft /p 
The first terms of both equations above correspond to the parasitisation of cells and are 
identical (see equation 4.11). In equation 5.6 the there is no term corresponding to the 
clearance of parasitised cells (-4,(0P(t) in equation 5.8). Death of parasitised cells due 
to clearance and senescence is not included in the model of this chapter as it is 
considered to be a much slower process than death due to parasite rupture. Including 
this would have added a —4,Rp(t) term to equation 5.6, which would be identical to the 
final term of equation 5.9. 
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Although the second terms of equations 5.10 and 5.6 appear to be different, they are in 
fact similar. If we assume that Sp = 0, and omit the delay, then the second term of 
equation 5.11 is given by be cp(t). Then if we assume that parastised cells have an even 
distribution in terms of the amount of time for which the cells have been parasitised 
(similar to Figure 5.1A), then we would have cp(t) -  P(t)// p . Thus, in the absence of 
bystander clearance of parasitised cells, and when there is an even distribution of length 
of time for which cells been parasitised the second terms of equations 5.12 and 5.6 and 
therefore equations 5.13 and 5.6 themselves are identical. 
Merozoites 
The closed form equation giverning the change in merozoites numbers for the model of 
chapter 4 has been presented earlier in equaton 4.16, and is repeated below: 
—dM = mre_gP ip c p(t—lp) — c p(t) 	 — gm M(t) 	 (4.16) 
dt 
The equation for the change in parasitised cells used in this chapter is presented in 
equation 5.5, and is repeated below (with the Rp(t) + Ep(t) term replaced by P(t)) to 
allow direct comparison with equaton 4.16. 
dM , r P(t) 	 M 	(t) — gM(t)(Eu(t) + pRu(t)) 	 (5.5) 
dt 	1 p 1,, 
The second and third terms in equations 4.16 and 5.5 represent the utilisation of 
merozoites to create parasitised cells and the decay of merozoites. These terms are 
identical in the two equations. The only difference between the above two equations lies 
in the first term, the creation of merozoites through parasitised cell rupture. Both terms 
multiply the total number of rupturing cells by the number of merozoites released per 
rupturing cell. We have already discussed above the similarities in the calculation of 
rupturing cells between the model of this chapter and that of chapter 4. 
5.3.2 Comparison with the basic ODE model of malaria infection 
The simplified model presented in equations 5.1 - 5.5 is based on a number of earlier 
models (Anderson et al., 1989, Gravenor et al., 1995, Hetzel and Anderson, 1996), 
however it differs in two important ways. Firstly, it allows for different infection rates 
of young and old cells (incorporated through the preference parameter, p) and secondly 
a compensatory response to anaemia is incorporated into the model (incorporated 
through (121(H)). 
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Direct parallels between the model equations presented in equations 5.1 - 5.5 and the 
basic ODE model equations presented in equations 2.1 - 2.3 can be observed. In fact, in 
the absence of density dependent RBC production and a preference for parasitising 
young cells, and by adding in a decay due to senescence for reticulocytes, equations 5.1 
- 5.5 reduce exactly to equations 2.1 - 2.3. 
Equations 5.1 and 5.2 correlate with equation 2.1 of the basic model, but have been 
modified firstly to allow for the production of new cells to be dependent on the total 
RBC level and secondly to incorporate an age structure, and so allow for an age 
preference of the parasite for younger cells. Equations 5.3 and 5.4 correlate with 
equation 2.2, but once again allow for age structuring, while equation 5.5 correlates 
with equation 2.3 of the basic model. 
In the simplified model of this chapter, as in the basic model, decay rates corresponding 
to the average lifetimes of cells are used to describe clearance of the parasitised and 
unparasitised cell populations, giving rise to exponential distributions for their lifetimes 
5.3.3 Functions for reticulocyte production 
We analyse the solution of equations 5.1 - 5.5 using two different families of functions 
forcI)(H): 
Sigmoid Reticulocyte production 
One family is a sigmoid family of functions, cD ig(H), which is the same family as was 
used in chapter 4 and described in (Mackey, 1997). The family of functions is 
described by: 
n j  
Osig V-1) = fR1 (H) = 11 Hne+ 011' 	* 
131 	 (5.14) 
As in chapter 4, the superscript I indicates the "intermediate" or fold value of 
reticulocyte production. A value of I = 1 corresponds to baseline reticulocyte 
production, and a value of I = 10 corresponds to normal reticulocyte production. The 
details of the parameters in equation 5.14 are the same as those given in section 4.3.5. 
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Linear Reticulocyte Production 
The other family of functions is the linear family, Ohn(1/), in which reticulocytes are 
produced according to a linear function of the red blood cell level. The form of this 
function is: 
tiin (H) 
 = (2 + Arise) 
100 
	 (5.15) 
The linear function increases from a production rate of )/day when the RBC count is 
100% of normal, to a production rate of (i1+ ; —rise)/day when the RBC count is 
(hypothetically) zero. 
Advantages and disadvantages of the different families 
Although a sigmoid function has been shown to closely approximate the true red blood 
cell replacement function (Mackey, 1997), inserting a sigmoid function into the 
differential equations renders them too difficult to solve analytically for their 
equilibrium solutions in a reasonable time frame. Even outside of this timeframe the 
results obtained are too complicated to interpret effectively. 
The advantage of using the linear function for t(I1) in equation 5.1 is that we can then 
find analytical solutions to the model equations at equilibrium, and the model gives 
some qualitatively similar behaviours with the linear function and with the sigmoid 
function. 
Relating the two functions for reticulocyte production 
When using the two different families of functions to describe reticulocyte production, 
it would be helpful to be able to equate a specific member of the cIoh„ family with a 
corresponding member of the (1),g family which shows an "equivalent" reticulocyte 
response to anaemia. Since the two functions 0,,g and Ohn have such different shapes 
we cannot easily equate their parameters. For example, it is not true that a member of 
the linear family of functions with a value of; —rise = 10 is the same as a member of the 
sigmoid family of functions with a fold change in RRR of 10. 
One way of linking a member of the the sigmoid family with an "equivalent" member 
for the linear family is to require that the two functions intersect when 1sig has risen to 
half its maximum value. This is depicted in Figure 5.2 for a member of the sigmoid 
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Figure 5.3 Relationship between fold changes in RRR in CoSig and the value of 2 —rise 
in Olin. 
The bottom left of the graph gives the parameters for baseline production, while the top 
right of the graph gives the parameters for normal production. 
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— 
gl„,(r —1) 
(5.19) 
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family with a fold increase of 8. An equivalent member of the linear family has a value 
of-rise = 11.35. There is no simple analytical formula to equate fold changes in RRR in 
the sigmoid family of functions with equivalent values of-rise  in the linear family of 
functions in such a manner. We can however compute the relationship using an iterative 
root finding process. This relationship, which equates a member of the Osig family and 
its associated fold change in RRR with an equivalent member of the c131,, family and an 
associated parameter of Anse, is depicted in Figure 5.3. We use this relationship to pair 
members of the sigmoid family of functions with "equivalent" linear functions. A linear 
function with -rise = 0 correlates with baseline production, and a linear function with arise 
— 18 is approximately equivalent to a normal reticulocyte replacement rate. 
5.4 Results 
5.4.1 Model Solutions at Equilibrium 
In this section we consider the equilibrium solutions to equations 5.1 - 5.5. As discussed 
earlier it is possible to do this analytically when a linear function is used for reticulocyte 
production. Thus for the remainder of this section we will use 43= cl)/,„(H) for 
reticulocyte production. 
We obtain equilibrium solutions for Ru, Rp, Eu, Ep and m by setting all differential 
equations to zero and solving them. This results in two solutions. The first is the trivial 
solution, where the parasite does not persist in the host. In this case at equilibrium we 
have m, Rp and Ep all equal to zero, and 
100( Arse + /1)lr  
rice ( lr + le) + 100 
100(2r,ce + /1,)le 	_ 
Eu = 	 . 
risellr + le ) +100 	l r  
The second, non trivial solution is: 
(5.17) 
Rt, 
z —1 (5.18) 
gpl„,(r —1) 
Ri, — (5.16) 
1001"11 2,gp(r — 1)(2 + 2,eire )-1,(1, +1,)2,,„(z —1)+1,(1p — le g ise pz —1001e(z — 1) 
Rp p 
	
	  
gpl„,1,(100 + /pAr,„)(/?, + /r )(r —1) 
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(5.20) 
100/ I
e 	
I
m 
 Agp(r —1)(2 + iir„,)—[100(l + 10+ 1 „(1, + lr )2,,,,,]pz-100l e(z -0 
Ep =lp 
	
	 (5.21) 
gpi n1,(100+ piir„,)(1,+1,)(r —1) 
_ 	le — (le + pl r )z 
Ml el r pgz 
where z is the smaller root of the quadratic az2 +bz+c=0 with 
a 	= 	100/rp — 4- Ariee(p — 1) 
b 	= 	AriseP +le — 1p)Arise 100(le + lr p) —1001r  le 1„,2gp(r — 1)(2 + Arise) 
C 	= 	le (100 + 1p  /rise)• 
Parasite Persistence 
This non trivial solution exists when the solutions for Rp, Ep and m in equations 5.20, 
5.21 and 5.22 are all positive. To determine the required conditions for the parasite to 
persist in the host we set equations 5.20 - 5.22 to zero and solve them simultaneously. 
We arrive at the following requirement: 
A 
100(/,,(/, pl,)2(r —1)+1)  (5.23) rise 	1001„,(1, +plr )g(r — 1) — (l +10 
Now it is not a biologically reasonable assumption to have a negative value for .),rise as 
this would imply that the reticulocyte production decreases when the red blood cell 
levels decrease. Even papers that discuss an insufficient erythropoietic response to 
malaria related anaemia do not predict that the response is lower than baseline 
production (Abdalla et al., 1980). Since there is always more than 1 merozoite released 
per rupturing parasite (r > 2) the numerator of equation 5.23 consists only of positive 
terms and so is always positive. If the denominator of equation 5.23 were also positive, 
the condition in equation 5.23 could then be simplified to the sensible assumption that 
Arise be non-negative. Thus, requiring that the denominator of equation 5.23 is positive 
and requiring Arise  to be non-negative is sufficient to satisfy the condition for parasite 
persistence. (In fact it is a more stringent requirement than is actually necessary). 
We conclude that parasite persistence will occur whenever 
e +4 
g > 	A 
1001m(l
l  
e + pl r )(r —1) 
and rise > 0. (5.24) 
(5.22) 
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Since p > 1 we can simplify equation 5.24 to 
g > 	1 	and Arise > O. 	 (5.25) 
100/.(r —1) 
Equation 5.25 gives a stringent (but interpretable) condition on the growth rate of the 
parasite that is necessary for parasite persistence in a system with a linear reticulocyte 
replacement rate that is either flat or increases with decreasing red blood cell levels. 
It is important that both 1 and )1 -rise are not equal to zero (although setting one or the 
other to zero is not problematic) as this would mean that no red blood cells were ever 
replaced and the system would tend towards an equilibrium where 
Ri, 	E„ Rp — 	M 0. 
5.4.2 Numerical integration of the model 
It is not possible to solve equations 5.1 - 5.5 analytically for their equilibrium solution 
when the sigmoid family of curves is used for reticulocyte production. It is, however, 
possible to integrate them numerically using a differential equation solver and so 
determine their long term solution. This has the advantage over using a root finder in 
that we can use the numerical solutions to extract features such as the minimum level of 
unparasitised cells and maximum level of parasitised cells attained. We apply this 
numerical integration method to determine the equilibrium cell levels of the model 
when using (13,,g(H) for reticulocyte production and also to uncover these minimum and 
maximum levels when incorporating both Ohn(R) and 0,,g(H) for reticulocyte 
production. 
We solve equations 5.1 - 5.5 (using 1 = 1im or(13,,g as appropriate) using Matlab®s 
ode4 5 solver, which is based on a Runge Kutta formula. At the starting time point of 
integration we set 2% of cells to be (unparasitised) reticulocytes and 98% to be 
(unparasitised) erythrocytes. To initiate infection we assume that a quantity of 
parasitised cells (10-4°/0 of the total number of cells) are injected into the host as 
parasitised erythrocytes. These initial conditions are almost identical to those described 
in the appendix of chapter 4 and so should allow for comparisons between this model 
and the one presented in chapter 4. 
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5.4.3 Eigenvalues of Equilibrium Solutions 
In chapter 4 we observed a threshold reticulocyte replacement rate (RRR). Increasing 
the RRR above this threshold value confers no benefit to the patient (in terms of the 
clinical parameters under consideration). Furthermore for an RRR above the threshold 
the system does not appear to oscillate significantly and the equilibrium level of 
unparasitised cells coincides almost exactly with the minimum level of unparasitised 
RBCs during acute infection. For values of the RRR below the threshold level, 
unparasitised RBCs decrease to a minimum level during acute infection and then 
oscillate towards a slightly higher equilibrium level. 
We hypothesise that the change in structure of the solution around the threshold RRR 
likely corresponds to the largest eigenvalue of the equilibrium solution switching from 
being a complex conjugate pair to being real valued. Reticulocyte replacement functions 
that give rise to a large complex conjugate eigenvalue should result in oscillations of the 
cell populations. In contrast, replacement functions for which the largest eigenvalue is 
real should lead to a solution without oscillations, and in this case we expect the 
minimum level of unparasitised cells to be identical to the equilibrium level. 
Eigenvalues for the linear family of functions (OW 
We first consider the eigenvalues of the equilibrium solution when reticulocyte 
production is determined by 1(1/) =0:13/41/). We construct the Jacobian of equations 5.1 
- 5.5 and use it to compute the eigenvalues of the equilibrium solution. The Jacobian is 
given by: 
J lin = 
— ii.rtse /100 — pgM *  —1;1 
pgM* 
4-1 
0 
— pgM*  
( 	2 \ 
	
— .1,„e 1100 	— A'rise 1100 	— A'rtse I100 
471 	1;1 	0 	0 
0 	gM* — 1;1 	0 
4-1 gM* 	1-' P 
rr P 	 — gM* 	r1 P-' 
— pgR: 
pgR: 
— gE : 
gE: 
— g(pRi, + Ez,) — 4;1  
A star next to a variable denotes its equilibrium concentration. The subscript of lin in Jim 
indicates that this Jacobian has been calculated using .013/,,,(R) for reticulocyte 
production. 
To compute the eigenvalues of Jhri we use the equilibrium solutions for Eu, Ru and in 
given in equations 5.18, 5.19 and 5.22 respectively and the values of the constants given 
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in Table 5.1. We use a growth rate of g = .06 as this is the value used in the integro-
differential equation model. 
We consider how the largest eigenvalue of fh, changes for a fixed value of the 
preference parameter and as Anse increases from 0 up to 202. Since 2=0.83 this 
corresponds to varying Anse from 0 to 16.67. The relationship given in Figure 5.3 shows 
that this is similar to increasing the RRR from baseline to close to normal reticulocyte 
production in the sigmoid family of functions. 
For very low values ofp the largest eigenvalue is complex for the entire range of; 
This is shown in Figure 5.4A for a value ofp = 1 and corresponds to a scenario where 
the cell populations always oscillate towards an equilibrium solution, independently of 
the replacement rate of RBCs (within the range we consider). Figure 5.4B and C 
compare the acute levels of unparasitised (Figure 5.4B) and parasitised (Figure 5.4C) 
cells with their equilibrium levels. Acute levels are determined by numerically 
integrating the model (as described in section 5.4.2). The minimum level of 
unparasitised cells attained during acute infection is below the equilibrium level 
regardless of the fold increase of-rise  above A (Figure 5.4B). Similarly the maximum 
level of parasitised cells during acute infection is higher than the equilibrium levels of 
such cells (Figure 5.4C). These features are typical of a system oscillating towards its 
equilibrium solution. 
For higher values ofp the largest eigenvalue becomes real for -rise above a certain value 
(the exact value of Arise  for which this occurs is dependent on p) . This situation is shown 
in Figure 5.5A for a preference value of p = 8. In this case the largest eigenvalue 
becomes real for a value of Anse that is 10-fold higher than A. We call the replacement 
rate where the largest eigenvalue transitions from being a complex conjugate pair to 
being real valued the "transition RRR". Figure 5.5B shows that for values of Anse which 
correspond to an RRR above the transition RRR (and some values of Anse  below this 
level) the minimum level of unparasitised cells coincides with the equilibrium level of 
unparasitised cells. 
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Figure 5.4 Eigenvalue and cell level plots for D = Colin and varying values of 
Arise with p = 1. 
A) Real and imaginary parts of the largest eigenvalue ofJhn. Note that the eigenvalues 
are always complex. 
B) Minimum and equilibrium levels of unparasitised RBCs. The minimum level of 
unparasitised cells is always below the equilibrium level. 
C) Maximum and equilibrium levels of parasitised RBCs. The maximum level of 
unparasitised cells is always above the equilibrium level. 
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Figure 5.5 Eigenvalue and cell level plots for cD = Orin and varying values of 
Arise with p = 8. 
A) Real and imaginary parts of the largest eigenvalue ofJhn. Note the transition from 
imaginary to real eigenvalues when Anse = 102. 
B) Minimum and equilibrium levels of unparasitised RBCs. Note that for values of the 
RRR above the transition RRR the minimum and equilibrium cell levels coincide. The 
same is also true for some RRRs below the transition RRR. 
C) Maximum and equilibrium levels of parasitised RBCs. The maximum and 
equilibrium levels of cells coincide for a critical RRR greater than the transition RRR. 
This is comparable to the fact that the critical RRR in terms of parasitaemia in the more 
complex model is higher than the threshold RRR (see section 4.4.5) 
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Two points should be observed in Figure 5.5B. First, there is not an exact match 
between the value of Anse for which the largest eigenvalue becomes real (marked with a 
dotted line as the transition RRR) and the value of 2rrse  for which the equilibrium and 
minimum RBC levels converge. This means that there is not an exact match between 
the transition RRR as determined by the eigenvalues offhn, and the threshold RRR as 
determined by the criteria of the previous chapter. This is most likely due to numerical 
error in the calculations of the minimum and equilibrium RBC levels, and in the 
differential equation solver. Second, we do not see the "ledge" in the minimum level of 
unparasitised RBCs that was observed in the structured model. (Compare Figure 5.5B 
with Figure 4.7A.) We would expect the flat section in Figure 4.7A to have a 
corresponding flat section in Figure 5.5B for Arse  in the range where the largest 
eigenvalue is complex. The fact that it does not is probably a result of the different 
functions used for reticulocyte production. In the next section we will see that this is 
partially rectified by using (NH) = (13,,g(H) for reticulocyte production. 
Thus, although the eigenvalue analysis of the simplified model with a linear reticulocyte 
replacement function exhibits qualitatively similar behaviour to that seen in the discrete 
model, it does not provide an exact correlation. 
Eigenvalues for the sigmoid family of functions (cDsig) 
To address the differences observed above, we now use (1),1g(ii) for reticulocyte 
production. This gives rise to the following Jacobian: 
r CD' sig PgM* —l;' 
pgM*  
6sig 
—1;1-1;1 
j  sig = 
1,71 0 
0 
— pgM*  
1,7 1 
ri 
°Sig 	I:p'sig 	 pgR: 
0 	0 pgR: 
	
gM*  —1e' 0 	—gE: 
gM* 	 gE: 
gM* 	r1;1 — g(pR: + E;) — 1;1 
MOI ni 	evir 
and H = R: + E: + R*p + 	A star next to a Where 4:13.'
s' 	((llegm )nt + 0,1712 
variable indicates its equilibrium population. As earlier the subscript of sig in ,./sig 
indicates that this Jacobian has been calculated using the sigmoid family of 
functions for reticulocyte production. 
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Once again we compute the eigenvalues of the Jacobian matrix, Jsig by using the 
parameter values in Table 5.1, g = 0.06 and the equilibrium cell populations of Eu, 
Ru and m. As discussed in section 5.4.2 we use numerical integration to obtain the 
equilibrium cell populations. 
We consider the largest eigenvalue of Jsig and its transition from being a complex 
conjugate pair to being real valued. We find that for low red cell replacement rates the 
largest eigenvalue is complex regardless of the value ofp. As the RRR increases the 
largest eigenvalue transitions to become real (just as when Oh, was used for the 
reticulocyte replacement function). 
Figure 5.6 shows graphs depicting the behaviour of the eigenvalues, unparasitised cells 
and parasitised cells for a range of RRRs and a preference value ofp = 8. Figure 5.6B 
and C look remarkably similar to Figure 4.7A and B of the previous chapter, showing 
that qualitatively this model is similar to the model of chapter 4. At an RRR of 4-fold 
above baseline the largest eigenvalue transitions from being a complex conjugate pair to 
being real valued (Figure 5.6A). This exactly corresponds to the RRR at which the 
equilibrium and minimum levels of unparasitised RBCs converge (Figure 5.6B). Thus, 
the transition and threshold RRRs coincide, which is precisely the behaviour that was 
predicted in our hypothesis. In addition, we see that the critical RRR for parasitaemia 
(marked in Figure 5.6C, where the maximum and equilibrium levels of parasitised cells 
coincide) is above the transition RRR. This is similar to the situation in section 0 where 
we observed that the critical RRR in terms of parasitaemia was above the threshold 
RRR. 
Interestingly, as the RRR increases beyond the transition RRR towards normal 
reticulocyte production (right hand side of Figure 5.6A) the largest eigenvalue again 
attains a complex value. At this new transition point we do not see a clear separation 
between the equilibrium and minimum levels of unparasitised cell levels (right hand 
side of Figure 5.6B). This is likely due to the fact that for larger values of the RRR the 
real part of the complex conjugate eigenvalue is a large negative value. This means that 
the unparasitised cell population undergoes a rapid decay to its equilibrium level and the 
majority of the decay occurs within one period of the oscillation. The oscillations are 
therefore not evident in the numerical solutions for these higher values of RRR. 
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Figure 5.6 Eigenvalue and cell level plots for chi  =1:13sig and varying values of fold 
changes in RRR with p=8. 
A) Real and imaginary parts of the largest eigenvalue of Jsig. Note the transition from 
complex conjugate to real eigenvalues when the RRR is increased to 4-fold above 
baseline. 
B) Minimum and equilibrium levels of unparasitised RBCs. Note that at the transition 
RRR the minimum and equilibrium cell levels begin to coincide. 
C) Maximum and equilibrium levels of parasitised RBCs. The maximum and 
equilibrium levels of cells coincide at the critical RRR which is greater than the 
transition RRR. This is comparable with the fact that the critical RRR in terms of 
parasitaemia in the structured model was higher than the threshold RRR (see section 
4.4.5) 
Chapter 5: Simplified ODE Model of a Malaria Infection 	 - 171 - 
As the RRR is increased from baseline we see an initial rise in the minimum level of 
unparasitised cells followed by a small hump which gradually drops off to meet the 
equilibrium level of unparasitised RBCs at the transition RRR (Figure 5.6B). Thus the 
optimum RRR as predicted by this model occurs at the top of the hump as this 
maximises both the minimum and equilibrium levels of unparasitised cells. This 
behaviour is not exactly the same as was seen in Figure 4.7, however it is qualitatively 
similar. It is unsurprising that we do not attain exactly the same results with the 
simplified ODE model as we did with the earlier version as the earlier version included 
a number of time delays as well as additional cell population decays. 
Thus, using the sigmoid family of functions for reticulocyte replacement instead of the 
linear family removes the two main discrepancies between this differential equation 
model and the earlier structured model. 
5.5 Discussion 
In this chapter we develop a simplified ODE version of the RBC model of a malaria 
infection presented in chapter 4. The simplified model captures the essential features of 
the earlier model, such as an increased reticulocyte response to anaemia and a parasite 
preference for young cells, but removes some of the complexity associated with the 
discrete processes of the earlier model. The simplified model equations allow us to use 
standard differential equation tools to investigate the behaviour of the model. For the 
linear family this can be done analytically, and for the sigmoid family computationally. 
This gives insight into the reason behind the emergence of the threshold RRR 
uncovered in chapter 4. Many of the results we obtain are qualitatively similar to the 
results of the previous chapter. We can use this simplified model to confirm that the 
conclusions in the previous chapter are general trends present in an infection with an 
age preference for younger cells and a differential replacement rate of these cells, and 
are not dependent on the complexity of the earlier model. 
The reason for our analysis of this simplified ODE model is two fold. First, it enables us 
to gain insight into the cause of the switch in model behaviour at the threshold RRR. 
Second, there has been debate within the literature about the use of exponential 
distributions to describe parasite populations (Saul, 1998, Gravenor and Lloyd, 1998). 
Given this debate, and the clear evidence for parasite rupture occurring after a fixed 
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time delay, we initially chose to analyse a more complex and therefore more realistic 
model. We did, however, want to compare this complex model with a simplified model 
to determine whether the simplified model could provide similar conclusions. The 
results of this chapter show that this is indeed the case; however it is only by analysing 
both the complex and simplified model that we are able to deduce that incorporating an 
exponential distribution for parasite lifetimes does not dramatically alter the model 
conclusions. 
Using a linear function for RBC replacement renders the simplified model analytically 
solvable for its equilibrium solution. Such a model displays comparable behaviour to 
the model of chapter 4 and allows us to formulate conditions for parasite persistence. 
Using the sigmoid function that was used in chapter 4 for reticulocyte replacement 
enables us to reconcile the structured and simplified models more effectively. The 
threshold RRR of the structured model can be matched to a point in the simplified 
model, the transition RRR, where the largest eigenvalue of the equilibrium solution 
transitions from being complex to being real. This shows that the threshold RRR does 
not result from the complexity of our earlier model, but rather is a feature of the model 
which signifies a transition in the model solutions. For RRRs lower than the threshold / 
transition RRR the largest eigenvalue is a complex conjugate pair and the unparasitised 
cell population oscillates towards its equilibrium level (which it eventually reaches). For 
RRRs above the threshold RRR the largest eigenvalue is real, or has a large negative 
real component. Unparasitised cell levels do not oscillate dramatically, but rather drop 
to their equilibrium levels with few fluctuations. It would be possible to perform a 
comparable eigenvalue analysis of the integro-differential equation model, however this 
would require infinite dimensional analysis and would be a major undertaking. Since we 
are able to reveal the reason behind the threshold RRR by analysing the simplified 
model, we do not see the advantage in providing a similar analysis of the more complex 
model. 
By solving the simplified ODE model described in equations 5.1 - 5.5 we are able to 
support the results derived by the more complex model of chapter 4. We are also able to 
explain the reason behind the threshold RRR in terms of eigenvalues of the equilibrium 
solutions. 
Chapter 6 
Modelling Cooperativity of Two Transcription 
Factors 
6.1 Overview 
Gene expression is regulated by transcription factor activity, which can be extremely 
difficult to measure directly. Previous modelling has shown how to extract the "hidden" 
transcription factor activity profile from micro-array data and use it to determine target 
genes. However this model was only effective at recognising genes that were the target 
of a single transcription factor. Many genes are coregulated by two transcription 
factors, and so we extend this model to enable us to elicit information about these two 
factors. 
Here we present a model that is able to extract two separate "hidden" transcription 
factor profiles using micro-array data from wild-type and knock-down experiments. The 
model is also able to establish targets of each of the transcription factors and predict the 
amount of cooperative regulation of the genes that occurs due to the interaction of the 
two transcription factors. 
We apply this extended model to simulated data, and show that it is highly successful at 
classifying genes into different categories based on their regulation by each of the 
transcription factors. We also show that we can accurately measure the effectiveness of 
a knock-down despite the inclusion of a reasonable amount of measurement error. 
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6.2 Motivation 
Pioneering studies in the model organism Drosophila melangoster have revealed that 
the insect innate immune system involves two main signalling pathways, the Toll and 
the Immune Deficiency (IMD) pathways. These culminate in the upregulation of the 
NF-KB like transcription factors Dorsal or Dif and Relish respectively. In the malaria 
vector, the mosquito Anopheles gambiae, orthologous transcription factors are REL1 
(for Dorsal) and REL2 (for Relish) are thought to be activated by signalling cascades 
related to the Toll and IMD pathways respectively (Christophides et al., 2002). 
Activation of these two transcription factors results in the upregulation of genes 
involved in the defence against infection by the malaria parasite (Meister et al., 2005, 
Frolet et al., 2006). A number of genes have been uncovered that are instrumental in 
this defence, most notably TEP1 and LRIM1 (Blandin et al., 2004, Osta et al., 2004), 
but the exact role of REL1 and REL2 in regulating these genes is not understood. More 
specifically there have been no genes uncovered in the mosquito that are exclusively 
downstream of either of the REL1 or REL2 pathways. This hinders efforts to 
genetically dissect the respective pathways and is in contrast to Drosophila in which, 
although some genes are downstream of both pathways (De Gregorio et al., 2002), there 
are genes that are predominantly regulated by only one pathway: the antimicrobial 
peptide (AMP) encoding gene, drosomycin is predominantly regulated by the Toll 
pathway while diptericin is predominantly regulated by the IMD pathway (Leclerc and 
Reichhart, 2004). This knowledge has facilitated much research into the Drosophila 
immune system. 
In order to better understand the mosquito immune system and facilitate further 
research, it would be beneficial to uncover genes that are downstream of each of the 
REL I and REL2 pathways. One of the obstacles to eliciting genes regulated by only one 
pathway could be that both pathways are involved in gene activation through some 
cooperative regulation mechanism (Frolet et al., 2006). This type of cooperative 
regulation has recently been reported in Drosophila. Synergistic activation of genes 
through both the Toll and IMD pathways has been uncovered in genes that were 
previously believed to be regulated via one pathway alone (Tanji et al., 2007). A more 
pronounced version of this is thought to occur in mosquitoes. 
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It would be instructive to be able to measure exact levels of activated REL1 and REL2 
present in a system and correlate these with gene expression levels, however it is 
currently not possible to differentiate between activated and inhibited levels of REL1 
and REL2. For REL1 to be activated, its inhibitor, CACT, must be degraded so that 
REL 1 is free to enter the nucleus. It technically very difficult to differentiate between 
levels of activated REL1 in the nucleus and inhibited REL1 in the cytoplasm. In order 
for REL2 to become active, its inhibitor ankyrin repeat domain is cleaved, leaving 
REL2 free to enter the nucleus. Despite the fact that in theory it may be possible to 
measure levels of activated REL2 by comparing the lighter (cleaved), activated REL2 
with the heavier, inactivated REL2, a suitable antibody for this has not yet been 
developed. 
It is thus necessary to use another method to measure the levels of activated 
transcription factors and to uncover genes downstream of each pathway. We set up a 
mathematical model to predict the levels of activated REL1 and REL2 from time course 
gene expression data. We extract their temporal profiles and use the model to estimate 
the sensitivities of genes to each transcription factor. We anticipate that this will assist 
in pinning genes to a single signalling pathway. 
In this chapter we set up the general model, which is applicable to a variety of different 
systems. In the following chapter we apply the model directly to data generated from 
mosquitoes and mosquito cell lines. 
6.3 Introduction 
Gene regulation occurs when transcription factors bind to the promoter regions of genes 
and initiate their expression. Although some genes may be regulated by a single 
transcription factor it is often the case that genes (or groups of genes) are regulated by a 
combination of factors (Chang et al., 2006, Pilpel et al., 2001, Banerjee and Zhang, 
2003). Experimental evidence for this exists in a number of systems from bacteria (Pul 
et al., 2005) and insects (Tanji et al., 2007) to human cells (Kim et al., 2003, Dunn et 
al., 1994, Zhou et al., 2003, LeClair et al., 1992). We sought to develop a generalised 
model of cooperative transcription factor regulation that can be applied to any 
cooperatively regulated system. 
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A number of models of cooperative transcriptional regulation have been put forward 
(Bonneau et al., 2006, Chang et al., 2006, Pilpel et al., 2001, Banerjee and Zhang, 2003, 
Wagner, 1999, Hannenhalli and Levy, 2002, Chiang et al., 2003, Tsai et al., 2005, Das 
et al., 2004). Very few, however, are able to predict levels of activated transcription 
factors and none consider the effects of cooperative regulation on the downstream 
products (genes), which is the focus of the work presented here. 
The majority of models (Pilpel et al., 2001, Banerjee and Zhang, 2003, Wagner, 1999, 
Hannenhalli and Levy, 2002, Chiang et al., 2003, Das et al., 2004) assess cooperative 
regulation by considering motifs that commonly occur together in the promoter region 
of genes. Some also assume that cooperatively regulated targets of the same 
transcription factor will have similar gene expression profiles (Pilpel et al., 2001, 
Banerjee and Zhang, 2003). This is certainly not always the case, and these models may 
miss some transcription factors involved in cooperative regulation, as genes with 
different profiles may also be regulated by the same transcription factors (Farina et al., 
2007). Tsai et. al. proposed a model that relates primarily to cell cycle control genes, 
and requires detailed knowledge of transcription factor targets in order to be effective 
(Tsai et al., 2005). Some later models (Bonneau et al., 2006, Chang et al., 2006) more 
closely resemble the modelling presented here. Both use a dynamic model to consider 
cooperative regulation, however they focus on predicting factors that cooperate in gene 
regulation rather than analysing the effect of cooperative regulation on the genes 
themselves. 
All the above models highlight the need to consider more than one influence when 
studying gene regulation in a complex system. To the best of our knowledge existing 
models all aim to uncover new pairs of cooperating transcription factors. In this work, 
we assume that the cooperating factors are known (either through use of one of the 
above models or through prior knowledge), and now wish to uncover the temporal 
profiles of the factors and the relative sensitivities of target genes to each of the factors. 
This work is an extension of the model and method developed by Barenco et. al. (2006) 
which was successful in eliciting the temporal profile of a single transcription factor and 
predicting the sensitivity of target genes to that transcription factor. Our model provides 
a method for uncovering the temporal profiles of two different transcription factors 
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using gene expression data and a set of training genes regulated by one or both of the 
transcription factors. It can then used to categorise genes that are more strongly 
regulated by one or the other of the transcription factors and to uncover the degree of 
cooperative regulation of genes by the two transcription factors. 
6.4 Methods 
We define a model that uses gene expression data to uncover the temporal profiles of 
two different transcription factors. The model also provides a means for determining the 
relative sensitivity of genes to each of the two transcription factors. We call the two 
transcription factors of interest TF1 and TF2 to simplify terminology. In order for the 
model to distinguish the transcription factor profiles effectively we require information 
from wild-type cells and from cells with the genes for TF1 and TF2 knocked down both 
separately and concurrently. 
6.4.1 Knocking down genes using RNAi 
Knocking down genes using RNA interference (RNAi) is a routine way of enhancing 
understanding of gene function. The method involves adding small interfering strands 
of RNA (siRNA) that have a complementary nucleotide sequence to the gene being 
knocked down. The siRNA binds to the area on the messenger RNA (mRNA) 
corresponding to the gene of interest and has the effect inactivating the mRNA strand. 
Knock-downs generated in this way are not completely effective, and some of the target 
gene will still be transcribed in the knock-down cells. 
This process is effective at removing significant amounts of a target RNA strand; 
however it may or may not be effective at halting production of the proteins transcribed 
by the target RNA. Specifically, even if we effectively knock-down the gene associated 
with a transcription factor, we cannot completely know its effects on the actual 
transcription factor protein. 
6.4.2 Description of the single transcription factor model 
Our model for gene expression is an extension of that by Barenco et. al. (2006). They 
proposed a model and method called hidden variable dynamic modelling (HVDM) 
which they applied to the p53 (a transcription factor) network to model p53 activation 
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following irradiation. The equation they used to model the change in levels of gene j (xj ) 
is: 
dx (t) — 	+ sj fit) - Di xj(t) 	 (6.1) 
dt 
represents the basal transcription rate of gene j, Si represents the sensitivity of gene j 
to p53, pi represents the degradation rate of gene j and f(t) gives the activity profile of 
p53. They applied equation 6.1 to time course micro-array data to estimate the p53 
activity profile and the sensitivity of genes to p53. The novelty of their approach is not 
so much in the equation they propose to describe gene transcription, as in the method 
used to solve the equation (described in sections 6.4.6 and 6.4.7 below). 
Initially a training set of genes known to be sensitive to p53 was used to estimate the 
p53 activity profile, j(t). Subsequently sensitivity parameters were estimated for each 
gene in the micro-array dataset. These sensitivity parameters were then ranked to 
determine genes most sensitive to p53. The model and method were applied with a high 
degree of success, and predictions from the model concurred with experimental 
verification. 
6.4.3 Model extension 
Initially we extended the model as follows: 
dxf (t) 	gi + sj  f(t) + T./ g(t) + Vj f(t)g(t) - Di xj(t) 
dt 
(6.2) 
It differs from the earlier model in two ways: 
1) A second transcription factor is included. In addition to TF1 (profile given by 
fit), sensitivity of Si for gene j) the model includes a second transcription factor, 
TF2 (profile given by g(t), sensitivity of T./ for gene j). 
2) It incorporates a cooperativity term (Vj f(t)g(t)). This allows the presence of the 
two transcription factors simultaneously to have a different effect to each one 
individually. The level of cooperativity for gene j is specified by V. 
The model presented in equation 6.2 is reasonable for modelling wild-type cells which 
contain both TF1 and TF2, and is similar to that proposed by Bonneau et. al. (Bonneau 
et al., 2006). In the absence of either transcription factor (say in the case of a knock-out) 
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all terms associated with that transcription factor (both individual and cooperative 
terms) must be removed. 
In actual fact knocking down certain RNA strands does not completely remove all the 
associated transcription factor protein (as discussed above in section 6.4.1). Thus, 
although equation 6.2 is useful for modelling wild-type cells, and full knock-out cells, it 
does not capture the partial knock-downs which occur by using RNAi. We further 
extend equation 6.2 to provide a model which can be used for wild-type, full knock-out 
and partial knock-down cells. 
The extended model is: 
chcf (t) 	Bj + S./ AO/et + T./ A0Kg + Vj J(t)g(t)Kf  - Di xj(t) (6.3) dt 
This model also includes parameters, termed "knock-down factors", that capture the 
efficacy of the knock-downs for each of TF1 and TF2. The parameter Kf  indicates the 
efficacy of the TF1 knock-down and Kg indicates the efficacy of the TF2 knock-down. 
A knock-down factor of 0 indicates a complete knock-out of that transcription factor, 
while a knock-down factor of 1 indicates no knocking down of the transcription factor. 
Therefore, in wild-type cells both K1 and Kg would be set to a value of 1. In a full knock-
out of TF1 Kf  would be set to a value of 0, while Kg would be set to a value of 1. In 
partially knocked down cells one or both of Kf  or Kg will take a value between 0 and 1. 
These intermediate values for the knock-down factors indicate the relative strength of a 
knock-down. A knock-down factor close to 0 indicates a highly effective knock-down, 
while a value close to 1 indicates ineffective knocking down of the transcription factor. 
None of the transcription factor profiles (At) and g(t)), the knock-down factors (Kf  and 
Kg), the sensitivities (Si, T./ and V) or other parameters (Bi and Di ) are known. This is 
similar to the situation in (Barenco et al., 2006) however there are now far more 
unknown parameters due to the extension of the model to include a second transcription 
factor. To enable us to elicit these additional parameters we assume that we have access 
to gene expression data from knock-down cell lines. Such experimental data is often not 
difficult to obtain, and may even have been previously generated (Frolet et al., 2006). 
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6.4.4 Generation of simulated data 
In order to assess the effectiveness of a model it must be tested on data. Initially it is 
always instructive to test a model on simulated data to assess its performance.. We 
therefore create simulated data which we make as realistic as possible, basing it closely 
on the parameters from the Barenco et. al. (2006) paper and on discussions with 
experimentalists. We add error to the simulated data to account for the measurement 
error in real experimental data. 
We choose a priori the functional form for the transcription factors (f(t) and g(t)) and 
the value of the knock-down factors (Kf  and Kg). A description of the functions used for 
fit) and g(t) is given in section 6.4.4.3 below. The gene specific parameters, B, S, T, V 
and D (which we term the BSTVD parameters) were selected using the methods 
described in section 6.4.4.2 (for training data) and section 6.5.3 (for the test set). 
Simulated data is generated by solving equation 6.3 using Matlab®'s ode4 5 solver, and 
extracting the value of xj(t) at the time points of interest (every two hours). 
6.4.4.1 Allowing for wild-type cells and partial knock-downs 
Some of the simulated data will mimic cells in which both transcription factors are 
knocked down. However, as in real biological experiments, we will also generate data 
to simulate gene expression measurements taken from wild-type cells and from cells 
where only one or the other of the transcription factors is knocked down. When 
generating (or fitting) data where one or more of the transcription factors is not knocked 
down we set the value of xy (or Kg) to 1 (full expression). For "experiments" in which 
one of the transcription factors is knocked down we set fcf  (or Kg) to the appropriate 
knock-down factor value. 
6.4.4.2 Form of BSTVD parameters 
The BSTVD parameters for the training genes are randomly selected and are based on 
the probability distributions given below. These distributions should match with the 
ranges of sensitivities seen in genes. Note that U(a,b) denotes a uniform distribution 
over the interval [a,b], N(µ,62) denotes a normal distribution with a mean of µ and a 
standard deviation of a and N+(µ,a2) denotes the positive part of a normal distribution 
with a mean ofµ and a standard deviation of a. 
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B 	N±(0, _100 ) 
— U(0,500) 
T U(0,500) 
V 	
500 N(0, 	 ) 
D U(0,1) 
Throughout the chapter we use the same five randomly selected training genes whose 
parameter values are given in Table 6.1. The BSTVD parameters used to test the model 
are given in section 6.5.3. 
The sensitivity parameter V is allowed to be negative. This corresponds to a situation 
where only one of TF I or TF2 is required for gene expression, but the presence of both 
TF1 and TF2 actually reduces the level of transcription. Despite this, overall gene 
transcription cannot be negative, so we discarded any combinations of sensitivity 
parameters that give negative transcription at any time point. Thus we require that at all 
time points 
Si f(t)icy + Tig(t)x-g + Vj f(t)g(t)ky Kg > 0 	 (6.4) 
A stricter condition, which does not depend on the knock-down factors, is that at all 
time points. 
S/(t) + TRW + V f(t)g(t) > 0 
	
(6.5) 
This is the condition we apply. 
B S T V D 
Training Gene 1 25.96572 62.4447 52.7496 11.62182 0.415869 
Training Gene 2 61.70318 61.68069 142.2976 -172.902 0.58421 
Training Gene 3 39.43689 113.7549 465.9256 282.9582 0.117612 
Training Gene 4 17.296 297.51 248.71 137.93 0.19105 
Training Gene 5 81.25499 379.985 417.8079 102.653 0.693458 
Table 6.1 Gene specific parameters used to generate the training set of genes. 
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6.4.4.3 Form of the transcription factor functions 
Throughout the chapter we use the same form for the functions describing transcription 
factor profile activity. The functions fit) and g(t) always rise linearly from a starting 
value of b to a peak over x hours, stay at the peak for two hours, and drop linearly back 
to a value of y over two hours. The function then remains at a value of y until the end of 
sampling, which occurs at 16 hours. The initial value of b represents the level of 
activated transcription factor that was present in the system before stimulation. Since 
there are no units for the transcription factor activity profile, the actual value that the 
function takes at its peak is unimportant, and so for simplicity we assume that its peak 
value is 1. The form of the transcription factor profiles used is depicted in Figure 6.1. 
Table 6.2 gives the parameters used to generate the transcription factor activity profiles 
(and their associated knock-down factors) for the majority of the results in the chapter. 
Sample transcription factor profile 
0 
	 4 	 8 	12 	16 
time (hours) 
Figure 6.1 Form of the transcription factor profiles used throughout the paper. 
The initial height, b, represents the level of activated transcription factor present before 
stimulation. x represents the time of the peak of the transcription factor and y shows the 
level that the transcription factor drops to after its decrease. 
B x 17  K 
fit) .08 2 .3 .1 
g(t) .005 8 .2 .4 
Table 6.2 Parameters used to generate transcription factor profiles and the 
associated knock-down factors. 
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6.4.5 Adding error to the simulated data 
Experimental data is always subject to some measurement error, and thus when 
assessing the performance of the model we must do so on data that contains some error. 
To incorporate error into the simulated data we add a random percentage error to the 
simulated data value. This is akin to assuming that the measurement error is 
proportional to the data value. We denote the percentage error by C%, and allowed syo —
N(0,o-), where o- is the standard deviation of the percentage error. We consider values of 
cr from 0.1 (10% error) to 0.2 (20% error). Thus a simulated data value of xj became 
xj0+syd once error is added to it. 
Adding error in this fashion will not exactly match the error resulting from experimental 
measurements. In fact it is sometimes observed that the percentage error in biological 
measurements tends to decrease as the measured value increases, as it is easier to 
measure larger quantities more accurately, although this is dependent on the 
experimental method used. As there is no hard and fast rule for the amount of error in 
experimental measurements, adding a random percentage error to the data seems a 
realistic approximation and should allow us to infer the effectiveness of our model. 
6.4.6 Model fitting 
The method we use to fit the data to the model in equation 6.3 is similar to that used by 
Barenco et. al. (2006). We construct a parameter vector /I, containing values of the 
parameters for which we need to solve. When fitting to training data we have 1.1 = 
(B 	.B,,, S ...S„„ T . 	V1. ..Vm, Di ...Din, fo• • if n, go...gn, KI; Kg) where m is the 
number of training genes and n is the number of time points sampled. When fitting to 
test data for gene/ we set pj = (B3, S3 7'3, V3, D3 ) and use the values for fo...fn, go...gn, Kf, 
and Kg determined during the training run. We then use the lower-upper decomposition 
method described in section 6.4.7 to solve for xj. 
The error between the estimated and simulated values of gene expression data for gene j 
is calculated according to 
( 
X (4) - j(ti ) 
i=0 
(6.6) 
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where xj(ti ) is the target value for gene expression, Xi (ti ) is the estimated value for 
gene expression (from the model) and o is the standard deviation of the error on the 
target value. Since the target (simulated) data contains error proportional to the data 
value (described in section 6.4.5) we have o-j(ti ) = 6 x j(4) where o-is the chosen standard 
deviation of the error. 
In an experimental situation we do not know the value of a apriori, and so a is one 
more parameter that must be calculated from the training genes. This is done using the 
method in section 6.4.6.1 below. Incorporating the expression for cri(t) into equation 6.6 
gives 
( X j ) — (t, ) 
2 
(t ) 
In the training phase the total error is given by 
E E ,=. (6.8) 
We use Matlab®'s nonlinear least squares optimisation procedure (1 sqnonl in) to find 
the parameter vector ,u which minimises the value of E and E., in the training and testing 
phases respectively. 
We constrain the optimisation procedure to search in the positive parameter space for all 
parameters other than the Vi parameters. 
6.4.6.1 Determining the value of a 
The exact value of a does not affect the model fitting described above, as setting o-to an 
arbitrary value of 1 in equation 6.7 does not affect the results of the fitting procedure. 
Thus, it is sufficient to know that o-i(t,) is proportional to x j(t,) and we can perform the 
training fitting without knowing the exact value of a. We later require an estimate for 
the value of a in order to apply the likelihood ratio test (section 6.4.6.2 below). This 
estimate is obtained using the residuals of the training fits. The formula for determining 
a- is given in equation 6.9. 
Ei 
Cr i=o 
(6.7) 
 
i=0 
 
ij(t1 ) 
   
a 	= 	standard deviation 
  
(6.9) 
  
    
Determining a in such a manner yields a very good estimate. 
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6.4.6.2 Determining an estimate for V using the likelihood ratio test 
We will later want to determine whether a fit is better with or without the cooperativity 
parameter V. This should determine whether or not there is significant cooperative 
regulation of a gene. This is done by fitting the model normally, as described in section 
6.4.6, and then applying a likelihood ratio test to a nested model that sets V= 0. We 
compare the fit from the nested model with the fit using equation 6.3 and determine 
whether V is significantly different from zero (at the 95% confidence interval). If the 
estimated value of V is not significantly different from zero we accept the estimate of 
V= 0. However if V is significantly different from zero we accept the V estimate from 
the original fit. 
6.4.7 Algebraic solution to the model 
During model fitting it is necessary to solve equation 6.3 a number of times. Using an 
ODE solver to do this has two drawbacks. First, it is computationally very expensive 
and slow. Secondly, the functionsf(t) and g(t) must be implicitly defined between the 
sampled points, despite the fact that we do not have this information available. We 
therefore use the method presented by Barenco et. al. (2006) and convert equation 6.3 
into an algebraic problem. 
To estimate the derivative at the point (ti, x) we fit a q-1 degree polynomial, P(t), 
through q points about the point (ti, x,) and establish its derivative at the point t,. We 
label the points around (t„ x1 ) as (tp, xp) 	(ti, x) ... (4, xr ), where r=p+q- I. We 
define 
P(t) 
	 E C(k, p, r, t) xk 	 (6.10) 
k=p 
where 
C(k, p, r, t) = 
1-Tr t - t. 
11 
p tk -tj  
j#k 
(6.11) 
We estimate the derivative of P(t) at time t, (denoted by A,) by differentiating P(t) and 
evaluating the derivative at t,. i.e. A, = —d P(t) 
dt 
Chapter 6: Modelling Cooperativity of Two Transcription Factors 	 - 186 - 
To determine A, we define 
E(k, p, r, t) = —d C(k, p, r, 	 (6.12) 
dt 
(a full description of E(k, p, r, t) is given below) and define a matrix A= (A,k) where 
E(k,t,r,t,) 	 r 
Atk (6.13) 
0 	otherwise •  
,JP 	r Then — = E Aik Xk, and A, = E Aik Xk = Ax and so the matrix A gives a linear 
dt 	k=p 	 k=0 
approximation to the derivative of the q point interpolation function, P(t). 
We obtain an expression for E(k, p, r, t,) by combining equations 6.11 and 6.12 above: 
E(k, p, r, t) = 
ti -t 
2.4 t __t 11 t -t' m=P k 	m J=P k 	 j 
m=k j*k,m 
1 	r 11 t1  tk -t, j=p tk tj  
1 	-1-r r t - t j 
tk -ti il=p i k -t j 
ii'k  r 	i 
Et. -t l=P 1 	j j*i 
for k i, since product term = 0 for m# i 
for k = i, since product term = 1 for k = i 
(6.14) 
Finally, we assume that at to all transcription factors are in equilibrium. The derivative 
of P(t) is therefore zero at to and so we should have Ao = 0. We would like to include 
this information in E(k, p, r, t) when to is one of the points used in the fit. To do this we 
introduce a dummy point (0, x_i) to ensure that Ao = 0 and recalculate definitions of 
E0(k, p, r, t,) (the refined function) using this point. (A full description can be found in 
the supplementary materials of (Barenco et al., 2006)). The refined function 
E0(k, p, r, t) is given by: 
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E 0(k, p, r, t,) = 
We can reformulate equation 
Axj 	= 	Bj + 
E(k,O,r,t,)
t
° 
E(i3O, r,t ,) 
E(0,0, r,ti ) 
6.3 using 
si f icy + 
—t; 
for k 	0,i 
for k = i,k 
for k = 0 
A as 
Di Xj. 
0 (6.15) 
(6.16) 
to — t 
1 
 +
ti  — to 
1 1+ 	—t,)E (to  
t - t j=1 	0 	 j 
the derivative matrix 
7; g Kg + Vj fg 1ff Kg 
Note that we have eliminated the variable t from the above equation for readability, 
however xj, f, and g are still functions of time. Defining xj as a vector (x(to),. .,x(t (,)), f as 
the vector OVO),...At 0), g as the vector (g(t 0), . .,g(tn)) and 1 as a vector of ones of 
length n (where n is the number of time points), we can solve equation 6.16 as 
	
xj = (A + Dj1)-1(Bi1 + Sjf + Tj g Kg + Vj fg Kf Kg Di Xj) 	 (6.17) 
using Lower-Upper decomposition. 
6.4.8 Parameter scaling 
It transpires that we obtain significant variation in the parameter estimates depending on 
the starting parameters used for model fitting. These variations are fairly uniform in 
format and consist of certain parameter scalings (given below in equation set 6.18). 
It is likely that the scaling is related to the fact that different parameter values can result 
in identical solutions to the model equation. Replacing f(t) by aAO+ fl and g(t)by 
y g(t)+6 in equation 6.3 and considering wild-type cells (Kf = Kg = 1) gives: 
dx j 
= 	Bj + Si f(t) + Tj g(t) + Vjf(t)g(t) - Dj xj (t) 
= 	Bj + Sj'• (a f(t)+f3) + Ti (y g(0+ (5) + V./ (a f(t)+16)(y g(t)+a) - Di xj (t) 
= 	(13j + Sj fi + Tj + V fib) + (Si a + Vj a(5) ./(t) + (Tj y + Vj y fi) g(t) 
+ 171 f(t)g(t) - Di xj (1) 
= 	Bj' + Sj At) + T./ ' g(t) + V if(t)g(t) - Di xj (t) 
Barenco et. al. remove a similar non-identifiability to that outlined above by fixing the 
value of S1 and f(0). We go some way towards eliminating the ambiguity using a similar 
method and set Si = 10 and T = 10 for one gene (arbitrarily the first gene in the training 
dt 
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set), however we cannot fix the value of the transcription factor at t = 0 when there are 
two transcription factors and knock-down factors without losing information. Setting 
AO) = 0 (or g(0) = 0) would mean that all transcription of gene j occurring at time t = 0 
is absorbed into the baseline production parameter, B1. Once either of the transcription 
factors are knocked down the total transcription of gene j at time t = 0 changes. Since 
f(0) = 0 (or g(0) = 0) Bj would have to change to allow for a change in transcription. The 
only thing that should change once one of the transcription factors has been knocked 
down, however, is the appropriate knock-down factor. Thus, we cannot force eitherf(0) 
or g(0) to be zero (or any other value). 
The variation in parameter estimates may also be related to the highly correlated 
variations that were observed by Barenco et. al. prior to fixing a degradation rate, and in 
so doing "anchoring" the data (Barenco et al., 2006). We did attempt to fix one of the 
degradation rates in our fitting in the hope that this would eliminate the variation in 
parameter estimates, however it did not. It appears that the added complexity of our 
model means that simply fixing one degradation rate is not enough to remove the 
variation. 
The scaling of parameter estimates from their true values are given in equation set 6.18. 
The true BSTVD parameters and functions have subscripts of T, and the estimated 
parameters and functions have subscripts of E. 
B jE 
	 ajB iT and 	 jE 	 apiT 
fE 
	
tYT 	and 
	
S jE 
	 fli  
gE 
	 rgT 	and 
	
T jE 
V jE 
	 A '7;  '  
V IT 
	 (6.18) 
a1  
with /3/3/ = ai and yyj = a j. 
For each training run /guild y are constant across the genes, while 	and yi ' vary 
for each gene and hence have a subscript ofj to denote the fact that they are gene 
specific scaling parameters. The scalings are not exact and show slight variations (i.e.fE 
is not exactly given by ffT at all points along the transcription factor curve, nor is ,3/3 
exactly equal to a j for each gene) however the trends are extremely reproducible. Since 
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the scaling factor /3 is actually not the same at all points along the transcription factor 
curve, we define leas max(fE) and similarly for the parameter y. 
max(fT ) 
The result is that we have a model that is somewhat ambiguous in its parameter 
estimates and has the potential for parameter scaling. Despite this we can still learn a 
great deal from this model. 
It is interesting to note that substituting the parameter scalings of equation set 6.18 into 
equation 6.3 still gives the correct derivative at t = 0. We have 
( 	
dx, r)  
d;) dt ) • 	 (6.19) E 	 T 
Now, at t = 0 the gene expression levels are in equilibrium, i.e. 
dx j  
= 0 for all genes. 
dt 
   
If the true derivative at t = 0 is zero, equation 6.19 tells us that so too will be the 
estimated (scaled) derivative. Slight shifts in the scaling of the transcription factor 
functions over the various time points can produce the correct non-zero derivative at 
other time points. 
6.4.8.1 Transcription factor function scaling 
In order to compare fits from different training runs and use them on a test set of genes 
it will be necessary to rescale any estimated transcription factor functions f(t) and g(t) to 
a uniform level to eliminate the parameters fi and y. Since we do not know the true 
transcription factor profiles we cannot do this exactly. Thus, we scale bothf(t) and g(t) 
by their maximum value to give them a scaled maximum of 1. 
6.4.8.2 Parameter ratios 
The transcription factor scaling does not eliminate the gene specific scaling parameters 
fli ' and y j '. These make it difficult to compare: 
a) The sensitivities of different genes to the same transcription factor (differences 
between ' and 	and 'yj' and y,' for genes x j and x, will obscure any 
relationship); and 
b) The relative sensitivity of a gene to TF1 as compared with TF2 (the scaling 
parameters A', y j' and aj  will mask any relationship between Si, 7; and Vi). 
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It will often be more instructive to consider what we term "parameter ratios". These 
eliminate the spurious scaling parameters. 
The parameter ratios we consider most frequently are: 
a) 
S
I 
 max( f) 
: This ratio eliminates the scaling parameter oci by dividing )8/3j ' by 
T max(g) 
yyj ' . It gives the relative contribution to gene expression by TF1 compared to 
TF2. If the parameters )6 and y have already been eliminated by scaling the 
functions f and g to a uniform level it will be sufficient to consider only the ratio 
Si  
b) and 	: These ratios eliminate the scaling parameter aj. They give the 
V V 
relative contribution of the transcription factors on their own compared to 
cooperative regulation. Note, for these ratios we have assumed that the 
parameters fi and y have already been eliminated by the transcription factor 
scaling. 
6.5 Results 
In this section we use simulated data to show the ability of the model in equation 6.3 to 
recover transcription factor profiles and sensitivities. We use a set of simulated training 
genes to recover the transcription profiles fit) and g(t) and the knock-down factors Kf 
and Kg. We then use these recovered values to estimate the gene specific parameters, BB, 
TI , V.1 and p, on a set of test genes. This will allow us to determine the effectiveness 
of our model at classifying the test genes into groups based on their relative sensitivities 
to TF1 and TF2. 
6.5.1 Estimating transcription factor profiles from data with no 
measurement error 
As a proof of concept we assess the ability of the model to correctly recover the 
transcription factor profiles and gene parameters in the absence of any measurement or 
experimental error. This clearly represents an unrealistic best case scenario, nevertheless 
it is important to establish that the model is capable of recovering parameters 
accurately. 
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A 	 f(t) estimate 
	 B 	g(t) estimate 
2 4 6 8 '10 12 14 16 
	
4 6 8 10 12 14 16 
Time (arbitrary units) 
	
Time (arbitrary units) 
Figure 6.2 Estimated transcription factor profiles from simulated data with no 
error added to simulated data. 
Solid lines are correct (target) transcription factor profiles. Dotted lines are model 
estimates. 
A) Target and estimated function for fit). 
B) Target and estimated function for g(t). 
Figure 6.3 Estimated gene parameters from simulated training data with no error 
added. 
For all panels blue bars represent simulated parameter values (marked as Est params 
in legend), maroon bars show target parameter values(marked as Real params in 
legend). The legend is in panel D. Note that all values have been scaled so that S1 =10 
and T1 = 10 as described in section 6.4.8. 
A) Target values and estimates for RI for each of the five training genes 
B) Target values and estimates for Si for each of the five training genes 
C) Target values and estimates for T.), for each of the five training genes 
D) Target values and estimates for V, for each of the five training genes 
E) Target values and estimates for DI for each of the five training genes 
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We find that both the transcription factor profiles (Figure 6.2) and gene specific 
parameters (Figure 6.3) are well estimated by the training genes. Estimates of the 
knock-down factors are almost exact (estimated Kf = 0.1001 and Kg = 0.4000). The 
confidence intervals on all parameter estimates are extremely tight, although not all 
target parameter values are within these confidence intervals. 
We deduce that in the absence of any error in measurements our model is able to 
effectively recover both the transcription factor profiles (and their associated knock-
down factors) as well as the gene specific parameters. 
6.5.2 Estimating transcription factor profiles from data with measurement 
error 
We next consider the performance of our model on simulated data with error. The data 
for the training genes is simulated and measurement errors added using the methods 
described in section 6.4.4. Measurement errors with a standard deviation of 10%, 15% 
and 20% are used. We perform fits on 100 different training data sets for each error 
level, and find qualitatively similar results for each error level. In the remainder of this 
chapter we present the results of fitting on data with a 15% standard deviation in the 
error measurement. 
We find that estimated and target profiles differ mainly in their scaling rather than 
shape. When scaled by their maximum value (see section 6.4.8.1) they very closely 
resemble the target functions. Figure 6.4 shows both the target profiles (coloured lines) 
and model estimates (black lines) for each of the 100 training fits. We see that all fits 
closely resemble the target functions, and are able to pick out the key features of the 
functions (i.e. the timing and extent of the rise and fall in the function). It appears that 
there is more variation in the estimation of the profile for TF1 (Figure 6.4A) than for 
TF2 (Figure 6.4B) especially towards the end of the time course. We hypothesise that 
this is because there is less variation in TF1 towards the end of the time course. Since 
our model works by considering changes in gene expression (through the derivative) it 
will be less accurate at estimating a transcription factor profile from data that is not 
changing significantly (as is the case at the latter time points of TF1) since any 
measurement errors, In the absence of significant data variation, will spuriously alter the 
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Figure 6.4 Estimates for the transcription factor profiles. f(t) (panel A) and g(t) 
(panel B) on 100 fits trained on the five training genes. 
Each fit was made with a measurement error (standard deviation 15% of the data 
value) added to the simulated data. Thick coloured lines show target transcription 
factor profiles, thin black lines show model estimates. 
A 	 f 
	 B 
	 K 
Figure 6.5 Histograms showing estimates of the knock-down factors on 100 
training fits described above. 
(A) Estimates for x-f. The target value for icf  is 0.1, 
(B) Estimates for Kg. The target value for Kg is 0.4. 
Both histograms are tightly centred about their target value. 
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derivative more than when the data has significant actual variation. Thus we 
hypothesise that this method is better at estimating the profiles for transcription factors 
that are changing significantly (which is generally the case when responding to a 
stimulus. 
The knock-down factors are well estimated, with tight distributions around the correct 
values (Figure 6.5). Correct estimation of the knock-down factors is not hindered by 
variation either in the transcription factor profiles, or the value of the knock-down 
factors themselves. This is shown in more detail by Figure 6.10 and Figure 6.11 in 
section 6.5.4, which show tight histograms of knock-down factor estimates when using 
a variety of profiles and knock-down values.Thus even with a biologically reasonable 
amount of measurement error added to the simulated data, good estimates for the two 
transcription factor profiles and their associated knock-down factors is provided by our 
model. 
6.5.3 Classification of genes based on sensitivities 
We next assess the ability of our model to estimate the sensitivity of a gene to one or 
both of the transcription factors. We group genes based on their sensitivity to each of 
the transcription factors and analyse the ability of the model to recover these groupings. 
We allow the sensitivity parameters S and T to take on either a high or a low value, and 
the cooperativity parameter V to be either high and positive (cooperative regulation), 
low and either positive or negative (no significant cooperative regulation) or high and 
negative (cooperative down regulation). 
High values are set arbitrarily at 400 and 500 (the upper end of the training distribution 
defined in section 6.4.4.2), while low values are 0, 10 or 30 (the lower end of the 
training distributions). Thus S and T are selected from (0, 10, 30, 400, 500) while V is 
selected from (-500, -400, -30, -10, 0, 10, 30, 400, 500). It is not possible to have 
negative transcription, so a high negative V parameter is only paired with a high value 
in either or both of S and T. We do not include genes with a low sensitivity for all of S, 
T and V. This is because such a combination would equate to a gene that is not sensitive 
to either of the transcription factors and is therefore not particularly interesting for this 
analysis. Allowing for all other possible combinations, we are left with 155 genes on 
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which to test the accuracy of our model. These make up the test set of genes, and data 
for these genes is simulated using the methods described in section 6.4.4. Once again 
we add a randomly generated error with a standard deviation of 15% of the data value. 
6.5.3.1 Definitions of Sensitivity and Specificity 
In order to assess the results of classification, we introduce slightly altered definitions of 
the terms sensitivity and specificity. These terms traditionally refer only to binary 
classification tasks, however we will be classifying genes into more than two different 
categories. For the purposes of this chapter we extend the definition of sensitivity to be 
"the percentage of genes truly belonging to a category that were correctly classified into 
that category" and the definition of specificity to be "the percentage of genes classified 
into a category that actually belonged there". This is a significant deviation from the 
traditional definition of specificity. Alternatively these definitions can be described as 
# genes belonging in Category X that were correctly classified 
Sensitivity — 
Total # Genes belonging in Category X 
# genes classified into Category X that belonged there 
Specificity — 	  
Total # Genes classified into Category X 
Since there are more than two categories for classification, we expect both the 
sensitivity and the specificity calculated using the definitions above to be significantly 
lower than in a binary classification task (when there are only two categories to chose 
from). The fact that both sensitivity and specificity are actually very high in our results 
indicates the effectiveness of our model at classifying the genes. 
6.5.3.2 Distinguishing the sensitivity to each transcription factor (S and 7) 
In this section we consider the ability of the model to distinguish between genes that are 
relatively more sensitive to one transcription factor or the other. We divide the test set 
of 155 training genes into three categories based on their S and T values and call these 
the ST-Categories. The ST-Categories are: (i) S-HI_T-LO, which encompasses genes 
more sensitive to TF1; (ii) ST-EQ, genes that are basically equally sensitive to both 
transcription factors; and (iii) S-LO_T-HI, genes more sensitive to TF2. Thus category 
S-HI T-LO contains genes with a high value for S and a low value for T. Similarly S-_ 
LO T-HI contains genes from the test set with a high value for T and a low value for S. _ 
ST-EQ contains genes with either a high value for both S and T or a low value for both 
S and T. These categories are independent of the cooperativity parameter, V. 
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To distinguish between genes more strongly regulated by either TF1 or TF2 (ignoring 
cooperativity) we consider the ratios S/T and T/S and ask whether they are greater than a 
threshold value. If S/T is greater than the threshold we classify the gene into S-HI_T-LO 
whereas if T/S is greater than the threshold the gene is placed into S-LO_T-HI. If 
neither ratio is above the threshold value the gene is assumed to be a member of ST-EQ. 
For the sake of this analysis the threshold was set at 3, as this value gives robust 
estimates for sensitivity and specificity (i.e. the sensitivity and specificity estimates do 
not change significantly when the threshold value is altered around a value of 3). 
Therefore a gene is recognised as being predominantly regulated by TF1 if the 
estimated sensitivity to TF1 is at least three fold greater than the estimated sensitivity to 
TF2 (and vice versa). 
Table 6.3 gives the percentage of correctly classified genes into each of the above 
categories for simulated data with a 15% error. All sensitivities are above 80% and all 
specificities are above 88%. Even when we consider data with a 20% error sensitivities 
qre all above 74% and specificities above 80%. 
The results of this classification are presented in more detail in Figure 6.6A and B. 
Figure 6.6A shows the classification of genes (rows) that truly fall into the categories 
given by the columns. Genes belonging to S-HI_T-LO (left column) are all classified 
correctly (100% sensitivity). Any misclassified genes of the ST-EQ category (middle 
column) are equally likely to be placed into S-HI_T-LO as S-LO_T-HI. Genes 
belonging in S-LO_T-HI are rarely misclassified, and if they are, they are only placed 
into ST-EQ. This suggests that no gross mistakes are being made in classification as the 
relationship between the S and T sensitivities is never entirely mixed up. 
Figure 6.6B shows where genes classified into categories given by the columns actually 
belong (rows). Almost all genes classified into ST-EQ belonged there (middle column 
contains a large circle in the middle row and almost nothing else). Similarly most genes 
classified into S-HI T-LO (left hand column) belong there (large blue circle in bottom 
left corner of Figure 6.6B), but some genes classified into S-HI_T-LO actually belong 
in ST-EQ (smaller green circle in the middle row of the left hand column). 
Reassuringly, no genes classified into S-HI_T-LO actually belonged in S-LO_T-HI 
(empty square in the top left of Figure 6.6B). Classification into S-LO_T-HI had a 
0 94% 99.9% 
• 
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Sensitivity (% correctly 
classified) 
Specificity (% classified into 
each group which belong 
there) 
S-HI T-LO 100% 89% 
ST-EQ 81% 99.9% 
S-LO T-HI 99.9% 94% 
Table 6.3 Sensitivity and specificity of model classification on each of the three ST-
categories for genes with a 15% error added to the training and test set. 
A 	 Sensitivity 	 B 	 Specificity 
S-1-11 T-LO 	ST Et.) 	S-LU T HI 
	
S HI T-LO 	ST-EU 	S-LU 
True Category Classification Category 
- 
Figure 6.6 Ability of model to correctly classify genes into the three ST-Categories 
with 15% error on the training and test data. 
A) Sensitivity: The size of each circle and the number inside it correspond to the 
percentage of genes belonging in the category of the corresponding column that are 
classified into the group indicated by the row. 
B) Specificity: The size of the circle and the number inside it relate to the percentage of 
genes classified into the group of the circle's column that actually come from the group 
of the circle's row. 
Circles of the same colour represent percentages adding to give 100%. 
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similar pattern. Most genes belonged there (right hand column of Figure 6.6B) and there 
were no genes belonging in S-HI_T-LO which were classified into S-LO_T-HI. 
Thus we can conclude that our model is able to classify between the ST-Categories 
extremely well, and is robust to error in the data. 
6.5.3.3 Distinguishing between levels of cooperativity (V) 
We next look at the ability of the model to distinguish between genes with different 
levels of cooperative regulation. We divide the test set into categories based on whether 
the V parameter is (i) high and positive; (ii)low; or (iii) high and negative. We called 
these the V-Categories and label them as V-POS, V-LO and V-NEG respectively. 
We find that while the model in equation 6.3 is exceptionally good at distinguishing 
between high and low sensitivities for S and T, it is not as good at correctly estimating 
the cooperativity parameter V. There are two possible reasons for this. First, when 
estimating Vthe model relies on a product of the estimates off(t), g(t), Kf  and Kg. This 
means that any errors in their estimates are multiplied by each other and compound the 
error in V. In contrast estimates for S or T only rely on the product of one transcription 
factor and one knock-down factor. Second, the scaling of parameters described in 
section 6.4.8 shows that the cooperativity parameter, V, is scaled by three separate 
scaling factors (/3', y' and a) compared with only one in the case of S and T. It is 
therefore not surprising that this translates into a larger error in the estimate of V. 
To distinguish between the V-categories we use the likelihood ratio test described in 
section 6.4.6.2. If V is assigned a value of zero, we place the gene into V-LO. However 
if V is significantly different from zero we assign the gene to V- POS if the V estimate is 
positive and to V-NEG if the V estimate was negative. 
The ability of the model to correctly classify genes into their correct V-Category is 
largely dependent on the amount of error in the data. When 10% random error is added 
to the data 91% of genes in V-POS are classified correctly. With 15% error added this 
drops to 75% and for a 20% error it drops to 66%. Similar decreases are seen in the 
other categories and for specificity. Table 6.4 shows the sensitivity and specificity on 
the V categories for data with an error of 15% added. 
L.L.1 
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Sensitivity (% correctly 
classified) 
Specificity (4)/0 classified into 
each group which belong 
there) 
V-POS 75% 84% 
V- LO 70% 78% 
V-NEG 86% 56% 
Table 6.4 Sensitivity and specificity of model on each of the three V-categories for 
genes with a 15% error added to the training and test genes. 
A 	 Sensitivity 	 B 	 Specificity 
w 
0 
01 
0 
C 
0 
it 
(7, 
R 
V -P OS 
	
V-Lo 	v_NEG 
	 V_POS 	V-L1) 	V-NEG 
True Category 
	
Classification Category 
Figure 6.7 Ability of model to correctly classify genes into the three V-Categories 
with 15% error on the training and test data. 
A) Sensitivity: The size of each circle and the number inside it correspond to the number 
of genes belonging in the category of the corresponding column that were classified into 
the group indicated by the row. 
B) Specificity.. The size of the circle and the number inside it indicate how many genes 
classified into the group of the circle's column actually come from the group in the 
circle's row. 
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Figure 6.7 gives a graphical representation of the results of classification. The large 
circles on the diagonals show that genes are generally well classified into their 
V-Categories. The very small circles in the upper left and bottom right corners show 
that it is rare that genes belonging in V-POS are classified into V-NEG and vice versa. 
Generally misclassified genes from either category are placed into V-LO, thus 
minimising the misclassification. 
6.5.3.4 Complete Classification of genes 
We next combine the results of the above two sections to consider the complete 
classification of genes in the test set. Test genes are further divided into categories 
based on their sensitivity to each of the transcription factors and on their cooperative 
sensitivity (i.e. based on their S, T and V parameters). Ten different categories result and 
are labelled intuitively. The categories and labels are given in Table 6.5. 
Methods of complete classification 
We used the ratios and conditions specified in the final column of Table 6.5 to classify 
the genes into categories. Classification into a category requires that: 
i) The estimate for V matches the criterion specified for that group (positive, 
negative or zero). 
ii) All listed ratios are greater than the specified threshold value. For the sake of 
this analysis the threshold is set at 3, as in section 6.5.3.2. 
iii) All negated ratios are not larger than the threshold. 
iv) Where the term "No ratios" is listed we require that no ratio comprised of a 
combination of S, T and V is greater than the threshold. This means that all 
sensitivities are of roughly equal magnitude. 
Ratios are considered based only on their absolute magnitude, regardless of their sign. 
Some genes are classified into any category using the above criteria. These are genes 
which, when fit by the model in equation 6.3 do not show significant enough 
differences in their sensitivities to be distinguished and are placed into an 
"Unclassified" category. 
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Category Label S T V Description Distinguishing Features 
S-HI T-LO V-POS _ 	_ I - I Regulated by TF1, 
cooperatively regulated by 
both transcription factors 
SV 	S 	V 
TT 	VS 
S-HI-T-LO V-LO C - - Regulated by TF 1 only S 
T 
— V=0 
' 
S-HI_ T-LO_ V-NEG t - I Regulated by TF1, 
negatively cooperatively 
regulated by both 
transcription factors 
SV 	S 	V 
TT 	VS 
S-LO T-HI V-POS - i i Regulated by TF2, 
cooperatively regulated by 
both transcription factors. 
T 	V 	7' 	V 
SSVT 
S-LO T-HI V-LO - I - Regulated by TF2 only T 7 ' v=o 
S-LO T-HI V-NEG - t I Regulated by TF2, 
negatively cooperatively 
regulated by both 
transcription factors 
TV 	T 	V 
SSVT 
S-HI_ T-HI V-POS _ l• I l• Regulated by both TF1 and 
TF2 and cooperatively 
regulated by both 
transcription factors 
No ratios, V> 0 
S-HI_ T-HI V-LO _ 't i - Regulated by both TF1 and 
TF2, no cooperative 
regulation 
ST 77, v=o 
S-HI_ T-HI V-NEG _ I T I Regulated by bothTFl and 
TF2, negatively 
cooperatively regulated by 
both transcription factors 
No ratios, V< 0 
S-LO_ T-LO V-POS _ 
(Group 3) 
- - I Cooperative regulation 
only 
VV 
S
, 
T
,V> 0 
Table 6.5 Categories of genes to be classified by the model. 
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For each category in the table an up arrow (1) in one of the S, T or V columns implies 
that within this category the respective sensitivity is high and positive; a down arrow 
(I) implies that the cprresonding sensitivity is high and negative; and a dash means that 
the sensitivity is low. The description column gives an understanding of the types of 
genes one would find in each category, while the final column indicates how we 
distinguish genes within the category. 
Results of complete classification 
Table 6.6 and Figure 6.8A and B provide a detailed break down of the classification 
results. Table 6.6 gives sensitivity and specificity results while Figure 6.8A and B show 
a more detailed picture. Figure 6.8A depicts how genes from each category (indicated in 
the columns of the grid) are classified by our model (into the rows) and is related to 
sensitivity. Figure 6.8B considers the genes that were classified into the categories 
given by the columns, and asks into which group they should have been classified 
(given by the rows). This is related to specificity. Figure 6.8B is arguably the more 
important figure as in an experimental situation we are concerned with the reliability of 
the estimates provided by the model. 
Figure 6.8 is coloured according to the S, T and V sensitivities of the categories. 
Categories with blue shadings have high S and low T sensitivities (S-HI_T-LO from 
section 6.5.3.2), green shadings signify low S and high T sensitivities (S-LO_T-HI), 
pink colours mean that both S and T are high and black indicates that S and T are low 
(both pink and black categories combine to make up to ST-EQ). Darkest shadings are 
used for values of V that are high and positive (V-POS from section 6.5.3.3), lightest 
ones indicate a high and negative value for V(V-NEG), while intermediate shadings are 
used for genes where V is low (V-LO). 
A number of observations can be made from the distribution of colours and shapes in 
Figure 6.8 and the results in Table 6.6. Firstly, the model is effective at classifying the 
genes into the correct category. This is indicated by large circles along the diagonals of 
Figure 6.8A and B. For nine out of the ten categories over half the genes are correctly 
classified. Similarly, in nine out of ten categories, over half the genes assigned into the 
category actually belong there (Table 6.6). This is not an easy task, as there are ten 
potential categories to which the genes could have been assigned. 
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% of genes actually in each 
category that are correctly 
classified (Sensitivity) 
% of genes classified into 
each category that actually 
belong there (Specificity) 
S-HI T-LO V-POS 59% 64% 
S-HI T-LO V-LO 60% 79%  
S-HI T-LO V-NEG 96% 52% 
S-LO T-HI V-POS 70% 89% 
S-LO T-HI V-LOW 84% 88% 
S-LO T-HI V-NEG 99% 77% 
S-HI T-HI V-POS * 31% 61% 
S-HI T-HI V-LOW _ 	_ 63% 63% 
S-HI T-HI V-NEG _ 	_ 54% 42% 
S-LO T-LO V-POS 98% 91% 
Table 6.6 Sensitivity and specificity results for the complete classification of test 
data with a 15% error added to both training and test data. 
Secondly, even when genes are incorrectly classified, the relationship between their S 
and T sensitivities is generally estimated correctly. This correlates with the fact that ST-
Categories are well estimated by the model (section 6.5.3.2) and is evidenced by the fact 
that in Figure 6.8A and B off-diagonal circles are almost all within one block of the 
diagonal and are generally in the same colour shade as the on diagonal circle. This 
shows that classification remains true to the S and T sensitivities and varyies mainly in 
the V parameter estimate. 
Finally, as in section 6.5.3.3, genes with a high positive cooperative sensitivity (dark 
shadings) are not confused with genes with a high negative cooperative sensitivity (light 
shadings) and vice versa. There are almost no circles of the darkest shade of a colour in 
a column where the diagonal is in the lightest shade of athe same colour, and similarly 
there are no circles of the lightest shade in a column when the diagonal is darkest. (This 
can also be observed by noting that there are no large circles more than one block away 
from the diagonal.) 
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v+ vo v- V+ VO v- v+ VO V- 
S-HI T-LO 	S-LO T-HI 	S-HI T-HI 	S-LO 
Classification Category 	T-LO 
Figure 6.8 Summary of complete gene classification for data with a 15% error 
added to both the training and test data. 
A) Sensitivity: Each column contains a number of circles. The size of each circle 
corresponds to the percentage of genes belonging in the category of the corresponding 
column that were classified into the group indicated by the row. 
B) Specificity: Each column contains a number of circles. The size of the circle 
indicates the percentage of genes classified into the group of the circle's column 
actually came from the group in the row. 
Chapter 6: Modelling Cooperativity of Two Transcription Factors 	 - 205 - 
Although the sensitivity and specificity estimates for some categories, say 
S-HI_T-HI_V-POS and S-HI_T-HI_V-NEG (marked with a § in Table 6.6) might be 
low it is important not to underestimate the results of the model at classification. 
Although only 54% of genes belonging to category S-HI_T-HI_V-NEG are correctly 
assigned, this is a far better result than a 54% sensitivity would be in a binary 
classification task (as discussed in section 6.5.3.1). There are ten possible categories to 
which a gene can be assigned, and so assigning 54% into the correct category is still 
significantly above what one would expect due to chance. It is also important to 
consider the categories into which misclassified genes are assigned. In the case S-HI_T-
HI V-NEG 94% of the remaining genes are classified into S-HI_ T-HI V-LO (column 9 _ 
of Figure 6.8A). This means that the estimates for both their S and T sensitivities are 
correct, and their cooperativity parameter is correctly recognised as not being high and 
positive (however it is incorrectly estimated as being low rather than being negative). 
Similarly some categories may get be a large number of genes that do not belong there 
and so these categories have a low specificity. However, considering the genes that are 
misclassified into each category the results look significantly more promising. As an 
example, consider the S-HI_T-LO_V-NEG category (column 3 of Figure 6.8B). Only 
52% of the genes assigned into S-HI_T-LO_V-NEG actually belong there, however the 
remaining 48% are all genes belonging to S-HI_T-LO_V-LOW, with the same S and T 
parameters and an adjacent V parameter. 
6.5.4 Varying the transcription factor profiles and knock-down factors 
All the analysis thus far has been based on the parameters given in Table 6.2. We now 
verify that similar results are obtained for different transcription factor activity profiles, 
and ask how the value of the knock-down factors affects the model results. 
To this end we run a number of fits altering transcription factor functions and knock-
down factors. The timing of the peak (x in Figure 6.1) is altered and the other 
transcription factor profile parameters are left as in Table 6.2. The peaks are chosen to 
occur at either 2, 4, 8 or 10 hours. We ensure that the peaks of TF1 and TF2 occur at 
different times, and to avoid duplication specify that the peak of TF2 must occur after 
the peak of TF1. The knock-down factors are chosen from 0.1, 0.4 and 0.7 and any 
combination of the two knock-down factors is allowed. Combining these possibilities 
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gives a total of 54 possible parameter combinations on which we analyse the model 
behaviour. 
Once again we use both training and test data with a measurement error of 15%. For 
each of the 54 parameter combinations we generate 10 different sets of training genes 
using the BSTVD parameters given in Table 6.1 and randomly adding error. We then 
use the model to recover knock-down factor estimates and transcription factor activity 
profile estimates. This results in 540 training estimates which we apply to test sets of 
data. Each test set contains 155 simulated genes which are generated using the same 
transcription factor and knock-down factor combination as the associated training set 
and some randomly generated error. 
6.5.4.1 Dependence of classification on knock-down efficacy 
We now consider how the knock-down efficacy affects the overall classification of the 
genes. Intuitively we expect that if the knock-down of one of the transcription factors is 
not particularly effective then the results obtained will be worse. This is because the 
inclusion of knock-down data from an ineffective knock-down does not add a great deal 
of information that is not already contained in the wild-type gene expression data. We 
aim to estimate how effective the knock-down needs to be in order for our model to still 
give reasonable results. 
In Figure 6.9A-F we depict the results of classification on the test set of genes, for 
different combinations of knock-down factor efficacy (and for the different transcription 
factor profiles described above). Each panel in Figure 6.9 is of a similar form to Figure 
6.8A and shows where genes in the category specified by each column were classified. 
Panel C corresponds to the knock-down factors used in section 6.5.3 and thus looks 
similar to Figure 6.8A.When both transcription factors are effectively knocked down 
(panel A - both knock-down factors are 0.1) then the sensitivity of all groups is very 
high (large circles along diagonal, very few off diagonal elements). If one or both of the 
knock-down factors is less effective (the knock-down factors increase) the classification 
becomes worse. This can be seen by an increase in the size of the off diagonal circles in 
panels B-F. 
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Figure 6.9 Summary of classification sensitivity for a variety of knock-down 
factors and transcription factor profiles. 
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Model is applied to simulated data with a 15% error added to both the training and test 
set. Each panel depicts the sensiticty of the classifier and is similar to panel A in Figure 
6.8. Each column of a panel contains a number of circles. The size of each circle 
corresponds to the percentage of genes belonging in the category of the corresponding 
column that are classified into the group indicated by the row. 
A) Both knock-down factors are 0.1. 
B) Knock-down factors are 0.7 and 0.1. 
C) Knock-down factors are 0.4 and 0.1. 
D) Knock-down factors are 0.7 and 0.4. 
E) Both knock-down factors are 0.4. 
F) Both knock-down factors are 0.4. 
From Figure 6.9 we can conclude that had we used smaller values for the knock-down 
factors in section 6.5.3 the results obtained could have been improved significantly. In 
addtion, it would appear that reasonable results are only obtained in panels A,C and E, 
and possibly B. Thus in order for our model to be used reliably we require that both 
knock-down factors are 0.4 or less. It may be possible to obtain reasonable results if one 
knock-down factor is greater than 0.4, as long as the other is very low (panel B). Since 
we can estimate the value of the knock-down factors accurately from training data 
(section 6.5.4.2 below) we have a reliable method to determine whether our model is 
appropriate for the data at hand. 
6.5.4.2 Estimation of knock-down factors 
Figure 6.10A-C shows histograms of the estimated knock-down factors for each of the 
possible values from the parameter combinations defined earlier in this section. Even 
when using varied transcription factor profiles the knock-down factors are extremely 
well estimated with tight histograms centred about the correct value. 
Further analysis shows that these histograms are not affected by the timing of the peak 
in the activity profile. Figure 6.11A-C show overlapping histograms of the knock-down 
factor estimates that are associated with each of the different transcription factor profile 
peaks. Regardless of when the peak in the transcription factor profile occurs, the 
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Figure 6.10 Histograms of the estimated knock-down factors derived from training 
using the model. 
A) Estimated knock-down factor when the true value is 0.1. 
B) Estimated knock-down factor when the true value is 0.4. 
C) Estimated knock-down factor when the true value is 0.7. 
Figure 6.11 Overlapping histograms of the estimated knock-down factors derived 
from training on different transcription factor activity profiles with different 
peaks 
Legend for all panels is the same and is shown in panel A. 
A) Estimated knock-down factor when the true value is 0.1. 
B) Estimated knock-down factor when the true value is 0.4. 
C) Estimated knock-down factor when the true value is 0.7. 
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distribution of knock-down factor estimates is fairly similar and closely resembles the 
overall distributions shown in Figure 6.10A-C. 
Using our model we are able to get a very reliable estimate for the knock-down factors 
used to generate the training data. Our model thus provides a useful and reliable method 
for evaluating the effectiveness of a knock-down of a biological experiment. 
6.5.5 Introducing a third transcription factor 
Thus far model verification has been performed on data generated using equation 6.3 
(plus some random error). We have not yet included any data which, in the absence of 
error, cannot be fit by the model. This type of data could arise from genes that are 
regulated exclusively by transcription factors other than those represented by the 
functions f(t) and g(t) and from genes that are co-regulated by one (or even both) of the 
transcription factor profilesf(t) and g(t) as well as by a third, unknown transcription 
factor. It is this last scenario that we consider in this section. 
We assume that the model is still trained on genes regulated only by the two 
transcription factors of interest, but is tested on data that is also regulated by a third 
factor. 
We extend the basic model of equation 6.3 to include a third transcription factor. We 
allow the third transcription factor (TF3) to have a profile given by h(t), and the genes 
to have a sensitivity of W to TF3. The extension is: 
6bc'  (t) 	Bi + Si f(t) cf  + Tig(t) + Vf(t)g(t) icf + Wh(t) - Dix j(t) 
dt 
(6.20) 
We set W to a value of 60 for all genes in the new test set, as this is above the very low 
sensitivity values but significantly below the high sensitivities. The purpose of this is to 
add in a significant but not major "distraction" by the third transcription factor. We use 
two different functions for h(t) and these are shown in Figure 6.12 (along withf(t) and 
g(t)). The parameters used to generate them are given in Table 6.7. The first profile, 
hi(t), peaks at 10 hours. This profile is fairly similar to g(t) and so we would expect 
some degree of confusion by the model. The second profile, h2(t), peaks at 5 hours. 
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Since we only sample every two hours, the interpolated version of this function (which 
is what is ultimately used) looks slightly different to the usual peaked function. This 
second function is quite different from both f(t) and g(t) and thus we might expect less 
confusion by the model when this profile is used for the third transcription factor. 
Transcription factor functions 
0 	2 	4 	6 	8 	10 	12 	14 	16 
Time (hours) 
Figure 6.12 Graph showing the different profiles of h(t) used for the third 
transcription factor. 
Profiles for hi(t) and h2(t) are overlayed on the profiles for f(t) (blue) and g(t) (green). 
The dotted red line shows the activity profile for hi (t), which peaks at 10 hours. The 
dashed red line shows the activity profile from h2(t) which peaks at 5 hours , but is only 
sampled every 2 hours and so has a slightly different shape to the other profiles. 
b x y 
hl (t) .01 10 .1 
h2(t) .01 5 .1 
Table 6.7 Parameters used to generate the third transcription factor profiles. 
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6.5.5.1 ST-Category and V-Category classification comparison 
Adding in the third transcription factor does not significantly worsen the ST-category 
groupings. In many cases it improved sensitivity (category ST-EQ) and specificity 
(category S-HI_T-LO). These results are summarised in Table 6.8 where they are 
compared to the results from Table 6.3. 
The most noticeable difference in results is on the V-category classification (Table 6.9). 
Sensitivity of V-POS decreases from 75% with no third transcription factor to 67% 
when h2(t) is included as a third transcription factor, and further decreases to 62% when 
Mt) is used. Sensitivity of V- LOW decreases in a similar fashion. Specificity decreases 
are seen in categories V- NEG and V- LOW. (The effect on V-NEG is stronger.) 
6.5.5.2 Overall results of gene classification incorporating a third transcription 
factor 
The results obtained when incorporating a third transcription factor are surprisingly 
good. As predicted, Mt) gives worse results than h2(t), however both are acceptable. 
The sensitivity and specificity results are summarised in Figure 6.13. It is clear that 
panels E and F (reproduced from Figure 6.8A and B), which do not have a third 
transcription factor incorporated, give the best classification results. This is evidenced 
by fewer circles far away from the diagonal than in the other panels. However panels C 
and D, which include h2(t), as a third transcription factor do not show significantly 
worse results, especially in specificity (compare panels D and F). Specificity is arguably 
the more important measure as this is the one we consider when applying the model to 
real data. 
The mean decrease in sensitivity on each of the ten categories when using h2(t) for the 
profile of the third transcription is 6.2% (standard deviation 7.9%), and only one 
category has a sensitivity decrease of more than 12% (S-LOT-HI_V-POS decreased 
by 21%). The mean decrease in the specificity of each category is 5.5% (standard 
deviation 5.2%). Only two categories (S-LO_T-HI_V-POS at 15% and 
S-LO T-HI V-NEG which decreases by 12%) have a decrease of more than 9%. _ _ 
The results when using Mt) for the third transcription factor are not as good, although 
they are still acceptable (panels A and B). Both panels A (sensitivity) and B (specificity) 
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Sensitivity 
(% correctly classified) 
Specificity 
(% classified into each group 
which belong there) 
3rd TF = 
hl(t) 
3rd TF = 
MO 
No 3rd 
TF 
3rd TF = 
hl(t) 
3rd TF = 
hl(t) 
No 3rd 
TF 
S-HI_T-LO 95% 99% 100% 100 99% 89% 
ST-EQ 91% 89% 81% 95% 99% 99.9% 
S-LO_T-HI 100% 99.9% 99.9% 91% 90% 94% 
Table 6.8 Sensitivity and specificity of model on each of the three ST-categories 
with a third transcription factor added. 
Model is applied to data with a 15% error added to the training and test sets of data. 
Results are shown for two different additional transcription factors (h1(t) and h2(t)) 
and compared to the results with no third transcription factor added (Table 6.3). 
Sensitivity 
(4)/0 correctly classified) 
Specificity 
(% classified into each group 
which belong there) 
3rd TF = 
MO 
3rd TF = 
h2(0 
No 3rd 
TF 
3rd TF = 
hi(t) 
3rd TF = 
h2(t) 
No 3rd 
TF 
V-POS 62% 67% 75% 85% 82% 84% 
V-LO 58% 64% 70% 70% 73% 78% 
V-NEG 88% 86% 86% 42% 49% 56% 
Table 6.9 Sensitivity and specificity of model on each of the three V-categories with 
a third transcription factor added. 
Model is applied to data with a 15% error added to the training and test sets of data. 
Results are shown for two different additional transcription factors (h1(t) and h2(t)) 
and compared to the results with no third transcription factor added (Table 6.4). 
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have more off-diagonal elements than panels C-F. The average decrease in the 
sensitivity (compared to when no third transcription factor is incorporated) of each 
category is 13% (standard deviation of 16.3%) and in specificity is 10.2% (standard 
deviation of 10.8%). 
Considering the results of section 6.5.5.1 it would seem that the main reason for error in 
the overall classification is the incorrect performance of the likelihood ratio test in 
correctly assigning the V-category. This is supported by the fact that in all panels of 
Figure 6.13 the circles appear in distinct colour groups (blocks of blue circles, blocks of 
green circles and blocks of pink circles), which signify the same ST-categories. 
We conclude that including a third transcription factor into the test data, especially one 
that is significantly different from the two transcription factors of interest, does not 
invalidate the results of our model. 
6.6 Discussion 
A decrease in the cost and an increase in the accessibility of conducting micro-array 
experiments means that it is now feasible to measure gene expression levels under an 
increased number of conditions and at more time points. From these measurements we 
would like to be able to provide useful insight into the behaviour of the system. 
Conventional approaches to analysing data, such as clustering, often do not provide 
enough insight into the system, and do not take into account the dynamic behaviour that 
is captured using time series measurements. 
In this chapter we develop a dynamic model to analyse cooperative regulation of genes 
by two transcription factors using gene expression data from micro-arrays (or other 
measurement techniques). We use the model to: (i) extract estimates for the activity 
profiles of two transcription factors of interest; (ii) estimate the efficacy of the knock-
downs of each transcription factor; (iii) predict the genes that are strongly cooperatively 
regulated by the two factors; and (iv) assess whether genes are more sensitive to one 
transcription factor or the other. 
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Figure 6.13 Comparison of classification results incorporating a third 
transcription factor into the simulated test data. 
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Model is applied to simulated data with a 15% error added to both the training and test 
set. 
Left hand panels (A, C, E) depict sensitivity. As in Figure 6.8A, each column contains a 
number of circles. The size of each circle corresponds to the percentage of genes 
belonging in the category of the corresponding column that were classified into the 
group indicated by the row. Right hand panels (B, D, F) depict specificity, again, as in 
Figure 6.8B each column contains a number of circles. The size of the circle indicates 
the percentage of genes classified into the group of the circle's column actually came 
from the group in the row. 
Panels A and B show results when the third transcription factor is given by kW. Panels 
C and D show results when the third transcription factor is given by h2(t). Panels E and 
F are shown for comparison and give classification results when there is no third 
transcription factor added. These panels are the same as Figure 6.8. 
Provision of these results requires time series data on gene expression profiles in wild-
type cells / organisms, as well as similar information from single and double knock-
downs. This knock-down information is required in order to tease apart the effects of 
the different transcription factors. We do not require expression data from full knock-
outs, as this is often experimentally difficult. Instead our model is able to provide good 
results using data from only partial knock-downs, and is also able to provide a reliable 
estimate for the efficacy of the experimental knock-down. 
It is widely accepted that significant cooperative regulation occurs in most biological 
systems (Kel et al., 1995). Previous studies have focused on uncovering the degree of 
this cooperativity and on identifying factors that synergistically activate gene expression 
(Pilpel et al., 2001, Chang et al., 2006, Bonneau et al., 2006). The work in this chapter 
presents a shift in focus of cooperative transcription factor modelling away from 
uncovering information about different interacting transcription factors, and towards 
understanding the effect of cooperative regulation on gene expression. Rather than 
analysing all transcription factors, we focus on two factors that are known to interact 
cooperatively. Using this knowledge we analyse the details of their cooperative 
behaviour, and attempt to gain insight into the symbiotic relationship for gene activation 
and expression that exists between them. Our model provides a prediction for the time 
varying activation profile of each transcription factor, something which is not done by 
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other models. We can then use this profile to determine genes that are strongly 
cooperatively regulated and those that are more sensitive to one transcription factor or 
the other. 
This work is particularly useful in a situation where two transcription factors are known 
to be involved in the regulation of target genes but their exact contributions and 
potential form of interaction are unknown. Such an example is found in the mosquito 
immune system, where REL1 and REL2 are both known to both be involved in the 
regulation of immune genes (Christophides et al., 2004), but exclusive downstream 
targets of either transcription factor have not been uncovered. 
We verify the behaviour of our model by applying it to simulated data. We add a 
random error to each point in an attempt to match the noise in our simulated data with 
the variability seen in experimental data. We also test the model on data that is 
additionally regulated by a third unrelated transcription factor. We find that the model 
provides accurate and reliable results even with the inclusion of this error and additional 
source of regulation and thus are able to conclude that the methods presented in this 
chapter should be able to be applied to experimental data sets. Although attempt to 
generate realistic simulated data (both through the addition of error and the inclusion of 
a third, unrelated regulating factor) it would still be beneficial to test the predictions of 
this model on a real world dataset, and verify their validity. 
Our model assumes a linear relationship between transcription factor activity and levels 
of gene transcript. Such a supposition has previously yielded insightful results (Barenco 
et al., 2006) and so we feel justified in making this assumption. In future however, we 
could extend the model to allow for a saturating effect of the transcription factors at 
high levels and a threshold for transcriptional activation at low levels, as was done in 
other models (Bonneau et al., 2006, Chang et al., 2006). This would require a more 
detailed understanding of the levels at which the threshold and saturation effects begin. 
The method presented here is useful for analysing cooperative regulation of genes in a 
variety of systems. It considers two transcription factors of interest and provides a 
profile of their activation levels, as well as detailed insight into their separate and 
cooperative regulation of target genes. 
Chapter 7 
Applying the Transcription Factor Model to 
Experimental Data 
7.1 Overview 
In response to immune challenge in the mosquito signalling pathways are activated 
which result in the upregulation of REL1 and REL2, two transcription factors known to 
be important in the regulation of mosquito immune genes. The exact contribution of the 
two transcription factors to the regulation of immune genes is undetermined. 
We apply the model developed in the previous chapter to two sets of data from 
challenged mosquitoes and mosquito cell lines, in order to tease apart the effects of each 
of the two transcription factors, and understand how they may cooperatively regulate 
gene transcription. 
We estimate the activity profiles of each of REL1 and REL2, and use our estimates to 
predict that REL2 has an oscillating profile in response to immune challenge, while the 
profile of REL1 is more stable. We also estimate the efficacy of the knock-downs of 
active REL1 and REL2 transcription factors and show that, in both datasets, REL2 is 
more effectively knocked down than RELI. Finally, we predict that the presence of both 
REL1 and REL2 causes negative cooperative regulation of TEP1 and CTL4, two genes 
that are important in the immune response to the malaria parasite. 
-218- 
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7.2 Introduction 
In this chapter we apply the model developed in chapter 6 to experimental data. We use 
two sets of reverse transcription polymerase chain reaction (RT-PCR) data. The first is 
taken from a previously published study (Frolet et al., 2006) which considered the 
effects of REL1 and REL2 on the mosquito response to malaria parasite invasion. The 
second was generated specifically for this work in collaboration with the 
Immunogenomics Lab, Imperial College. The second data set was designed to uncover 
the roles of REL1 and REL2 in the mosquito response to infection. Although neither of 
these data sets is exactly suited to the analysis presented in chapter 6, as they do not 
contain sufficient numbers of genes, applying our model to the data sets reveals a 
number of interesting observations, which confirms its utility for experimental data. 
Initially we had planned to generate micro-array data which was complementary to the 
PCR data presented in section 7.4 and use this micro-array data to provide similar 
analysis to that presented in chapter 6. Experimental issues (discussed in section 7.4) 
prevented this from happening within the time frame of this thesis and mean that the 
application of the model to micro-array data remains an area of continued work (and is 
discussed in the further work section of chapter 8). We apply the model from chapter 6 
to two sets of data and present the results below. Section 7.4 gives the result of fitting to 
data from Frolet et. al. (2006) and section 7.5 gives the results of fitting to data 
specifically generated for model analysis. 
7.3 Methods for experimentally generating data 
7.3.1 Reverse transcription polymerase chain reaction (RT-PCR) 
Reverse Transcription polymerase chain reaction (RT-PCR) is a method which 
amplifies the amount of deoxyribonucleic acid (DNA) present in vitro using enzymatic 
replication. By using a primer which is complementary to the DNA region of interest a 
specific section of a DNA strand can be amplified and thus it is useful for measuring 
levels of a specific gene. As we are interested in the amount of messenger ribonucleic 
acid (mRNA) present in the cells we initially use reverse transcription to create 
complementary DNA strands. Standard polymerase chain reaction (PCR) is then used 
on the generated DNA strand to quantify the abundance of the mRNA. Due to the 
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reliance on a primer for the gene, PCR is used to calculate information on the gene 
expression levels for only one gene at a time. 
PCR replicates DNA through a number of cycles. In theory this replication is 
exponential with the amount of DNA after each replication cycle. This means that 
knowing the amount of DNA present after a defined number of cycles should make it 
possible to calculate the original concentration of DNA. Unfortunately there are two 
problems with this. Firstly the replication is not always exponential, and often plateaus 
after a certain number of cycles, making it more difficult to calculate the initial DNA or 
RNA levels and secondly exact doubling is typically not seen and growth is geometric 
with an index somewhat less than 2. Quantitative real time PCR (qRT-PCR) attempts to 
rectify these problems by using fluorescence to measure the concentration of DNA after 
each replication cycle, and thus gives a more accurate reading of DNA levels. Although 
this does improve the quantitative results from PCR, the readings obtained still vary 
widely depending on the strength of the primers used and their affinity for the DNA 
region of interest. This last issue can be overcome with careful standardisation. 
When using RT-PCR to calculate gene expression levels for a few different genes, or at 
different time points after challenge, we treat a number of different groups of cells in a 
similar fashion, and later apply PCR to the cells. In order to do this, specifically 
designed microtiter plates are used. Cells are placed into and allowed to grow in the 
wells of these plates and the entire plate is treated in the same way. At the appropriate 
time, cells are lysed and RNA is prepared using specific chemical reagents. The RNA is 
subjected to reverse transcription and PCR measurements are then made. 
7.3.2 Generation of RT-PCR data 
A description of the methods for generating the data presented in section 7.4 is given in 
the experimental procedures section of Frolet et. al. (2006). 
The experiments generating the data in section 7.5 were performed in 96-well (section 
7.5.1) and 24-well (sections 7.5.2 and 7.5.3) plates: 2x106 Sua 5.1* cells were seeded 
and allowed to settle for at least 2 hours before the medium was removed and 4.5 I.tg of 
double stranded RNAs (dsRNA) were added in serum-free medium. The dsRNAs used 
corresponded to green florescent protein (GFP) which is a control, GFP and RELI, GFP 
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and REL2, and REL1 and REL2. After 48 hours of incubation with dsRNA 3001.11 of 
serum-enriched medium was added to the cells complemented with 10 µg/ml of 
peptidoglycan. Peptidoglycan is a potent immune challenge, known to activate immune 
signalling pathways. RNA was extracted from the cells at Omin, 5min, 15min, 30min, 
lhr, 2hr, 4hr 8hrs 12 hr and 24 hr time points for the data in section 7.5.1 and at Ohr, 
lhr, 4hr, 8hr, 12hr and 24hr time points for the data in sections 7.5.2 and 7.5.3. 
Complementary DNA (cDNA) was synthesized using flag of RNA. Quantitative real 
time PCR was performed with 50 ng of cDNA using the Power SYBR green mastermix 
and the Applied Biosystems 7500 Fast Real time PCR Machine. Expression in the 
various samples was normalised against transcripts of the housekeeping S7 gene, and 
the RELI, REL2, CECI and DEF1 gene expression was calculated by absolute 
quantitation using a standard curve. 
7.3.2.1 Absolute, Fold Induction and Baseline Relative Expression Measurements 
To minimise the amount of error associated with the PCR measurements the readings 
for each gene of interest are compared to levels of the "housekeeping" S7 gene (in this 
case S7) which is thought to remain at a fairly constant level during the experiment. 
This has the effect of ironing out fluctuations which occur due to slight changes in the 
experimental conditions as well as variable amounts of RNA. The ratio of the 
measurements of the gene of interest and those of S7 give what we refer to as the 
absolute expression levels for that gene. Note that, although we refer to them as such 
(since they are different from the fold induction measurements we discuss below) these 
values to not actually represent real absolute expression levels, as they have been 
normalised to the expression level of S7. 
It is common to normalise measurements to the initial gene expression level of the gene 
of interest. This gives the fold induction level of the gene at subsequent time points. To 
achieve these values we first normalise the gene expression levels to the housekeeping 
gene as discussed above, and then calculate the ratio of the absolute gene expression 
levels at later time points with that at time t = 0. 
We often compare the gene expression levels in knock-down cells with those in wild-
type cells at the initial time point. To do this we calculate the absolute gene expression 
levels as described above, and then consider the ratio of the absolute gene expression 
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levels in knock-down cells with those in wild-type cells. This gives us the relative gene 
expression in the knock-down cells. 
7.4 Results of fitting to data from Frolet et. al. (2006) 
The data we analyse from Frolet et. al. (2006) consists of PCR gene expression data 
from three genes taken from wild-type mosquitoes, as well as mosquitoes which have 
either REL1, REL2 or both REL1 and REL2 knocked down. The genes that are 
examined are Telomerase-associated protein 1 (TEP1), Leucine-rich immune 
response 1 (LRIM1) and C-type lectin 4 (CTL4). The data shown in Figure 7.1 is 
reproduced from Frolet et. al. (2006). Frolet et. al. observed that despite the fact that 
baseline gene expression levels were lower in the knock-down mosquitoes (Figure 
7.1B), following infection with the Plasmodium parasite the fold induction levels of the 
genes were not significantly altered (Figure 7.1A). This led them to conclude that REL1 
and REL2 were most important in pre-invasion defence against the parasite. 
To utilise the data in Figure 7.1 we read off the mean values from the plots. This gives 
fold induction and baseline relative expression levels for each of the three genes. We 
can determine the absolute gene expression levels at time t by multiplying the fold 
induction level at time t (determined from Figure 7.1A) by the baseline reduction (or 
increase) due to the knock-down (determined from Figure 7.1B). We should then 
multiply this value by the level of the gene present at time t = 0 in wild-type 
mosquitoes. The formula for this calculation is expressed more clearly by 
AbsoluteExpression(t) = Foldlnduction(t)•BaseRelativeExpr•WTBaselineLevel 
(7.1) 
Unfortunately the final piece of information (baseline gene expression level in wild-type 
mosquitoes) could not be determined from the published data; therefore, we set this 
value to an arbitrary constant of 10. 
The absolute gene expression levels that we calculate and use for future modelling are 
shown in Figure 7.2. 
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Figure 7.1 Expression levels of TEP1, LRIM1 and CTL4 determined by Frolet et. 
al. 
(A) Fold induction data at four different time points for the three genes. Error bars 
show standard deviations of 3-5 experiments. 
(B) Baseline relative expression of the three genes in each of the knock-down 
mosquitoes. 
Image is modified from Frolet et. al. (2006). 
Figure 7.2 Absolute gene expression levels derived from data in Figure 7.1 using 
the formula in equation 7.1. 
Colours for all panels are the same (legend is in panel C) and are as in Figure 7.1. 
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7.4.1 Estimation of measurement errors 
In order to apply the model from chapter 6 we would like to obtain an estimate of the 
standard deviation of the measurement errors. This can be achieved for the fold 
induction levels at times t = 7, 24 and 48 hours by measuring the error bars of Figure 
7.1A. The values we estimate from the figure are shown in Table 7.1 Since at t=0 the 
fold induction must be 1 (with no possibility for measurement error), we set the 
standard deviation at time t = 0 to a uniformly low value of 0.01 (also shown in Table 
7.1). The standard deviation of the baseline relative expression measurements can be 
determined from the replicate values in Figure 7.1B. Our estimates for the baseline 
standard deviations are given in Table 7.2. 
It is not possible to determine the standard deviation of errors in the derived absolute 
gene expression levels in a similar manner as no values or error bars were published. In 
addition, we cannot simply multiply the standard deviations of the fold induction errors 
and baseline relative expression errors was we did in for the data values (using equation 
7.1). This is because, in general, the standard deviation of a product of two random 
distributions is not the same as the product of their standard deviations. Instead we 
make a similar assumption to the one in chapter 6, namely that the standard deviation of 
errors in the absolute gene expression levels is proportional to the expression levels 
themselves. 
7.4.2 Results of fitting 
There are two different methods we use to fit the data derived above. We term these the 
absolute percentage error (APE) fitting method and the fold and base (FAB) fitting 
method and discuss them both below. 
APE fitting 
The first fitting method is very similar to that used in chapter 6. We fit to absolute gene 
expression levels and assume that the measurement error is a percentage of the 
measured value. We call this method the Absolute Percentage Error (APE) fitting 
method. Figure 7.3 and Figure 7.4 and Table 7.3 and Table 7.4 give the results of fitting 
using the APE fitting method. We obtain relatively good fits to the data points in most 
experiments. The only dataset that is not fit well is CTL4 activation in double knock-
down mosquitoes (Figure 7.3L). 
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Gene Knock-down type 
Time (hours) 
0 7 24 48 
TEP1 
ds LacZ 0.01 1.4 1.4 0.8 
ds REL1 0.01 0.8 1.6 0.4 
ds REL2 0.01 1.6 2 1.5 
ds REL1 / ds REL2 0.01 0.1 1.2 1.6 
LRIMI 
ds LacZ 0.01 1.5 3.1 0.7 
ds REL1 0.01 0.8 1.6 0.6 
ds REL2 0.01 0.6 0.7 0.4 
ds REL1 / ds REL2 0.01 0.3 0.4 0.9 
CTL4 
ds LacZ 0.01 0.2 0.6 0.4 
ds REL1 0.01 0.9 0.4 0.2 
ds REL2 0.01 0.9 0.4 0.8 
ds REL1 / ds REL2 0.01 0.3 0.9 0.5 
Table 7.1 Standard deviations of fold induction measurements estimated from 
Figure 7.1A 
Knock-down type TEP1 LRIM1 CTL4 
ds LacZ 0.01 0.01 0.01 
ds REL1 0.55 0.49 0.3 
ds REL2 0.62 0.46 0.64 
ds REL1 / ds REL2 0.08 0.13 0.05 
Table 7.2 Standard deviations of baseline relative expression estimated from 
Figure 7.1B. 
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Figure 7.3 Results of fitting to the data from Frolet et. al. (2006), using the APE 
fitting method. 
Target values are depicted with solid lines, estimated values are depicted with dashed 
lines (legend is in panel H). Fits to TEP1 data are in panels A-D, fits to LRIMI data are 
in panels E-H andfits to CTL4 data are in panels I-L. Black graphs (left column) show 
fits to wild-type mosquitoes, yellow graphs (middle-left column) show fits to RELI 
knock-down mosquitoes, red graphs (middle-right column) show fits to REL2 knock-
down mosquitoes and blue graphs (right column) show fits to double REL1 and REL2 
knock-down mosquitoes. 
TEP1 LRIM1 CTL4 
B (baseline transcription) 0.39 3.08 3.28 
S (REL1 sensitivity) 10 15.05 1.92 
T (REL2 sensitivity) 10 7.52 3.61 
V (cooperative sensitivity) -5.52 0.25 -1.01 
D (decay rate of gene) 0.61 0.92 0.48 
Table 7.3 Gene specific parameters estimated using the APE fitting method to fit to 
the data from Frolet et. al. (2006). 
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Figure 7.4 Estimates for the activity profiles of REL1 and REL2 using the APE 
fitting method on the data from Frolet et. al. (2006). 
Error bars show 95% confidence intervals on the function estimates. 
Blue line shows the estimated activity profile of REL1, green line shows the estimated 
activity profile of REL2. 
KRELI (knock-down factor of REL1) 
	
0.39 
KREL2 (knock-down factor of REL2) 
	
0 
Table 7.4 Knock-down factors estimated using the APE fitting method to fit to the 
data from Frolet et. al. (2006). 
FAB fitting 
Using the second fitting method we fit directly to the fold induction data (Figure 7.1A) 
and the baseline relative expression levels at time t = 0 (Figure 7.1B). We call this 
fitting method the Fold and Base (FAB) fitting method. When using FAB fitting to fit 
the data from Frolet et. al. (2006) we use the standard deviations in measurement errors 
given in Table 7.1 and Table 7.2 
The results of using the FAB fitting method are shown in Figure 7.5, Figure 7.6 and 
Figure 7.7 and Table 7.5 and Table 7.6. It is more difficult to fit the double knock-
downs well when using this method of fitting (Figure 7.5D and L). 
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Figure 7.5 Results of fitting to the data from Frolet et. al. (2006) using the FAB 
fitting method. 
Target values are depicted with solid lines, estimated values are depicted with dashed 
lines (legend is in panel H). Fits to TEP I data are in panels A-D, fits to LRIM1 data are 
in panels E-H and fits to CTL4 data are in panels I-L. Black graphs (left column) show 
fits to wild-type mosquitoes, yellow graphs (middle-left column) show fits to RELI 
knock-down mosquitoes, red graphs (middle-right column) show fits to REL2 knock-
down mosquitoes and blue graphs (right column) show fits to double RELI and REL2 
knock-down mosquitoes. 
Figure 7.6 Baseline fitted values to the data from Frolet et. al. (2006) using the 
FAB fitting method. 
Solid bars represent values determined from Frolet et. al. (2006), dashed bars represent 
estimated values from FAB fitting. Note that wild-type baseline gene expression is 
scaled to 10 in all cases. 
RELI 
REL2 
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TEP1 LREIll CTL4 
B (baseline transcription) 0.48 0.85 1.78 
S (REL1 sensitivity) 10 21.60 2.99 
T (REL2 sensitivity) 10 18.87 3.29 
V (cooperative sensitivity) -38.01 -129.48 -16.53 
D (decay rate of gene) 0.29 0.40 0.24 
Table 7.5 Gene specific parameters estimated by using the FAB fitting method to 
fit to the data from Frolet et. al. (2006). 
1.5 
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Figure 7.7 Estimates for the activity profiles of REL1 and REL2 using the FAB 
fitting method on the data from Frolet et. al. (2006). 
Error bars show 95% confidence intervals on the function estimates. 
Blue line shows the estimated activity profile of RELI, green line shows the estimated 
activity profile of REL2. 
KREL1 (knock-down factor of REL1) 
	
0.15 
KREL2 (knock-down factor of REL2) 
	
0.07 
Table 7.6 Knock-down factors estimated by using the FAB fitting method to fit to 
the data from Frolet et. al. (2006). 
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7.4.3 Common features the two fitting methods applied to data from Frolet 
et. al. (2006) 
Depending on the fitting method used different activity profiles for REL1 and REL2 
(compare Figure 7.4 and Figure 7.7) and different parameter values (compare Table 7.3 
and Table 7.4 with Table 7.5 and Table 7.6) are obtained. This is not particularly 
surprising given the relatively few time points at which we have available data, and the 
fact that we did not have access to the complete data set. It is important to remember 
that this method was developed with the intention of applying it to expression level data 
from micro-arrays (which would include data from many genes) taken at more than four 
time points. 
The difficulties we have encountered here in reconciling the results of the APE and 
FAB fitting methods on the data from Frolet et. al. (2006) serve to highlight the fact that 
it is very difficult to apply modelling methods such as those developed in chapter 6 to 
retrospective data. These are generally not methods which can be provided as a service, 
but rather which should be developed in close collaboration with experimentalists (as 
was our aim in collaborating with experimentalists to generate the data in section 7.5). 
Despite the differences between the fits, however, there are some consistencies between 
them. It is likely that these common features represent plausible predictions resulting 
from the model (although we currently do not have a way of verifying this). The 
common features of the fits are discussed in the following sections. 
REL2 is more effectively knocked down than REL1 
The knock-down factor estimated for REL2 is lower than that for REL1, using both the 
APE and FAB fitting methods (Table 7.4 and Table 7.6). This suggests that dsREL2 is 
more effective at knocking down REL2 than dsREL1 is at knocking down REL1. Table 
S2 of Frolet et. al. (2006) shows that following injection of dsREL2 levels of REL2 
gene drop to 61% of normal, whereas following injection of dsREL1, levels of RELI 
drop to only 74% of normal, indicating a less effective knock-down. Therefore our 
results are consistent with data from Frolet et. al. (2006). 
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REL1 is the main contributor to transcription at 48 hours 
Although the shapes of the function estimates for REL1 and REL2 in Figure 7.4 (APE 
fitting method) and Figure 7.7 (FAB fitting method) are different there are some 
commonalities between them. The level of REL2 transcription factor is zero in both 
Figure 7.4 and Figure 7.7 at time t = 48 hours. In contrast the level of REL1 is above 
zero at this time. This indicates that REL1 is the only one of the two transcription 
factors contributing to gene transcription at the 48 hour time point. 
TEPI and CTL4 experience negative cooperative regulation by REL1 and REL2 
Both the APE and the FAB fitting methods assign a negative cooperative regulation 
term (V) to TEP I and CTL4 (Table 7.3 and Table 7.5). This indicates that the presence 
of both of REL1 and REL2 causes negative transcriptional regulation of TEP1 and 
CTL4. From this dataset it is not possible to deduce how the presence of both of REL1 
and REL2 affects LRIMI expression as the APE fitting method assigns a positive 
cooperativity parameter to LRIM1 whereas the FAB fitting method assigns a negative 
one. 
Levels of gene expressions not attributable to REL1 or REL2 
In the absence of REL1 or REL2 the model equation presented in equation 6.3 of 
chapter 6 for gene expression of gene j reduces to 
dx .1(t) 	- DAM 	 (7.2) 
dt 
When this is in equilibrium the level of gene j is given by B;/DJ. Therefore for any gene 
the ratio B/D gives a measure of the amount of the gene that is present due to factors 
other than REL1 and REL2. We can compare the B/D ratio to the expression levels of 
the wild-type cells at time t = 0 (in this case set at a value of 10) to determine the 
percentage of baseline gene levels that are not attributable to REL1 or REL2. 
In both fits we find the B/D ratio to be highest for CTL4. The B/D ratio is 7.5 and 6.9 in 
the APE and FAB fits respectively, indicating that between 69% and 75% of CTL4 
transcript levels are caused by other transcription factors. In contrast the B/D ratio is 
consistently lowest for TEP1 (.6 and 1.7 respectively in the two fits). This indicates that 
less than 17% of TEP1 transcript is attributable to other factors. Finally, between 21% 
and 34% of LRIMI transcript is generated by factors other than REL1 or REL2. 
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7.5 Results of fitting to data specifically generated for this model 
In order to verify the results of the analysis in chapter 6 our experimental collaborators 
generated data using both wild-type cells and cells that had one or both of REL1 and 
REL2 knocked down. The original plan was to first generate PCR data at a large number 
of time points for a few genes of interest and use these to determine the "interesting" 
time points on which to run micro-array analysis. The genes for which we generate PCR 
data are Cecropin (CECI) and Defensin (DEF I). We then planned to apply the methods 
of chapter 6 to the generated micro-array data. Due to unforeseen experimental 
difficulties we have as yet been unable to generate PCR data of sufficient quality to 
justify further micro-array analysis. The PCR data generated thus far is discussed in the 
following sections, along with some analysis of the final data set. 
7.5.1 First Pass of PCR data 
In the first instance PCR analysis was applied to two technical replicates of wild-type 
and knocked down cells. Measurements were taken at times of t = Omin, 5min, 15min, 
30min, lhr, 2hr, 4hr, 8hr, 12hr and 24hr after stimulation with peptidoglycan . The 
results of the PCR analysis are shown in Figure 7.8. There is significant induction of the 
genes following stimulation (up to 35 fold increase is seen in Figure 7.8A), however, 
there appears to be very little correlation between the two replicates (compare Figure 
7.8A and C with Figure 7.8B and D respectively). In addition, unexpected increases in 
the baseline expression levels of CECI are observed following either RELI or REL2 
knock-down in the first replicate, and neither of the replicates show a significant 
decrease in baseline CECI levels in the double knock-down (Figure 7.8E). These results 
are not at all what was expected, and likely indicate significant experimental error. For 
these reasons we concluded that the experiment was not a success and decided to 
generate a new data set. 
It is worth noting that the significant difference between the technical replicates was 
only uncovered when we began attempting to model the data, and realised the 
magnitude of the experimental differences by calculating standard deviations of the 
measurements. Modelling places more rigorous demands on experimental data than 
traditional experimental analysis. Applying rigour such as this to experimental data is 
just one of the advantages that the modelling of biological systems can have. 
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Figure 7.8 First pass of PCR data. Fold induction of CEC1 and DEF1 following 
stimulation by peptidoglycan. 
Panels A and B show fold induction data from the first technical replicate, panels C and 
D show data from the second technical replicate. Dotted lines in panels A-D indicate 
that there was no measurement taken at an intermediate time point (due to experimental 
error). Panels C and D show baseline relative expression levels in knock-down cells 
relative to wild-type cells. Left hand bars of each panel show first technical replicate, 
right hand bars show second technical replicate. Numbers inside the black bars give 
absolute expression levels at baseline in the wild-type cells. Colours for all panels A-F 
are the same (legend is in panel B) and are as for Figure 7.1. 
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7.5.2 Second Pass of PCR data 
It was hypothesised that the difference between the replicates in the first pass of the data 
was a sensitivity problem due to the low amount of RNA present in each well of the 96 
well plate used to generate the data. For this reason, 24 well plates were used to 
generate a new and more accurate data set. This has the disadvantage that we are not 
able to collect data from as many time points (using a single plate), however we 
expected that the data generated would be more robust. 
The second set of data is shown in Figure 7.9. Panels A and B show fold induction 
changes following challenge with peptidoglycan, and panel C shows the baseline 
relative expression in the knock-down cells. 
Figure 7.9 Second pass of PCR data generated by the Christophides Lab. 
Panels A and B show fold induction data for (A) CEC1 and (B) DEF1.. Panel C shows 
baseline relative expression levels of the three genes. Numbers inside the black bars of 
panel C show absolute expression levels at baseline in the wild-type cells. Colours for 
all panels are the same (legend is in panel C) and are as for Figure 7.1. Dotted lines in 
panels A indicate that there was no measurement taken at an intermediate time point 
(due to experimental error). 
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For this experiment the maximum fold induction achieved following challenge was 3.3 
fold. This is significantly lower than the induction that was obtained during the first 
PCR experiments (compare Figure 7.9A and B with Figure 7.8A-D) and that which was 
expected for this experiment. For this reason this set of data was once again deemed to 
be of insufficient quality for modelling. 
7.5.3 Third Pass of PCR data 
It was hypothesised that the reason for the low induction of genes in the second 
experiment may have been that in the larger wells of the 24 well plate the cells were not 
able to mix properly with the peptidoglycan. Peptidoglycan is a relatively large macro-
molecule which is generally in suspension in the cell medium. This means that there is 
likely a non-uniform distribution of the peptidoglycan within the medium. A third 
attempt at data generation was made by altering the protocol in two ways in the hope of 
to rectifying this. Firstly the peptidoglycan was first sonicated (broken up using sound 
waves) so that it was broken up into smaller fragments that were more accessible to the 
pattern recognition receptors on the cell surface. Secondly cells were all given equal 
access to the peptidoglycan. Within each well of a plate cells attach to the bottom and 
by secreting proteins and metabolytes into the medium they turn it into a "conditioned 
medium". To give all cells equal access to the peptidoglycan we removed half of the 
medium, mixed it with approximately half of the peptidoglycan and then added it back 
to the cells before initiating the time course experiment. 
The results of the third PCR experiment are shown in Figure 7.10A-D. This experiment 
appears to result in a reasonable fold induction of genes following challenge (Figure 
7.10A and B) and a significant decrease in the baseline relative expression of both 
CEC1 and DEF1 in the knock-down cells compared with the wild-type cells (Figure 
7.10C). We thus decided it was suitable for modelling. It is important to note that due to 
time constraints only one technical replicate was generated and so we cannot be certain 
that the values obtained here are reproducible. 
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Figure 7.10 Third pass of PCR data generated in response to peptidoglycan 
challenge 
A and B) Fold induction of CEC1 (A) and DEF.' (B) following challenge by 
peptidoglycan . Note that there is no reading at 24hrs for DEFI in the double 
knockdown as there was an experimental error at this time point. 
C) Baseline relative expression of CEC1 (left) and DEFI (right) in the knock-down cells 
compared to the wild-type cells. Numbers inside the black bars give absolute expression 
levels at baseline in the wild-type cells. 
D) Effectiveness of the knockdowns. Blue and green bars depict the relative levels of the 
REL1 and REL2 genes respectively (compared to wild-type cells) in each of the 
knockdowns. 
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E-F) Absolute gene expression levels for CEC1 (E) and DEFT (F). By comparing the 
levels of CEC1 and DEF1 with a householder gene (S7) we obtain absolute values for 
their expression levels. Once again there is no data point at 24hours for DEF I due to 
an experimental error. 
Colours for panels A-C and E-F are the same (legend is in panel C) and are also the 
same as for Figure 7.1. 
In the REL2 knock-down cells the level of the REL1 gene (blue bars in Figure 7.10D) is 
reduced to below 50% of its level in wild-type cells. Similarly in the REL1 knock-down 
cells REL2 gene expression is significantly lowered (green bars in Figure 7.10D). It is 
possible that this result is indicative of a feedback loop between REL1 and REL2 and 
this feedback would provide an interesting area for further research. However, a similar 
result was not reported in Frolet et. al. (2006); thus it is also possible that it only applies 
to this experimental system (cell lines challenged with peptidoglycan). 
7.5.4 Results of fitting to the third pass of data 
In this section we apply both the APE and FAP fitting method to the data in Figure 7.10. 
We do not have a way of estimating measurement errors for this dataset (as there is only 
one replicate) and so we assume that the measurement error is a percentage of the data 
value (for both absolute values and fold induction values). 
APE fitting 
We calculate absolute expression levels for the data in Figure 7.10 by comparing the 
levels of CEC1 and DEF1 with those of a housekeeping gene, S7. The absolute gene 
expression levels are shown in Figure 7.10E and F. We apply the APE fitting method to 
this data and obtain the results in Figure 7.11, Figure 7.12, Table 7.7 and Table 7.8. 
A 	CEC1: WT 
1.5  
7 ..t . 	 ----- 
6+,  0.5 	 p 	 
<e
e0 	/ 	•,.,..... ......... 
01 4 8 12 	24 
Time (hrs) 
WT 
24 
= 
Time (hrs) 
D CEC1: REL1 '2 KD 
1.5 
1 
1-1-, 0.5 
001 4 8 12 	24 
Time (his) 
• DEF1: REL1.2 KD 
3 
2 
01 4 8 12 	24 
Time (hrs) 
Ab
s  E
xp
r  L
ev
el
 
Target 
	 Estimate 
Chapter 7: Applying the Transcription Factor Model to Experimental Data 	- 238 - 
B 
1.5 
To 
...- 7  
", 	0.5 	 
?) 
•-t-t 
F 
z 
z 
,.= z 
Lo 	1 	 
2 a 
0 
1 
0 
CEC1: RELI KD 
. 	. 
0.5 
a 
1.5 	 
0 
CEC1: REL2 KO 
3 	 
01 4 	8 12 
Time (hrs) 
DEF1: REL1 KD 
, 	. 
24 
G 
T., 
.. >,- 
0, 	1 	 N -c a 
0 
3 	 
2 	 
01 4 	8 12 	24 
Time (hrs) 
DEF1: REL2 KD 
01 	4 8 	12 
Time (hrs) 
24 01 	4 8 	12 	24 
Time (hrs) 
Figure 7.11 Results of fitting to the third pass of PCR data using the APE fitting 
method. 
Target values are depicted with solidlines, estimated values are depicted with dashed 
lines (legend is in panel H). Fits to CEC1 data are in panels A-D and fits to DEF1 data 
are in panels E-H. Black graphs (left column) show fits to wild-type cells, yellow graphs 
(middle-left column) show fits to RELI knock-down cells, red graphs (middle-right 
column) show fits to REL2 knock-down cells and blue graphs (right column) show fits to 
double RELI and REL2 knock-down cells. 
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Figure 7.12 Estimates for the activity profiles of REL1 and REL2 using the APE 
fitting method on the third pass of PCR data. 
Error bars show 95% confidence intervals on the 'Unction estimates. 
Blue line shows the estimated activity profile of REL1, green line shows the estimated 
activity profile of REL2. 
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CEC1 DEFT 
B (baseline transcription) 71.833 892.86 
S (REL1 sensitivity) 10 321.9 
T (REL2 sensitivity) 10 127.25 
V (cooperative sensitivity) -0.05515 -1.8929 
D (decay rate of gene) 4760.5 23217 
Table 7.7 Gene specific parameters estimated by using the APE fitting method to 
fit to the third pass of PCR data. 
KRELI (knock-down factor of REL1) 
	
0.61 
KREL2 (knock-down factor of REL2) 
	
0 
Table 7.8 Knock-down factors estimated by using the APE fitting method to fit to 
the third pass of PCR data. 
FAB fitting 
We also fit to the fold induction and baseline data values (Figure 7.10A-C) using the 
FAB fitting method. The results of FAB fitting are shown in Figure 7.13, Figure 7.15, 
Table 7.9 and Table 7.10. 
7.5.5 Common aspects of the two fitting methods applied to specifically 
generated data 
As in section 7.4.2 we now consider features that are common between the two fitting 
methods. 
Levels of REL1 transcription factor increase over the 24 hour period 
Both APE and FAB fitting methods predict that REL1 increases (with some small 
oscillations) over the first 24 hours following stimulation with peptidoglycan (blue 
curve in Figure 7.12 and Figure 7.15). This finding is consistent with the result of APE 
fitting to the data from (Frolet et al., 2006) (Figure 7.4) although it is not consistent with 
FAB fitting to the same data after 7 hours (Figure 7.7). 
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Figure 7.13 Results of fitting to the third pass of PCR data using the FAB fitting 
method. 
Target values are depicted with solidlines, estimated values are depicted with dashed 
lines (legend is in panel H). Fits to CECI data are in panels A-D and fits to DEF1 data 
are in panels E-H. Black graphs (left column) show fits to wild-type cells, yellow graphs 
(middle-left column) show fits to RELI knock-down cells, red graphs (middle-right 
column) show fits to REL2 knock-down cells and blue graphs (right column) show fits to 
double REL1 and REL2 knock-down cells. 
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Figure 7.14 Baseline fitted values to the third pass of PCR data using the FAB 
fitting method. 
Solid bars represent target values, dashed bars represent estimated values from FAB 
fitting. 
A) CEC I baseline relative expression levels 
B) DEFT baseline relative expression levels 
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CEC1 DEF1 
B (baseline transcription) 26.294 0 
S (REL1 sensitivity) 10 3527.9 
T (REL2 sensitivity) 10 625.39 
V (cooperative sensitivity) -0.09274 -32.234 
D (decay rate of gene) 1038.7 39218 
Table 7.9 Gene specific parameters estimated by using the FAB fitting method to 
fit to the third pass of PCR data. 
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Figure 7.15 Estimates for the activity profiles of REL1 and REL2 using the FAB 
fitting method on the third pass of PCR data. 
Error bars show 95% confidence intervals on the function estimates 
Blue line shows the estimated activity profile of RELI, green line shows the estimated 
activity profile of REL2. 
KREL1 (knock-down factor of REL1) 
	
0.54 
KREL2 (knock-down factor of REL2) 
	
0.15 
Table 7.10 Knock-down factors estimated by using the FAB fitting method to fit to 
the third pass of PCR data. 
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Levels of REL2 transcription factor oscillate 
In contrast to the relatively steady increase in REL1 levels, REL2 appears to oscillate 
over the 24 hour period, peaking once at 4 hours, and again at 24 hours. This oscillation 
is a common feature of both fitting methods. It is possible to reconcile the estimated 
activity profiles of REL2 shown in Figure 7.12 and Figure 7.15 with those estimated by 
fitting to the data from Frolet et. al. (2006) (shown in Figure 7.4 and Figure 7.7). The 
data from Frolet et. al. (2006), reproduced in Figure 7.1, contains no measurements 
between 0 hours and 7 hours. Therefore fits to it contain no estimates for REL2 between 
these time points. It is entirely possible that the peak at 4 hours was missed in the REL2 
activity profile estimates of Figure 7.4 and Figure 7.7. 
Although the estimates for REL2 activity are in response to different stimuli 
(Plasmodium parasites and adult mosquitoes were used in generating the data by Frolet 
et. al. (2006), whereas peptidoglycan and cultured cells were used for the specifically 
generated data) we might expect to see some reconcilable results. In fact both datasets 
combine to estimate an oscillating function that increases to a peak at 4 hours and 
decreases at around 7 or 8 hours. The function then peaks a second time at the 24 hour 
mark before dropping back down at 48 hours post challenge. 
REL2 is more effectively knocked down than REL1 
Both the APE and FAB fitting methods yield estimates of more than 0.5 for the knock-
down factor associated with REL1. This indicates that the REL1 transcription factor 
knock-down is less than 50% effective. In contrast the REL2 knock-down factor is 
estimated at 0.05 and 0.15 by the two methods and these values suggest that it is 
effectively knocked down. The results for both knockdowns are consistent with the 
knock-down information presented in Figure 7.10D. This figure shows a significant 
decrease in the REL2 gene following REL2 knock-down (third green bar of Figure 
7.10D) whereas the knock-down for REL1 is less effective at decreasing the amount of 
REL1 gene present (second blue bar of Figure 7.10D). 
It is worth noting that the knock-down factors estimated for REL1 by both fitting 
methods are greater than the critical value of 0.4, determined in chapter 6 to be the limit 
for effective analysis of data. It is possible that the poor quality of the REL1 knock-
down could impair the results obtained from this analysis. 
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CECI and DEF1 are primarily generated by REL1 and / or REL2 
As in section 7.4.3 we can determine the percentage of baseline CECI and DEF1 
transcript that is attributable to a factor other than either REL1 or REL2. We consider 
the B/D ratio and compare it to the level of the gene at time t = 0. CECI has B/D ratios 
estimated by the two fitting methods at 0.015 and 0.025. Comparing these values to the 
baseline expression level of CECI (0.096) indicates that between 16% and 26% of 
CEC1 transcript is not attributable to REL1 or REL2. The B/D ratios generated by the 
two fitting methods for DEF I are 0.038 and 0. Comparing these to the baseline level of 
DEF1 (0.357) reveals that less than 11% of DEFI transcript is generated by factors 
other than REL1 and REL2. Therefore we can conclude that the majority of both CECI 
and DEF1 production is due to REL1 and REL2, but that a significant proportion of 
CECI may be generated by factors other than REL1 and REL2. 
7.6 Discussion 
Here we apply the model of equation 6.3 in chapter 6 to two sets of experimental data, 
both of which assess the mosquito response to immune challenge. A number of 
interesting observations concerning transcription factors and target genes are uncovered 
despite the fact that neither dataset is ideally suited for our purposes. 
We verify our modelling results by applying two different fitting methods to each 
dataset and only considering features common to both fitting methods. Clearly further 
verification of these results is required and we plan to continue collaboration with 
experimentalists to generate data appropriate for this verification. We plan to generate 
micro-array data, similar to that proposed in chapter 6 to which we can apply our model. 
This would also allow us to further verify the model results presented here and in 
chapter 6. 
Following challenge by either peptidoglycan or plasmodium parasites the level of active 
REL2 transcription factor appears to oscillate while the level of active REL1 displays 
more stable behaviour. Both oscillatory and non-oscillatory behaviour has been reported 
for NF-KB transcription factors in mammals (Hoffmann et al., 2002, Covert et al., 2005, 
Nelson et al., 2004) and it is possible to relate the results obtained here with previous 
findings. 
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Experimental evidence has shown that stimulating mammalian cells with LPS (and 
primarily activating the TLR pathway) results in stable behaviour of the NF-KB 
transcription factor (Covert et al., 2005) whereas stimulating cells with TNFa , and so 
activating the TNF-R pathway, leads to oscillatory NF-KB dynamics (Hoffmann et al., 
2002, Covert et al., 2005, Nelson et al., 2004). This is very similar to the behaviour 
predicted by the modelling presented in this chapter. REL1, which belongs to a pathway 
homologous to the mammalian TLR pathway, shows stable behaviour, while REL2, 
which belongs to a pathway that is considered to be analogous to the TNF-R pathway, 
shows oscillatory behaviour. 
The difference between the NF-KB dynamics observed following stimulation with LPS 
and TNFa is discussed in (Covert et al., 2005). They suggest that LPS-stimulation of 
the TLR pathway may indirectly lead to activation of the TNF-R pathway by causing 
production of TNFa after an initial delay period. They hypothesise that the activation of 
both pathways may stabilise any NF--KB oscillations in the system. This stabilisation 
requires that the downstream NF-KB products of the TLR and TNF-R pathways are 
identical. As this is not the case for the Toll and IMD pathways in the mosquito (REL1 
is downstream of the Toll pathway, while REL2 is downstream of the IMD pathway) it 
is unlikely that such feedback is the cause of the stable REL1 behaviour in our case. 
A possible explanation for the difference in the profiles of REL1 and REL2 can be 
inferred from another paper which models NF-KB in mammalian cells (Hoffmann et al., 
2002). Hoffman et. al. show that altered NF-KB profiles occur in cells deficient for one 
or more IKB isoforms. (A Drosophila homolog of /KB is Cactus and a mosquito 
homolog is CACT.) By combining biological experiments with mathematical modelling 
they show that mammalian cells containing only IKBa isoforms display oscillatory 
NF-KB dynamics in response to stimulation with TNFa, while cells deficient in IKBa 
and containing only IKBfi and / or /KBe isoforms have more stable NF-KB profiles. It is 
believed that IKBa rapidly causes NF-KB activation and has strong negative feedback, 
thereby causing oscillatory dynamics. IKBP and IKBe are believed to be slower in 
activating NF-KB and so act to dampen oscillations in the NF-KB profile. It is possible 
that the inhibitor of REL2 shows behaviour similar to IKBa and thus induces 
oscillations, while the inhibitor of REL1 is more similar to either IKBP or IKBC, and thus 
activation of the REL1 pathway results in a stable profile for REL1. It would be very 
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interesting to investigate these possibilities in future research and it may be instructive 
to establish whether REL1 does in fact appear later than REL2 due to slower activity of 
the REL1 inhibitor. 
We predict that levels of active REL2 are more effectively knocked down in both 
experimental conditions than those of REL1. This agrees with each of the measured 
levels of RNA knockdowns (Table S2 of Frolet et. al. (2006) and Figure 7.10D) which 
also show that REL2 RNA was more effectively silenced than REL1 RNA. Since it is 
difficult to measure levels of activated REL1 and REL2 transcription factor, 
experimental methods can only measure the efficacy of silencing the RELI and REL2 
RNA to provide an estimate of the knock-down effectiveness. The advantage presented 
by our model is the ability to quantitatively estimate the effect that this RNA silencing 
has on the levels of the active transcription factors. 
Our model also predicts the percentage of target gene levels attributable to factors other 
than REL1 or REL2. Significant quantities of CTL4 transcript cannot be attributed to 
either REL1 or REL2 transcription, indicating that it may not be a strong target of these 
transcription factors. In contrast, approximately three quarters (or more) of CEC1, 
DEF1 and TEPI transcripts are generated through REL1 and / or REL2 transcription. 
This agrees with the data presented in Figure 7.2B and Figure 7.10C showing that 
knocking out both RELI and REL2 does not have a significant effect on baseline gene 
expression levels of CTL4, but has a significant effect on baseline levels of TEP I , 
CEC1 and DEF1. 
The difficulties encountered here serve to highlight some important points concerning 
the application of mathematical models to experimental data. As discussed in section 
7.4.3, it is often very difficult to model retrospective data. There are a certain examples 
of datsets that have been generated with sufficient detail and quality to allow 
retrospective modelling (Cabusora et al., 2005), however when modelling requires 
perturbations of a system the chance of finding a suitable data set is significantly 
reduced. It is far more fruitful to develop both experimental data and mathematical 
models in conjunction with each other. This is what we have aimed to do during our 
experimental collaboration. 
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Secondly, modelling places far more stringent requirements on the data quality than 
standard analysis techniques, where it is often sufficient to uncover general trends in 
expression levels, and relate these back to the experimental conditions. Modelling 
requires that replicates are sufficiently similar to fit all replicates meaningfully, and that 
experimental conditions are sufficiently different to warrant an alteration in model 
parameters. These stringent requirements result in more severe checks on experimental 
data and these checks can help to prevent the use of inadequate data (as was seen in 
sections 7.5.1 and 7.5.2). 
Additionally, one of the major hindrances to modelling the data from Frolet et. al. 
(2006) effectively was that all data was presented in a normalised form. Although this is 
the form in which biologists are used to expressing their results and so is often 
considered to be more meaningful, it can obscure a significant amount of information 
that would be useful for modelling. Effective modelling often requires access to non-
normalised data. This indicates that biologists and modellers should collaborate to 
generate data that is useful to both groups but does not result in a loss of potentially 
valuable information. 
This chapter shows only a limited aspect of the capabilities of the model presented in 
chapter 6. By applying our model to experimental data we were able to draw a number 
of interesting and potentially useful conclusions. These conclusions serve both as 
interesting observations in their own right and also to highlight the significant potential 
of such a model in understanding the behaviour of interacting transcription factors and 
their targets. 
Chapter 8 
Conclusions and Future Work 
Nearly half the world's population is exposed to malaria, one of the WHO's "Big 3" 
diseases. To date the disease has evaded attempts at eradication and control, despite 
continued efforts to both protect the host and eradicate or manipulate the vector. In 
parallel with efforts in the wider malaria community to combat malaria from the 
perspective of both the host and vector, in this thesis we present a dual pronged 
approach which uses dynamical modelling to better understand the effect of malaria on 
its host and vector. 
The models presented here enable us to form a number of conclusions about the host 
and vector response to malaria. Although the responses are vastly different, the malaria 
parasite elicits a reaction in both members of its lifecycle chain. Within the host the 
response is often fatal and is typified by fever and either cerebral malaria or severe 
malarial anaemia (SMA). In the first part of the thesis we model the host response of 
SMA and shed some light on the dynamics involved in controlling the severity of the 
disease. In the vector the response to the parasite involves the killing of early parasite 
forms and of increased expression of certain immune related genes. In the second 
section of the thesis we model the activation of transcription factors in response to 
mosquito immune challenge. This assists us in gaining a better understanding of the 
dynamics of the mosquito response to the parasite. 
The malaria parasite infects a wide range of hosts, including primates, rodents, birds 
and marsupials as well as humans. In this thesis we model its effects on two hosts -
mice and humans. Mice are one of the most common models of malaria, since specific 
aspects of the disease can be considered by combining specific strains of mice and 
parasite. We consider a P. berghei infection of BALB/C mice, which is a model for 
SMA. By setting up an age structured model of red blood cell (RBC)dynamics during 
an infection we quantify the preference of the P. berghei parasite for reticulocytes 
(young RBCs) at around 150 fold over its preference for older cells. Although a 
preference for young cells has been commented on in the literature, to the best of our 
knowledge the extent of the preference has not been previously quantified. We also 
assess the mice's reticulocyte response to anaemia during acute infection and conclude 
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that, in contrast to the reduction in reticulocyte levels that is observed during the first 
week of infection, during the latter stage of infection their response is not suppressed 
and is appropriate for the degree of anaemia. 
By modifying our model slightly to make it self contained and to incorporate parameters 
appropriate to humans, we are able to consider the RBC dynamics during infection of a 
human host. This enables us to put forward the hypothesis that a lowered rate of red cell 
replacement (as is seen in malaria infections (Abdalla, 1990, Kurtzhals et al., 1997)) is 
not an unfortunate consequence of inflammation, but is in fact a host protective effect 
that limits parasite growth and long term anaemia. In contrast, excessive replacement of 
red cells, in the presence of a parasite preference for young cells, can lead to more 
severe infection and anaemia. It transpires that there is an optimal replacement rate of 
RBCs which minimises the negative effects of a malaria infection, whilst still protecting 
from long term anaemia. This optimal replacement rate is often far lower than the 
"normal" replacement rate that is seen in healthy subjects. We also use a simplified 
model to show that the emergence of an optimal reticulocyte replacement rate is due to 
a shift in the largest eigenvalue of the model solution from being a complex conjugate 
pair to being real valued. 
Uncovering such an optimal rate suggests that what appears to be erythropoietic 
suppression in malaria subjects may in fact be the replacement of red cells at this 
optimal rate. Increasing production of red cells to combat anaemia would provide more 
of the parasite's preferred target and so "fuel the fire" of infection. In contrast, by 
reducing its erythropoietic response the host avoids this and has the potential to starve 
the parasite of its growth environment. Thus, it is likely that that limiting the supply of 
young red cells is at least in part a host protective effect which is a form of "innate 
immunity". 
The idea that excessive red cell replacement worsens a malaria infection, and that some 
suppression of the erythropoietic response can be protective, is strongly supported by 
the results of experimental studies - both of young children and of iron status. Younger 
children suffer from more acute malaria infections than do older children. This is 
commonly attributed to the fact that they have not yet acquired sufficient immunity; 
however, it could also be due to their stronger erythropoietic response to anaemia 
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(O'Donnell et al., 2007). Using the erythropoietic response to explain malarial immunity 
not only explains why malaria is more severe in children under five, but also helps to 
explain the shift in disease profile away from SMA as children get older (Greenwood, 
1997). 
In malarious regions iron levels appear to be strongly correlated with malaria disease 
severity. (In non-malaria endemic regions iron supplementation does not appear to be 
strongly associated with measures of health (Tielsch et al., 2006)). Iron deficiency and 
mild anaemia protect from malaria (Nyakeriga et al., 2004, Koka et al., 2007, Michon et 
al., 2007), while iron supplementation increases the incidence of malaria and malaria 
related adverse events (Sazawal et al., 2006, Smith et al., 1989, Oppenheimer et al., 
1986a, Oppenheimer et al., 1986b). The exact reasons for the correlation between iron 
status and malaria incidence have not been established, but we believe that a key factor 
could be the effect that iron levels have on erythropoiesis. It is therefore important to 
take the dynamics of red cell production into account when considering the health of 
individuals in malaria endemic regions. 
Chapters 6 and 7 represent a shift in the focus of our modelling from the host to the 
vector. We set up a model of transcription factor activation and gene transcription that is 
motivated by the response of the vector to the malaria parasite, and apply this to data 
from mosquitoes and mosquito cell lines. The model is a general model of cooperative 
gene transcription that can be applied to any system in which there are two transcription 
factors cooperatively regulating a number of genes. By fitting the model to simulated 
data we show that it can be effective in eliciting a number of useful observations from 
micro-array data. First we are able to estimate the efficacy of the knock-downs of active 
transcription factors, having used RNAi to knock-down sections of RNA that are 
associated with the transcription factors of interest. Second, the model provides a 
reasonably accurate estimate of the temporal profiles of the two transcription factors 
under study. Third, and most important in meeting the objectives of the chapter, we 
show that the model effectively distinguishes between genes that are more significantly 
regulated by one transcription factor or the other, as well as those that are cooperatively 
regulated by the two transcription factors. We hope that this will prove particularly 
useful in determining mosquito genes that are exclusively downstream of either RELI 
or REL2, and so facilitate understanding of the mosquito immune system. In turn this 
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understanding should help in the effort to control the malaria parasite within the 
mosquito vector. 
We apply the model to RT-PCR data from mosquitoes and mosquito cell lines. 
Although this data is not ideally suited to the model developed in chapter 6 (as we had 
anticipated applying it to time course micro-array data) we are still able to make a 
number of interesting observations. As predicted by our earlier analysis, we calculate 
the efficacy of the active transcription factor knock-downs, and find that REL2 is more 
effectively knocked down than REL1. We also determine the percentage of the 
transcripts of each of the six genes considered that can be attributed to factors other than 
REL I and REL2. Finally, we use our model to form the hypothesis that the temporal 
profile of REL2 oscillates in response to challenge, while the profile of REL1 does not. 
We are able to relate this hypothesis to NF-KB modelling studies in human cell lines, 
which provide support for both oscillating and non-oscillating transcription factor 
profiles. 
This thesis addresses the dynamics of both the host and vector responses to malaria 
through the use of mathematical modelling. Understanding the impact of the parasite on 
both members of its lifecycle is essential in the quest to eradicate the disease. Through 
the development and analysis of mathematical models we have been able to investigate 
responses to the malaria parasite from the perspective of both host and vector, and reach 
a number of conclusions which increase understanding of the disease. 
8.1 Future Work 
A significant number of the conclusions of this thesis have been made by applying 
models of malaria retrospectively to existing data, or by analysing models that have not 
been directly fit to experimental data. This is always an important first step when 
creating mathematical models of infection and immune activation and has allowed us to 
reach a number of interesting and potentially important conclusions. In the future 
however, it would be beneficial to test these conclusions by applying the models to 
specially generated data. 
We are able to conclude that the reticulocyte response during a P. berghei infection is 
appropriate for the degree of anaemia. We also conclude that a lower replacement rate 
Chapter 8: Conclusions and Future Work 	 - 251 - 
of red blood cells in response to malaria related anaemia in humans could be a host 
protective effect. This leads us to the question of whether the severity and lethality of a 
P. berghei infection in mice could be precisely because they have an appropriate or 
"normal" response to anaemia. This has been partially confirmed, as it has been shown 
that x-irradiated mice (who have lowered red cell replacement capabilities) have lower 
parasite levels than normal mice (Singer, 1953) while rats bled before infection (and so 
having increased reticulocyte production levels) have increased parasitaemias 
(Zuckerman, 1957). Neither study, however, related their observations to a "normal" 
response to anaemia in a healthy mouse or rat. It would also be interesting to consider 
the response to anaemia of mice infected with other strains of mouse malaria (such as P. 
chabaudi or P. yoelii), and determine whether we can correlate disease severity across 
the different strains with the degree of their response to anaemia. In addition, we could 
use the model developed in chapter 3 to estimate the preference of the malaria parasite 
for reticulocytes in other strains of malaria and correlate these with disease severity. 
In chapter 4 we predict that a lowered reticulocyte response to anaemia can protect 
against severe infection, and therefore explain why mechanisms leading to this (such as 
iron deficiency or mild anaemia) may be associated with less severe malaria infections. 
Although the conclusions from this model agree qualitatively with a host of evidence 
from the literature, it would be particularly interesting to fit this model to data from 
human malaria infections. This would allow us to determine more conclusively if there 
is a correlation between reticulocyte response to malaria and survival. There are a 
number of malaria studies (Michon et al., 2007, Snow et al., 1997) where cohorts of 
people routinely have blood samples taken and have their blood screened for malaria 
parasites. Obtaining data on haemoglobin levels, parasite counts and reticulocyte counts 
as well as clinical symptoms from these studies would allow us to fit the model to real 
data and verify some of the conclusions we have reached. This is an essential next step 
in the application of our research. 
A recognised limitation of the model presented in chapter 4 is its inclusion of only a 
basic immune response to the malaria parasite. Although we have discussed the reason 
for this within the chapter (namely that the form of the immune response to malaria is 
unknown) it may nevertheless be instructive to attempt to introduce an immune 
response into the model. In order to do this we would almost certainly require some data 
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against which to fit the modified model (discussed above). We could then try a number 
of different immune functions and attempt to determine which one best fits with the 
data. 
In chapter 6 we develop a model to analyse cooperative gene transcription. We had 
intended to apply the majority of the analysis performed in chapter 6 on simulated data 
to micro-array data from mosquito cells, that had been knocked down for REL1 and 
REL2. Due to experimental difficulties this micro-array data was not generated in time 
for inclusion in this thesis, and so is an area of ongoing research. Our collaborators still 
intend to generate such micro-array data, and we plan to apply the analysis developed in 
chapter 6 to the data, with the hope of determining genes that are downstream of one of 
REL I or REL2. 
By applying the model to experimental RT-PCR data we made a number of 
observations regarding the genes downstream of REL1 and REL2, and the activity 
profiles of these transcription factors. The most interesting observation was that the 
activity profile of REL2 appears to oscillate, while that of REL1 is more stable. These 
observations are clearly very preliminary and must be verified by further experiments 
and modelling. This is therefore an area for continued research. 
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